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3BAbstract 
 
ClC-K chloride channels, members of the ClC membrane protein family, are needed for the 
function of the kidney and the inner ear. They are organized as dimers while each monomer 
builds a discrete pore, called protopore. They can be gated individually by a fast protopore 
gate, or in common by a slow gate. Both gates are under the control of the β-subunit barttin. 
Besides gating modulation, barttin facilitates membrane trafficking of all ClC-K chloride 
channel orthologs. 
The human chloride channel hClC-Ka is only active in presence of barttin, the rodent ortholog 
rClC-K1 is already conducting without, but barttin changes its voltage dependence. The effect 
of barttin on gating, and thus its binding, becomes more obvious when a pore-lining valine of 
rClC-K1 channels is mutated to the so called ´gating glutamate´ V166E.  
Little is known about functional determinants within the structure of barttin. It consists of 320 
amino acids which form two transmembrane helices near the N-terminus (aa9-26 and 
aa35-55) that are crucial for binding to ClC-K channels as shown by barttin truncation Y57X. 
Chaperone function of this barttin is still conserved.  
To figure out binding amino acids, we performed site-directed mutagenesis, substituting every 
single amino acid of the two proposed helices to tryptophan in order to prevent binding due to 
the introduction of a bulky amino acid. The binding of mutant barttin to hClC-Ka or V166E 
rClC-K1 was analyzed by confocal microscopy, biotinylation assays and whole cell patch 
clamp recordings in heterologous expression systems. Surprisingly, binding could not be 
prevented by a single point mutation. 
Several mutations (I12W, G15W, A20W, G48W, S52W and Q55W barttin) lead to a 
reduction in chaperone function and are therefore likely to be part of the binding interface. 
These residues also modulate the gating behavior of the channels, also indicating their 
interaction. While almost the entire first helix is thoroughly needed for the activity of the fast 
gate, several residues within the second transmembrane helix of barttin alter mainly the slow 
gating of V166E rClC-K1. T36W and M44W barttin lost all their capability to modulate 
gating, but still bind to both observed channels. Different structure of the channel is assumed 
at the positions which bind to the residues G10, V13, L14, A39 and M40. In contrast to other 
positions, mutation of one of the mentioned five evokes effects on regulation of hClC-Ka that 
cannot be compared with the effects on V166E rClC-K1. 
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Besides the interface, the binding stoichiometry should be determined. Therefore, we 
covalently linked barttin to V166E rClC-K1. Our results suggest a stoichiometry 
barttin:ClC-K of at least 2:1. 
Within the channel structure, two binding domains were published. Here, we validate the 
binding of barttin to the B-helix of the channel by a chimeric channel protein. Furthermore, 
we postulate that this binding to the B-helix occurs via the first transmembrane helix of 
barttin. 
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4BZusammenfassung 
 
ClC-K Chlorid Kanäle sind Mitglieder der ClC Membranproteinfamilie und werden für die 
Funktion der Niere und des Innenohrs benötigt. Sie sind als Dimer organisiert, wobei jedes 
Monomer eine eigenständige Pore bildet, die Protopore genannt wird. Diese können 
individuell durch das schnelle Protoporengate, oder gemeinsam durch das langsame Gate 
reguliert werden. Beide sind unter der Kontrolle der β-Untereinheit Barttin. Neben der 
Veränderung der Spannungsabhängigkeit ermöglicht Barttin den verstärkten Membraneinbau 
der Kanalproteine. 
Im Gegensatz zum humanen hClC-Ka Chlorid Kanal ist das Rattenortholog rClC-K1 auch 
ohne Barttin leitend. Allerdings verändert Barttin dessen Spannungsabhängigkeit. Der Effekt 
des Barttins auf das Schaltverhalten von rClC-K1 – und damit deren Interaktion - wird nach 
Mutation eines porenständigen Valins zum sogenannten ´Gatingglutamat´ V166E deutlicher. 
Über die Funktionsweise des Barttins ist bisher wenig bekannt. Es besteht aus 320 
Aminosäuren, die in der Nähe des N-Terminus zwei transmembrane Helices bilden 
(Aminosäuren 9-26 und 35-55). Dieser transmembrane Kern ist für die Bindung an ClC-K 
Kanälen notwendig, wie am Beispiel eines stark verkürzten Barttins deutlich wird. Y57X 
Barttin zeigt noch immer einen verstärkten Membraneinbau des Kanals.  
Wir führen einen Mutagenese Scan durch, bei der jede einzelne Aminosäure der beiden 
Helices des Barttins gegen Tryptophan ausgetauscht wurde. Falls die Mutation innerhalb der 
Interaktionsdomäne liegt, sollte theoretisch die Bindung verhindert werden. Die Bindung des 
mutierten Barttins mit hClC-Ka oder V166E rClC-K1 wurde mittels konfokaler Mikroskopie, 
Biotinylierungsassays und elektrophysiologischen Ganzzellableitungen in heterologen 
Expressionssystemen untersucht. Überraschenderweise wurde die Bindung durch keine 
Mutation verhindert. 
Mehrere Mutationen (I12W, G15W, A20W, G48W, S52W und Q55W Barttin) führen zu 
einem verminderten Membraneinbau des Kanals und sind daher Teil der Interaktionsdomäne. 
Diese Aminosäuren beeinflussen auch das Schaltverhalten, ein weiteres Indiz der Interaktion. 
Die Regulierung des Schaltverhaltens scheint komplexer zu sein, da viele Aminosäuren an der 
Bindung beteiligt sind. Während annähernd die gesamte erste Helix des Barttins die Aktivität 
des schnellen Gates von V166E rClC-K1 reguliert, konnte der Einfluss einiger Aminosäuren 
der zweiten Helix auf das langsame Gate gezeigt werden. Durch die Mutationen T36W und 
M44W hat Barttin seine Funktion auf das Schaltverhalten, aber nicht auf den Membraneinbau 
beider untersuchter Kanäle verloren. Unterschiedliche Strukturen der Känale werden an 
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Positionen vermutet, an denen Barttin via G10, V13, L14, A39 oder M40 bindet. Im 
Unterschied zu anderen Positionen, führt hier eine Mutation zu Effekten auf die Regulierung 
von hClC-Ka, die nicht vergleichbar sind mit den Effekten auf V166E rClC-K1. 
Neben der Bestimmung der Interaktionsdomäne sollte die Bindungsstöchiometrie ermittelt 
werden. Dazu wurde Barttin kovalent an den V166E rClC-K1 verlinkt. Unsere Ergebnisse 
deuten auf eine Stöchiometrie Barttin:V166E rClC-K1 von 2:1 oder höher hin. 
Bisher wurden zwei Bindungsdomänen für Barttin in der Kanalstruktur nachgewiesen. In 
dieser Studie belegen wir die Bindung des Barttins an die B-Helix des Kanals mittels eines 
chimeren Kanals. Weiterhin postulieren wir, dass diese Bindung an die B-Helix über die erste 
Transmembranhelix des Barttins stattfindet. 
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1 5BIntroduction 
 
Barttin is an accessory subunit of ClC-K chloride channels (Estévez et al. 2001). The protein 
with unknown high-resolution structure consists of 320 amino acids. Secondary structure 
prediction (HHpred – University of Tübingen) reveals two transmembrane helices (TM) near 
the N-terminus (TM1 aa9-26 and TM2 aa35-55) and a long C-terminus.  The transmembrane 
core of barttin is needed for channel transport, post-translational modification and gating 
regulation of ClC-K chloride channels (Scholl et al. 2006, Fischer et al. 2010). A sorting motif 
for basolateral plasma membrane insertion of ClC-Ka lies within the long C-terminal tail of 
barttin (Janssen et al. 2009). 
Up to date, it is unknown how barttin regulates the α-subunit of ClC channels. Moreover, the 
binding stoichiometry is not solved yet.  
 
 
ClC proteins are found in many kingdoms, such as bacteria (Fujita et al. 1994), fungi (Huang 
et al. 1994), plants (Hechenberger et al., 1996) and animals (Miller, 1982, Jentsch et al., 
1990). They mediate ion flux/transport over cell membranes. Unique features of ClC family 
members are their organization in homo-dimers (Middleton et al. 1996, Dutzler et al. 2002) 
and their gating properties. Each monomer exhibits a pore, the so called protopore, which can 
be individually gated (Middleton et al. 1996, Ludewig et al. 1996). Additionally, there is a 
common gate, which opens or closes both protopores simultaneously (Fischer et al. 2010, 
Miller 1982, Saviane et al. 1999; Zuniga et al. 2004, de Santiago et al. 2005, Scholl et al. 
2006). Due to time courses and dwell-times of the gating events, the protopore gate is called 
fast gate, the common gate is called slow gate. Barttin influences the fast as well as the slow 
gate of ClC-K channels (Fischer et al. 2010). 
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1.1 0B14BClC chloride channel/transporter family 
 
 
The family of ClC proteins consists of channels and 
transporters. In mammalians, nine members are known, ClC-1 
to ClC-7, ClC-Ka/ClC-K1 and ClC-Kb/ClC-K2. In the 
dendrogram of Fig.1, the relationship of these nine types of 
protein is depicted together with the prokaryotic EcClC from 
Escherichia coli and the eukaryotic CmClC from a red alga 
Cyanidioschyzon merolae, which both had been crystallized. In 
the upper branch, ClC-Ka to ClC-2, ClC channels are clustered 
together with ClC-0, the chloride channel of the electric organ 
from Torpedo marmorata. These family members are all 
located at plasma membranes. ClC-0 was the first ClC chloride 
channel protein that was cloned (Jentsch et al. 1990, 
Steinmeyer et al. 1991).  
The lower branch includes the H+/Cl--transporters ClC-3 to 
ClC-7 which are all located in membranes of intracellular compartments. EcClC and CmClC 
both act as transporter, although from their sequences of amino acids, they are closer related 
to the channels. Channels and transporters share the homodimeric organisation. The formation 
of protopores is unique within the known channels. Channels and transporters within the same 
family of membrane proteins is another rare feature and serves as an example for the close 
functional relationship of these two transport mechanisms. 
 
 
 
 
 
 
 
 
 
Fig.1 Dendrogram of the ClC 
protein family 
Channels (ClC-Ka to ClC-2) and 
transporters (ClC-3 to ClC-7) are 
closely related. Bacterial EcClC 
represents prokaryotic ClC 
transporters. EcClC and CmClC, a 
chloride transporter from a red algae, 
are closer related to the channel 
branch than to the transporters. ClC-0 
is the closest relative to ClC-1.
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Fig.3 Topology model of ClC proteins 
16 transmembrane helices, two more helical stretches and two CBS 
domains form the tertiary structure of a monomer.  
Fig.2 Crystal structure of homodimeric CmClC 
Highlighted are the monomers (silver and black) with the B-
(blue) and J-(orange) helices. The black lines indicate the plasma 
membrane. Beyond the plasma membrane, two CBS domains per 
monomer are shown. Modified from Feng et al. 2010. 
1.1.1 14B28BStructure of ClC proteins 
 
Dutzler et al. crystallized EcClC in 2002 at 
2.5 Å resolution. Further X-ray structure 
analyses followed. But there is no structure 
available from mammalian ClC proteins at 
present. In 2010, the eukaryotic CmClC 
protein was crystallized at 3.5 Å resolution 
(Fig.2, Feng et al. 2010). Like formerly 
crystallized ClC proteins, CmClC is a 
transporter. Nevertheless, because of the high 
homology of the ClC proteins, these crystals 
give insights into the ClC channel function-
structure relationship as well. The two 
monomers are shown in silver and black. It is a side view with denoted plasma membrane 
segments. The highlighted B- (blue) and the J-helices (orange) are proposed to bind the 
β-subunit barttin in ClC-K2 (Tajima et al. 2007).  Fig.3 shows a topology model of the 
α-subunit. 
 
 
A pore-forming monomer, a so called protopore, consists of 16 transmembrane helices, two 
adjacent helices (A+R helix) and two cytoplasmatic CBS domains. CBS domains were first 
identified in name-giving cystathionine β-synthetase (Bateman 1997, Ignoul and Eggermont 
2005). Further studies have proven CBS domains to regulate catalytic activity of enzymes by 
binding to nucleotides (Scott et al. 2004, Townley and Shapiro 2007). Adenosine nucleotides 
were shown to regulate some ClC channels and transporters via CBS domains (Stölting et al. 
2013, Vanoye and George 2002, Hebeisen et al. 2004, Hebeisen and Fahlke 2005, Bennetts et 
al. 2005, Meyer et al. 2007). EcClC lacks this cytoplasmatic domain (Dutzler et al. 2002). 
CBS domains of several ClC proteins have been crystallized (ClC-Ka Markovic and Dutzler 
2007, ClC-5 Meyer et al. 2007, ClC-0 Meyer and Dutzler 2006, CmClC Feng et al. 2010) and 
stated to participate in channel gating and dimerization (Bykova et al. 2006, Pusch et al. 1997, 
-- Introduction -- 
 - 4 - 
Fig.4 (A) Scheme of the open and closed pore 
conformation of EcClC and (B) an alignment of the highly 
conserved chloride binding sites of ClC family members  
(A) modified from Dutzler et al. 2003. In closed conformation, 
the anion-binding sites Sint and Scen are occupied by chloride 
ions (red circles), while Sext is occupied by the side chain of 
E148 (red). Movement of the side chain of E148 opens the 
channel, Sext is now occupied by a third chloride ion. S107 is 
the internal binding site, the central binding site is coordinated 
by I356, F357 and Y445, and the external binding site is 
formed by F357. 
(B). The binding sites are highly conserved throughout the 
family. S107, F357 and Y445 are always present (grey bars). 
The gating glutamate E148 is substituted by valine/leucine in 
ClC-K channels (grey and black; upper right alignment). 
Besides the pore coordinating tyrosine, a regulatory lysine is 
highlighted in the lower right alignment 
 
EcClC   (102) PEAGGSGIPEI   (142) GMVLGREGPTVQ 
ClC-Ka  (116) PSSGGSGIPEL   (160) TLFLGKVGPFVH 
ClC-Kb  (116) PSSGGSGIPEV   (160) TLFLGKVGPFVH 
ClC-K1  (116) PFSGGSGLPEL   (160) TIFLGKVGPFVH 
ClC-K2  (116) PSSGGSGIPEV   (160) TIFLGKLGPFVH 
ClC-1   (184) PQAVGSGIPEM   (226) GIPVGKEGPFVH 
ClC-2   (157) PQAVGSGIPEM   (199) GMPLGKEGPFVH 
ClC-3   (234) PYACGSGIPEI   (276) GLSLGKEGPLVH 
ClC-4   (176) PYACGSGIPEI   (218) GLSLGKEGPLVH 
ClC-5   (163) PYACGSGIPEI   (205) GLSLGKEGPLVH 
ClC-6   (152) PVAAGSGIPEV   (194) GLFVGKEGPMIH 
ClC-7   (199) PVAAGSGIPQI   (241) GLAVGKEGPMIH 
CmClC    (75) TEAEGSGLPQM   (119) GLPVGWEGPNVH 
ClC-0   (118) PQAVGSGIPEL   (160) GFPLGKEGPFVH 
 
 
EcClC   (352) APGGIFAPML    (441) GKPLYSAILART 
ClC-Ka  (421) MPAGYFMPIF    (516) QPSFYDGTIIVK 
ClC-Kb  (421) MPAGYFMPIF    (516) QPSFYDGTVIVK 
ClC-K1  (421) MPAGYFMPIF    (516) QPSFYDGTIMAK 
ClC-K2  (421) IPAGYFLPIF    (516) QPSFYDGTIIVK 
ClC-1   (479) IPCGGFMPVF    (574) QPSLYDSIIQVK 
ClC-2   (454) VPCGAFMPVF    (549) QPSLYDSIIRIK 
ClC-3   (522) VPSGLFIPSM    (626) REGIYEAHIRLN 
ClC-4   (464) IPSGLFIPSM    (568) KEGIYEAHIHLN 
ClC-5   (450) IPSGLFIPSM    (554) REGIYDAHIRLN 
ClC-6   (484) VPSGLFVPSL    (572) NKGIYDIHVGLR 
ClC-7   (509) VSAGVFIPSL    (598) IEGLYDMHIQLQ 
CmClC   (340) LPAGVFVPSF    (426) NRSLYETLVLMK 
ClC-0   (413) VPCGAFVPVF    (508) QPSLYDSIIQIK 
Fong et al. 1998,  Estévez et al. 2004). By comparison of nucleotide-binding CBS domains of 
ClC-0 and ClC-5 with CBS domains of hClC-Ka, it became clear that the CBS domains of 
hClC-Ka do not bind nucleotides. 
The pore region of EcClC (Dutzler et al. 2002, 2003, 2004A+B, 2006, 2007, Cohen and 
Schulten 2004) and CmClC (Feng et al. 2010) is well described. Fig.4A depicts the pore 
coordinating amino acids of EcClC. The high homology of the pore region is shown in 
alignments in Fig.4B. Three chloride binding sites are formed by highly conserved amino 
acids. The external binding site for chloride, the peptidical bound amino group of F357 at the 
end of αN, is not always accessable, because of a glutamate side chain (E148) swinging in and 
out the pore in a voltage dependency and/or upon protonation. This glutamate E148 is 
proposed to be the fast gate (Fig.4A, Fahlke et al. 1997, Dutzler et al. 2003, Zuñiga et al. 
2004, de Santiago et al. 2005) and again highly conserved thoughout the familiy. 
 
 
A        B 
 
 
 
-- Introduction -- 
 - 5 - 
All ClC family members have a now-on called ´gating glutamate´ at the beginning of their 
F-helix, except ClC-K channels, which bear a valine/leucine at this position (Fig.4B upper 
right alignment). Substitution of V166 to glutamate in rClC-K1 leads to prominent changes in 
gating properties (Waldegger et al. 2000). These findings will be described later in detail, 
illustrating the functional purpose of barttin for gating regulation. Even though ClC-K WT 
channels lack this gating glutamate, they exhibit fast gating as well. Thus, the mechanism of 
gating is not fully understood, yet. 
The internal anion binding site is coordinated by a serine, localized at position S107 in EcClC. 
The central binding is coordinated by S107, Y445 and I356. S107 and Y445 are suggested to 
participate in gating, they are even called ´putative gate´ (Jayaram et al. 2008) or intracellular 
gate (Picollo et al. 2009 and 2012, Accardi and Picollo 2010). The suggestion of the 
paritcipation of Y445 in gating (Chen et al. 2003, Accardi and Pusch 2003) was confirmed by 
Elvington et al. (2009) who showed a Y445-movement. Despite of Y445 being in the 
Cl--pathway, Walden et al. (2007) showed that a decrease in side chain volume at this position 
disrupts H+-transport, although Accardi et al. (2006) as well as Elvington et al. (2009) stated 
that there is no direct involvement of this tyrosine in the H+-pathway.  
Residues of the selectivity filter, S107, F357 and Y445 are highly conserved throughout the 
ClC family, however the mechanism of binding, especially the simultaneous occupancy of the 
binding sites, is discussed controversely (Lobet and Dutzler 2006, Engh and Maduke 2005, 
Engh et al. 2007). 
Mutation of Y445 (Y512 in ClC-0) hardly influences single channel conductance of ClC-0 
(Chen et al. 2003, Accardi and Pusch 2003) although it is part of the selectivity filter in 
cooperation with S107. Same groups and others (Chen and Chen 2003, Wang et al. 2010) 
reported a lysine K519 in ClC-0, corresponding to T452 in EcClC, to be crucial for channel 
activation. This lysine is highly conserved within the adjacent R-helix of channels of the ClC-
family (Fig.4 B lower right alignment) and lies within the pore mouth of the channel. FRET-
analysis revealed that the C-terminal – the intracellular CBS domains next to the R-helix - of 
the channels moves during common, slow gating (Bykova et al. 2006).  
Not only the C-terminal, but a cystein residue at the end of the G-helix (C277 in ClC-1, C212 
in ClC-0) in the interface of the two protopores was shown to influence common gating 
(Weinberger et al. 2012, Bykova et al. 2006, Lin et al. 1999, Accardi and Pusch 2000, Zuñiga 
et al. 2004, de Santiago et al. 2005). For ClC-5, many mutations within this interface were 
found in Dent´s disease (Lourdel et al. 2012). 
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1.1.2 15B29BThe family members of ClC chloride channels and transporters 
 
1.1.2.1 36B50BhClC-Ka/rClC-K1 and hClC-Kb/rClC-K2 
 
This study was made with the renal and inner ear family members ClC-K. "K" is the 
abbreviation for kidney, where these channels were found first (Kieferle et al. 1994). hClC-Ka 
and hClC-Kb are the human, rClC-K1 and rClC-K2 are the rodent isoforms. Due to the high 
homology (83 % among rat isoforms, 91 % among human isoforms and 80 % among the two 
orthologs, Kieferle et al. 1994, Kobayashi et al. 2002, Fahlke and Fischer 2010, Krämer et al. 
2008), similar regulation is expected, but a remarkable difference between the channel 
orthologs is that hClC-Ka, hClC-Kb and rClC-K2 are non-conducting without barttin, while 
rClC-K1 is always conducting without barttin, but its voltage dependence of gating is altered 
upon barttin-binding. The mechanisms of binding and gating regulation of ClC-K channels 
are unknown at present. 
ClC-K channels form a complex of homodimeric organized α-subunits together with barttin as 
β-subunit. The stoichiometry α:β is unknown at present. Besides barttin, no further ClC-K 
binding partner has been reported, but calcium is needed for channel activity (Waldegger and 
Jentsch 2000, Martinez and Maduke 2008, Gradogna et al. 2010, 2012). The physiological 
role of ClC-K channels is described in the following passage as well as the function of barttin. 
 
 
 
1.1.2.1.1 60B74BRole of ClC-K channels in the kidney and the inner ear 
 
ClC-K channels are predominantly expressed in the ascending limb of Henle´s loop in the 
kidney and in marginal cells of the stria vascularis in the inner ear (Vandewalle et al. 1997, 
Rai et al. 1999, Maulet et al. 1999, Uchida 2000A+B, Uchida and Marumo 2000, Uchida et 
al. 1993, 1995, Estévez et al., 2001, Qu et al. 2006). The thin ascending limb is impermeable 
to water (Gross et al. 1975). Morgan et al. (1970), Imai and Kokko (1976) found a conductive 
pathway for anions on both the basolateral and apical membrane side, while Na+, but 
moreover divalent cations, seemed to diffuse paracellularly (Friedman and Gesek, 1993). 
Years later, it was found out that the transcellular anion conduction is mediated by a ClC 
chloride channel (Uchida et al. 1995) – in human hClC-Ka, respective the rodent homolog 
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Fig.5 Localization and physiological function of ClC-K channels in (A) the nephron and (B) the inner ear 
A) Expression sites of hClC-Ka/K1 (red, left panel) and hClC-Kb/K2 (blue, left panel) in the nephron. ClC-Ka/K1 channels mediate passive 
NaCl reabsorption in the thin ascending limb. ClC-Kb channels are necessary for secondary active reabsorption of NaCl in the outer medulla 
and cortical regions of the nephron (PT proximal tubule, tDL thin descending limb of Henle´s loop, tAL thin ascending limb of Henle´s loop, 
TAL thick ascending limb of Henle´s loop, DCT distal convoluted tubule, CNT connecting tubule, CCT cortical collecting tubule, CD 
collecting duct). B) Distribution of ClC-Ka/K1 and ClC-Kb/K2 in the inner ear. Both isoforms are expressed in the marginal cells of the stria 
vascularis, contributing to the secretion of K+ into the endolymph of the scala media. Modified from Fahlke and Fischer 2010. 
 
rClC-K1 (Kieferle et al. 1994). Fig.5 illustrates the expression sites of ClC-K channels. hClC-
Ka is expressed in the thin ascending limb of Henle´s loop at the apical and basolateral sides. 
 
 
The water impermeable, thick ascending limb and further distal regions shelter 
hClC-Kb/rClC-K2, but in contrast to hClC-Ka, only on the basolateral side (Kobayashi et al. 
2001A+B). To achieve salt-resorption, a secondary active transport mechanism requires more 
participants here. The coordinated function of a set of transmembrane proteins is needed. 
Apical, the inward rectifying potassium channel (ROMK1, renal outer medulla potassium 
channel, Kir1.1) and Na+-K+- U2CUl--cotransporter (NKCC2) with basolateral anion channels 
(hClC-Kb) and Na/K-ATPase work for secondarily active NaCl reabsorption (Greger et al. 
1983, Greger and Schlatter 1981, 1983, Schlatter et al. 1983). A basolateral calcium sensing 
receptor CaR regulates ROMK1 and NKCC2 (Brown and MacLeod 2001, Naderi and Reilly 
2008, Riccardi and Brown 2010) by several cascades. Phospholipase A2 activation via CaR 
results in arachidonic acid production (Handlogten et al. 2001, Kifor et al. 2001). Metabolic 
activation of arachidonic acid via cytochrome P-450 makes it an inhibitor of ROMK and 
probably NKCC2. With a novel statistical method to evaluate quantitative traits of multi-locus 
genotyped SNPs (single nucleotide polymorphism), interaction of the unlinked genes coding 
for CaR, ClC-Kb and NKCC2 was shown (Jung et al. 2009), but no functional investigation 
was performed. ClC-K channels themselves are Ca2+-dependent (Gradogna et al. 2010, 2012, 
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Waldegger and Jentsch 2000). Two residues in the loop between the I- and J-helices were 
shown to bind regulatory calcium-iones. Another regulation pathway for ClC-K channels is 
mediated by proinflammatory cytokines that have down-regulating effects on ROMK, Na/K-
ATPase and/or ClC-K (Schmidt et al. 2007). 
Both isoforms, ClC-Ka/K1 and ClC-Kb/K2, co-express in the stria vascularis of the inner ear 
(Estévez et al. 2001). In marginal cells they are contributing to K+-secretion into the scala 
media. K+ is needed for sensory transduction in inner hair cells. Hence a high potassium 
concentration in the endolymph is essential for hearing. Cooperation of NKCC1, KCNQ1 and 
ClC-K is needed for the maintenance of this high [K+] in the endolymph. 
 
 
 
1.1.2.1.2 61B75B artter Syndrome 
 
In 1962, Frederic Bartter first described a renal failure accompanied with hyperaldosteronism 
and hypokalemic alkalosis. Later, mutations in ClCNKB, the gene coding for one of the two 
human ClC-K chloride channel homologs, were figured out to be the reason for the disease, 
called classical bartter syndrome. Mutation within the BSND gene coding for barttin may lead 
to atypical type of bartter syndrome with sensorineural deafness, bartter syndrome type IV 
(Birkenhäger et al. 2001, Miyamura et al. 2003, Estévez et al. 2001, Waldegger et al. 2001). 
In respect to the efforts of Frederic Bartter, barttin was named after him. 
Bartter syndrome is a genetic disease with the characteristic symptoms of renal salt waste, 
elevation of renin and aldosteron plasma level with normal or low blood pressure, 
hypokalemic metabolic alkalosis, polyuria and polydipsia.   
Up to now, 5 types of Bartter syndrome can be distinguished by the mutated gene (Tab.1).  
 
Bartter Syndrome Dysfunctional Protein/Gene affected tissue 
Type I NKCC2/SLC12A1 kidney 
Type II ROMK1/KCNJ1 kidney 
Type III ClC-Kb/ClCNKb kidney 
Type IV Barttin/BSND kidney/inner ear 
Type V CaR/CASR kidney 
 
 
 
Tab.1 Types of Bartter syndrome, their cause and the affected tissues 
5 types of bartter syndrome have been described, all affecting kidney function. Renal salt waste is caused by 
gene defect in genes coding for NKCC2 (I), ROMK1 (II), ClC-Kb (III), Barttin (IV) or CaR (V).  
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Type I-IV are inherited autosomal recessive, with bartter syndrome type III being the classical 
bartter syndrome (Jeck et al. 2000) with a defect in ClC-Kb coding gene causing characteristic 
symptoms mentioned above. Type V is inherited autosomal dominant (Pearce et al. 1996) and 
sums mutations in CASR gene, coding for the calcium receptor CaR, leading to renal failure. 
Mutations in SLC12A1 or KCNJ1, genes coding for NKCC2 or ROMK1, may cause bartter 
syndrome types I or II.  
At present, no bartter syndrome causing mutation in ClCNKA, coding for the other human 
homolog ClC-Ka, is known, but ClCNK1 -/- mice suffer from diabetes insipidus (Matsumura 
et al. 1999).  
Only patients with bartter syndrome type IV suffer from hearing loss in addition to renal 
dysfunction (Birkenhäger et al. 2001, Hebert 2003, Landau et al. 1995, Jeck et al. 2001, 
Janssen et al. 2009, Riazuddin et al. 2010), because both channel homologs, ClC-Ka and ClC-
Kb, are also located in the inner ear and need barttin to become conductant.  
 
 
 
 
1.1.2.2 37B51BClC-1 and ClC-2 
 
ClC-1 is expressed in adult skeletal muscle and maintains the high anion conductance at 
resting potentials which is inevitable for muscle fibre function (Steinmeyer et al. 1991A+B). 
Mutations in ClC-1 coding gene ClCN1 can lead to myotonia congenita (Koch et al. 1992, 
George et al. 1993). For a long time, ClC-1 was called “the skeletal” chloride channel, but a 
recent study has shown ClC-1 in the brain (Chen et al. 2013). 
ClC-2 is broadly expressed throughout the tissues. It was found in the central nervous system 
fulfilling an excitatory task (Kleefuss-Lie et al. 2009, Saint-Martin et al. 2009, Földy et al. 
2010, Rinke et al. 2010), in the retina for wound healing purposes (Cao et al. 2010), and in 
various epithelia for anion resorption (Bösl et al. 2001, Catalán et al. 2004, Peña-
Münzenmayer et al. 2005). Dysfunction of ClC-2 can be correlated with idiopathic epilepsy 
(Stölting et al. 2013). 
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1.1.2.3 38B52BClC chloride/proton antiporter 
 
ClC-transporters are predominantly expressed in intracellular compartments (Friedrich et al. 
1998, Wang et al. 2006, Graves et al. 2008, Buyse et al. 1998). ClC-3 to ClC-7 are 
chloride/proton antiporters that usually exchange two chloride ions by one proton. Thus, the 
coupled electrogenic transport passes three net charges across the membrane for each 
transport cycle. 
 
 
 
1.1.2.3.1 62B76BClC-3, ClC-4, ClC-5 
 
ClC-3 is located in intracellular vesicles (Stobrawa et al. 2001). Although broadly expressed 
over the whole brain, ClC-3 knockout mice show complete postnatal neurodegeneration of the 
hippocampal CA1 region, only (Farmer et al. 2012). ClC-3 has been shown to be functionally 
linked to NMDA-receptors in hippocampal synapses (Wang et al. 2006). 
Little is known about ClC-4. This transporter is expressed in the brain, muscle and liver. It 
contributes to acidification of endosomes (Mohammad-Panah et al. 2003). By certain 
extracellular anions (thiocyanate) ClC-4 transporters change their chloride/proton 
stoichiometry and are thought to functionally convert to regular anion channels (Alekov and 
Fahlke 2009). 
Like ClC-4, ClC-5 is an outward rectifying chloride transporter of endosomes that supports 
acidification of such intracellular compartments. ClC-5 is detectable in endosomes of renal 
epithelial cells (Günther et al. 1998). Dysfunction of ClC-5 leads to Dent´s disease, affecting 
endocytosis in the proximal tubule of the nephron.  
 
 
 
1.1.2.3.2 63B77BClC-6 and ClC-7 
 
ClC-6, but also ClC-2, ClC-3, ClC-4, ClC-5 are found in the retina, where they might play a 
role in wound healing (Cao et al. 2010). Little is known about the physiological role of ClC-6 
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at present (Neagoe et al. 2010). ClC-6 and ClC-7 form a distinct branch within the ClC 
family. ClC-6 as well as ClC-7 knockout mice develop unexpected fatal paediatric storage 
disorders (Pressey et al. 2010). ClC-7 is essential for bone growth and stability (Kornak et 
al. 2001). Ostm1 is the β-subunit of ClC-7 (Lange et al. 2006, Leisle et al. 2011).  
 
 
 
1.1.3 16B30BInteracting proteins of ClC channels and transporters 
 
1.1.3.1 39B53BAdaptor proteins 
 
Several binding partners are reported for ClC channels and transporters (Stauber and Jentsch 
2010), like adaptor proteins (AP1-4), clathrin or GGA (golgi-localized, γ-ear containing, Arf-
binding). Dileucine motifs (DE)XXXLL or tyrosine-based motifs NPXY or YXXΦ (with Φ 
being a bulky, hydrophobic amino acid) are recognized for sorting events (Bonifacino and 
Traub 2003). Zhao et al. (2007) described dileucine-motif dependent sorting of ClC-3. 
Besides sorting function, adaptor proteins or GGA family members mediate transport between 
the trans-Golgi network, plasma membrane and early or late endosomes (Braulke and 
Bonifacino 2006, Kelly et al. 2008).  
 
  
Ec ClC   (118) DQRPVRWWRVLPVKFF (---) 
ClC-Ka   (132) GVILEDYLDIKNFGAK (646) NLFKLLNLQS 
ClC-Kb   (132) GVVLEDYLDIKNFGAK (646) NLFELLNLHS 
ClC-K1   (132) GVVLEDYLDIKNFGAK (646) SLFERLTLQS 
ClC-K2   (132) GVILEDYLDIKNFGAK (646) NLFELLNLQL 
ClC 1    (200) GVVLKEYLTMKAFVAK (839) TLFSLLGLHL 
ClC 2    (173) GVVLKEYLTLKTFIAK (808) TIFSLLGVDH 
ClC-3    (250) GFIIRGYLGKWTLMIK (773) DIFRKLGLRQ 
ClC-4    (192) GFIIRGYLGKWTLLIK (715) DIFRKLGLRQ 
ClC-5    (179) GFIIRGYLGKWTLVIK (701) DIFRKLGLRQ 
ClC-6    (168) GVKVPGIVRLRTLLCK (825) NLFRTMGLRH 
ClC-7    (215) GVKIPHVVRLRTLVIK (759) KLFRALGLRH 
CmClC     (91) GFYDKMRSALELRVLF (592) FLFVMLMPSM 
ClC-0    (134) GAVLHEYLTLRTFVAK      (739) TLFSLLGLDR 
 
 
In ClC-2, another motif was found. A tyrosine based motif within the loop of D- and E-helix 
mediates recycling of ClC-2 between endosomes and plasma membrane (Cornejo et al. 2009). 
These two motifs are highly conserved within the channels and transporters of the 
ClC-family, as shown in Tab.2. In EcClC, this functional tyrosine is replaced by a tryptophan.  
Tab.2 Alignment of two regulatory domains of 
ClC proteins 
In the left panel, a tyrosine between D- and E-helix 
is responsible for membrane insertion and 
recycling, as reported for ClC-2, only. This 
tyrosine is highly conserved through almost the 
entire family. The sorting of membrane insertion is 
regulated by another motif (right panel). A 
dileucine motif is needed for sorting events, as 
shown again for ClC-2. This dileucine motif is 
highly conserved for the channel proteins within 
the ClC-family. 
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Intracellular trafficking of ClC-1 and ClC-2 is mediated via adaptor proteins. The N-terminus 
of ClC-1 interacts with AP-2 (Stauber and Jentsch 2010). The C-terminus (dileucine motif) of 
ClC-2 interacts with AP-1B for basolateral orientation (Peña-Münzenmayer et al. 2005). For 
ClC-K channels, no adaptor protein has been described so far. But, an auxiliary subunit, 
barttin, was found which fulfils analog functions like membrane trafficking and sorting of 
chloride channels as well as gating regulation and stability of the pore-forming subunit. The 
above mentioned motifs could be influenced upon barttin binding. 
 
 
 
 
 
1.1.3.2 40B54Bβ-subunit barttin 
 
All ClC-K channels are regulated by a β-subunit called barttin. Secondary structure prediction 
reveals two transmembrane helices TM1 and TM2 with a short N-terminus and a long C-
terminal tail. Both termini are intracellular. A topology model of barttin is shown in Fig.6. 
 
 
 
 
 
 
 
 
Barttin affects ClC-K channels in several ways. It is needed for channel trafficking to the 
plasma membrane, channel stability and modulation of the voltage dependence of gating 
(Estévez et al. 2001). Scholl et al. (2006) showed that the transmembrane core of barttin with 
Fig.6 Topology model of barttin  
Secondary structure prediction 
revealed barttin to form two 
membrane spanning helices (grey 
cylinders). A short N-terminal 
stretch of 8 amino acids and a 
long C-terminus completes the 
secondary structure.  
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an additional short stretch of the C-terminus is sufficient to bind to ClC-K and to regulate the 
gating of ClC-K channels. Truncation of barttin at position 72 (I72X barttin) still activates 
V166E rClC-K1 in WT-barttin-like manner. Truncation at T61X reduces the unitary 
conductance and further truncation until Y57 still allows membrane insertion of ClC-K 
channels. Janssen et al. (2009) have proven E88X barttin to fulfil almost all functional 
purposes, besides a sorting distortion that result in pathological salt transport. hClC-Kb/E88X 
barttin is brought to the basolateral and to the apical membrane. In the same work, it is stated 
that barttins first helix alone fails to regulate ClC-K channels. Truncated Q32X barttin leads 
to entire loss-of-function and was found in patients suffering from Bartter Syndrome Type IV 
(Kitanaka et al. 2006).  
 
A Nedd4-2 ubiquitin ligase can bind to the PY-motif of barttin via its WW-motif to mediate 
endocytosis (Estévez et al. 2001, Embark et al. 2004, Flores et al. 2003). A serum- and 
glucocorticoid-inducible kinase regulates the ubiquitin ligase (Flores et al. 2005). Interruption 
of this binding PY-motif, as shown for Y98A barttin (Hayama et al. 2003), leads to an 
extended exposure of barttin to the plasma membrane, as well as to higher stability of the 
barttin/ClC-K complex. Such a mutated barttin increases currents of whole cells cotransfected 
with hClC-Kb cDNA. Similar endocytosis regulation via Nedd4-2 ubiquitin ligase and 
corresponding PY-motif were found for Na+-channel ENaC or ClC-5 (Flores et al. 2003, 
Kamynina and Staub 2002). As described above, a tyrosine based motif for regulation of 
endocytosis is found for almost all ClC-family members in the cytoplasmatic loop between 
the D- and the E-helix. Barttin facilitates plasma membrane exposure and stability of ClC-K 
channels and this loop is a possible target for the regulation of this purpose.  
Another regulatory mechanism is to modify barttin with palmitate. This fatty acid is attached 
to barttins cysteine residues C54 and C56 (unpublished data, Steinke et al. 2013). Without 
palmitate, hClC-Ka/Kb is non-conductant and the gating of V166E rClC-K1 is altered. 
Besides Q32X and E88X barttin, which were described above, more disease-causing barttin 
mutations have been identified and characterized (Janssen et al. 2009). The severity of 
symptoms varies depending on the position of mutation in the BSND gene. All patients are 
deaf. R8L, R8W and G10S barttin evoke a severe renal phenotype, but without causing renal 
failure. G47R barttin provokes a late onset of the bartter syndrome with a mild phenotype 
(Miyamura et al. 2003, García-Nieto et al. 2006), and interestingly, I12T barttin is only 
affecting inner ear function (Riazzudin et al. 2010, Janssen et al. 2009, Fahlke and Fischer 
2010). 
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Due to this huge variety of symptoms of Bartter Syndrome Type IV introduced by single 
point mutations, it gets obvious that barttin regulates its α-subunit distinct. Several molecular 
determinants within the transmembrane core are expected, because of stabilizing effects and 
chaperone function. In addition with a short cytoplasmatic stretch (I72X), slow and fast gating 
of ClC-K channels is coordinated, but only the transmembrane core of barttin is needed for 
the binding to ClC-K channels. 
 
 
 
 
1.2 1B15BAim of this study 
 
The interaction of barttin and ClC-K channels is poorly understood. Little is known about 
binding interfaces, stoichiometry or possible further binding partners. At present, only one 
publication postulates the B- and the J-helices of ClC-K channels to bind to barttin (Tajima et 
al. 2007). Even less is known about the determinants important for binding to the channel 
protein on behalf of barttin. 
 
The aim of this study was to determine amino acids in the transmembrane helices of barttin 
that interact with the pore-forming subunits of ClC-K/barttin channels. We substituted each 
amino acid of the two transmembrane helices by bulky tryptophan residues to investigate the 
interaction via this position with the -subunit.  
The barttin mutants were co-expressed with hClC-Ka or V166E rClC-K1, a well described 
mutant of rClC-K1 (Scholl et al. 2006), in a heterologous expression system and investigated 
using standard patch clamp methods, biochemical approaches and confocal imaging.  
 
We found several functional determinants within both helices of barttin that are necessary for 
trafficking of barttin and ClC-K/barttin to the plasma membrane, for the binding of barttin and 
the ClC-K -subunit, and for activation of the ClC-K/barttin channel complex. Almost the 
entire first transmembrane helix of barttin is needed for fast gate regulation, while several 
amino acids within the second transmembrane helix are needed especially for slow gate 
regulation.  
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2 6BMaterial and methods 
 
2.1 2B16BMaterial 
 
As long as not otherwise declared, chemicals and solutions were at least of p.A. purity. 
Chemicals and other material was purchased from BD (Heidelberg), BioRad (Munich), 
Calbiochem (Bad Soden), Fluka (Neu-Ulm), Gibco (Eggenstein), Glycon (Luckenwalde), GE 
Healthcare (Solingen), Harvard apparatus (March-Hugstetten), Ibidi (Martinsried), Invitrogen 
(Karlsruhe), Merck (Darmstadt), Moyco Dental Wax(York, PA, USA), New England Biolabs 
(Frankfurt), Quiagen (Hilden), Roche (Basel), Roth (Karlsruhe), Serva (Heidelberg), Sigma-
Aldrich (Munich) and Thermo Scientific (Bremen). 
Agilent (Waldbronn) and Roche (Basel) provided PCR Kits.  
 
 
 
Several devices were used: Typhoon Fluorescence Scanner (GE Healthcare), Puller P-9750 
(Sutter Instruments), Microforge MF-830 (Narishige, Japan), GeneGnome5 (Syngene, UK), 
Victor Plate reader 1420 Multilabel Counter (Perkin Elmer), Centrifuges (Table centrifuges 
(5415D) (Eppendorf), Heraeus cooled centrifuge, Coulter Avanti J-25 (Rotor: JLA 
10.500),(Beckman)), Nanodrop Photometer (Thermo Fischer), Photometer Ultrospec 2100 
pro (Amersham Bioscience), Fluorolog (Jasco), Thermoblock TDB-120 (Kisger), 
EnviroGenie (Scientific Industries inc.), Shaker Multitron Eco/ Infors HT PCR (Biometra 
Professional Trio), Gel-Doc (Bio-Rad, München) and Fusion SL (Peqlab). The equipment for 
electrophysiology is described in corresponding section of this chapter. 
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2.2 3B17BMethods 
 
For heterologous expression of proteins, corresponding genes are cloned into vectors and 
transfected into expressing cells. Mutations within in the gene can be introduced by PCR 
(polymerase chain reaction) strategies. With PCRs, proteins can also be covalently fused to 
another. 
After the expression of the desired protein - in this case ClC-K chloride channels and their 
β-subunit barttin – they can be characterized with biochemical and electrophysiological 
approaches. 
 
 
2.2.1 17B31BMolecular Biology – Vectors used 
 
For protein expression in HEK293T, MDCKII or Flp-in T-Rex cells, we used several vectors: 
 
UpSVL 
This vector harbors IRES (internal ribosome entry site) with a promoter for the CD8 antigen, 
which can be recognized by CD8-antibody carrying Dynabeads. This binding indicates 
successful transfection of cells. It is a low expressing vector. An ampicillin resistance gene is 
encoded for selection. Initially in this study, we used a pSVL vector that encodes for 
YFP-hClC-Ka. 
 
UpRcCMV  
It is a high-level expression vector for mammalian cells, due to the introduction of CMV 
(cytomegalovirus)-promoter which is recognized and used for biosynthesis preferentially. A 
polyadenylation signal leads to enhanced mRNA stability. This vector is a derivative of SV40 
(simian virus 40). An ampicillin resistance gene is encoded for selection. In this study, we 
used pRcCMV vectors encoding for YFP rClC-K1 and YFP V166E rClC-K1. 
 
UpcDNA3.1(+) and pcDNA3.1(-) 
This vector is derived from the pRcCMV vector. pcDNA3.1 vectors are high-level expression 
vectors in mammalian cells, because of the CMV promoter. Multiple cloning site in forward 
(+) or reverse (-) orientation is completed by a polyadenylation signal for enhanced mRNA 
stability. Its origin is SV40. Neomycin and ampicillin resistances genes can be used for 
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selection. Here, pcDNA3.1 (+) barttin (mCFP) was used. This vector was taken as template to 
generate all tryptophan mutants. We also used pcDNA3.1 (-) YFP hClC-Ka. 
 
UpcDNA5/FRT/TO 
This vector has a CMV promoter for high expression in mammalian cells, a flip-in 
recombinase site for gene integration in Flp-InTM T-Rex host cell genom, as well as ampicillin 
and hygromycin resistance genes for selection. This vector was used for stable expression of 
chimeric channel constructs. As described later, domains of ClC-K and ClC-2 channels were 
exchanged on genetic level, cloned into pcDNA5/FRT/TO vectors and transfected into 
Flp-InTM T-Rex cells for stable expression. Transcription of these genes is tetracycline-
dependent. Cells transfected with this vector were incubated with tetracycline-free medium. 
 
 
2.2.2 18B32BPCR strategies  
 
As mentioned, tryptophan scanning should reveal functional determinant of barttin. Therefore, 
we substituted every single amino acid of the two proposed transmembrane helices by 
tryptophan. This was done with site directed mutagenesis PCRs. Corresponding codons 
within BSND were pointwisely mutated to TGG, coding for tryptophan. 
Another PCR strategy was used to concatenate proteins. The side overlap extension PCR 
(SOE PCR) allows the elongation of an existing gene and the introduction of a random linker 
sequence which bears a complementary sequence of another gene or restriction sites. This 
linker and overlap is needed to fuse the two genes.  
SOE PCRs were also performed to exchange single helical domains of two channels. 
All primers were designed with a combination of HHUwww.bioinformatics.org/primerX/ UHH and 
vectorNTI software. Sigma-Aldrich provided the oligonucleotides. After arrival, the 
oligonucleotides were dissolved in TE-buffer (Quiagen) to an end concentration of 100 µM. 
Quikchange®-PCR was carried out with nucleotides, polymerases and buffers from Agilent 
(Stratagene), SOE-PCR with Fermentas High Fidelity PCR Kit (Roche). Enzymes for vector 
restriction and ligation were ordered at FD Fast Digest. The concentrations of template vector, 
primers, dNTPs, buffer and polymerase remained the same in all PCR reactions and are listed 
in Tab.3. For PCR-amplification of fragments of, or entire vectors, a general protocol is 
shown in Tab.4. An initial denaturation step was followed by 15 circles of step 2-4. The 
temperature of the annealing step is dependent on the length and G/C-content of primers. The 
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duration of the elongation step 4 is dependent on the expected length of DNA (approximately 
1 min/kb). After a terminal elongation step, the PCR reaction is stopped and the sample stored 
at 4 °C.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.2.1 41B55BSubstitution of single amino acids to tryptophan:  
QuikChange® site directed mutagenesis 
 
 
A generalized procedure was followed stepwise. The here listed steps are explained in more 
detail in the next passages.  
- QuikChange®PCR for point mutation 
- Template digestion with DpnI 
- Transformation 
- Mini prep 
- Control restriction and sequencing 
- Subcloning 
- Transformation 
- Maxi prep 
- Sequencing 
 
 
 
 
 
PCR composition Volume (µl) 
Template vector (50 ng/µL) 1 
Primer (s/as) (125 ng/µL) 1+1 
10x buffer 5 
50x dNTPs 1 
Polymerase 1 
H2O ad. 50 
PCR step Temperature Duration 
1 denaturation 95 °C 1 min 
2 denaturation 95 °C 20 sec 
3 annealing 55 ± 3 °C 65 ± 5 sec 
4 elongation 68 °C 1 min/kb 
5 terminal elongation 68 °C 5 min 
6 end/storage 4 °C infinite 
Tab.3 Mix for PCR reactions 
Template vector, primer, buffer, dNTP (deoxy-nucleotide-
tri-phosphate) and polymerase are diluted in H2O as 
indicated. 
Tab.4 PCR program 
Stardard PCR protocols are run for amplification. Initial 
denaturation is followed by 15 circles of denaturation, annealing 
and elongation until a terminal elongation phase terminates 
amplification. DNA can be stored at 4 °C for long time. 
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2.2.2.1.1 64B78BQuikchange® PCR 
 
Based on the backbone pcDNA3.1 (+) barttin mCFP, primers were designed to generate a 
tryptophan codon at desired position. The entire vector is amplified with an intended 
mutation, introduced by PCR reaction with a pair of complementary primers. These primers 
used for QuikChange® (Stratagene) site directed mutagenesis are listed in Tab. 5. The 
mutated nucleotides are marked in bold letters. The mutated triplet was always substituted to 
5´-TGG-3´ (antisense 5´-CCA-3´) coding for tryptophan.  
 
Mutation s/as Primer sequence (5´-3´) 
s GAGAAGACCTTCCGGTGGGGCTTCATTGTGCTG 
I9W barttin mCFP 
as CAGCACAATGAAGCCCCACCGGAAGGTCTTCTC 
s GAAGACCTTCCGGATCTGGTTCATTGTGCTGGGG 
G10W barttin mCFP 
as CCCCAGCACAATGAACCAGATCCGGAAGGTCTTC 
s GACCTTCCGGATCGGCTGGATTGTGCTGGGGCTTTTC 
F11W barttin mCFP 
as GAAAAGCCCCAGCACAATCCAGCCGATCCGGAAGGTC 
s TTCCGGATCGGCTTCTGGGTGCTGGGGCTTTT 
I12W barttin mCFP 
as AAAAGCCCCAGCACCCAGAAGCCGATCCGGAA 
s GGATCGGCTTCATTTGGCTGGGGCTTTTCC 
V13W barttin mCFP 
as GGAAAAGCCCCAGCCAAATGAAGCCGATCC 
s CGGCTTCATTGTGTGGGGGCTTTTCCTGC 
L14W barttin mCFP 
as GCAGGAAAAGCCCCCACACAATGAAGCCG 
s GCTTCATTGTGCTGTGGCTTTTCCTGCTGG 
G15W barttin mCFP 
as CCAGCAGGAAAAGCCACAGCACAATGAAGC 
s TTCATTGTGCTGGGGTGGTTCCTGCTGGCCCT 
L16W barttin mCFP 
as AGGGCCAGCAGGAACCACCCCAGCACAATGAA 
s TTCATTGTGCTGGGGCTTTGGCTGCTGGCCCTCGGTACGT 
F17W barttin mCFP 
as ACGTACCGAGGGCCAGCAGCCAAAGCCCCAGCACAATGAA 
s CATTGTGCTGGGGCTTTTCTGGCTGGCCCTCGGTACGTTC 
L18W barttin mCFP 
as GAACGTACCGAGGGCCAGCCAGAAAAGCCCCAGCACAATG 
s ATTGTGCTGGGGCTTTTCCTGTGGGCCCTCGGTACGTTCCTCA 
L19W barttin mCFP 
as TGAGGAACGTACCGAGGGCCCACAGGAAAAGCCCCAGCACAAT 
s GGCTTTTCCTGCTGTGGCTCGGTACGTTCCTC 
A20W barttin mCFP 
as GAGGAACGTACCGAGCCACAGCAGGAAAAGCC 
s CTTTTCCTGCTGGCCTGGGGTACGTTCCTCATG 
L21W barttin mCFP 
as CATGAGGAACGTACCCCAGGCCAGCAGGAAAAG 
s CTTTTCCTGCTGGCCCTCTGGACGTTCCTCATGAGCCATG 
G22W barttin mCFP 
as CATGGCTCATGAGGAACGTCCAGAGGGCCAGCAGGAAAAG 
s CTTTTCCTGCTGGCCCTCGGTTGGTTCCTCATGAGCCATGATC 
T23W barttin mCFP 
as GATCATGGCTCATGAGGAACCAACCGAGGGCCAGCAGGAAAAG 
s CCTCGGTACGTGGTTGATGAGCCATGATC 
F24W barttin mCFP 
as GATCATGGCTCATCAACCACGTACCGAGG 
s CCCTCGGTACGTTCTGGATGAGCCATGATCGG 
L25W barttin mCFP 
as CCGATCATGGCTCATCCAGAACGTACCGAGGG 
s CCTCGGTACGTTCCTCTGGAGCCATGATC 
M26W barttin mCFP 
as GATCATGGCTCCAGAGGAACGTACCGAGG 
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s GGCCCCAGGTCTACTGGACCTTCTATGCCATG 
G35W barttin mCFP 
as CATGGCATAGAAGGTCCAGTAGACCTGGGGCC 
s GATCGGCCCCAGGTCTACGGCTGGTTCTATGCC 
T36W barttin mCFP 
as GGCATAGAACCAGCCGTAGACCTGGGGCCGATC 
s GTCTACGGCACCTGGTATGCCATGGGCAG 
F37W barttin mCFP 
as CTGCCCATGGCATACCAGGTGCCGTAGAC 
s GGTCTACGGCACCTTCTGGGCCATGGGCAGCGTCATG 
Y38W barttin mCFP 
as CATGACGCTGCCCATGGCCCAGAAGGTGCCGTAGACC 
s GTCTACGGCACCTTCTATTGGATGGGCAGCGTCATGGTG 
A39W barttin mCFP 
as CACCATGACGCTGCCCATCCAATAGAAGGTGCCGTAGAC 
s CTACGGCACCTTCTATGCCTGGGGCAGCGTCATGGTGATC 
M40W barttin mCFP 
as GATCACCATGACGCTGCCCCAGGCATAGAAGGTGCCGTAG 
s GCACCTTCTATGCCATGTGGAGCGTCATGGTGATCG 
G41W barttin mCFP 
as CGATCACCATGACGCTCCACATGGCATAGAAGGTGC 
s CACCTTCTATGCCATGGGCTGGGTCATGGTGATCGG 
S42W barttin mCFP 
as CCGATCACCATGACCCAGCCCATGGCATAGAAGGTG 
s CTTCTATGCCATGGGCAGCTGGATGGTGATCGGGGGCATC 
V43W barttin mCFP 
as GATGCCCCCGATCACCATCCAGCTGCCCATGGCATAGAAG 
s GGGCAGCGTCTGGGTGATCGGGGGCATCATCTG 
M44W barttin mCFP 
as CAGATGATGCCCCCGATCACCCAGACGCTGCCC 
s CAGCGTCATGTGGATCGGGGGCATCATCTG 
V45W barttin mCFP 
as CAGATGATGCCCCCGATCCACATGACGCTG 
s CATGGGCAGCGTCATGGTGTGGGGGGGCATCATCTG 
I46W barttin mCFP 
as CAGATGATGCCCCCCCACACCATGACGCTGCCCATG 
s GCGTCATGGTGATCTGGGGCATCATCTGG 
G47W barttin mCFP 
as CCAGATGATGCCCCAGATCACCATGACGC 
s CGTCATGGTGATCGGGTGGATCATCTGGAGCATG 
G48W barttin mCFP 
as CATGCTCCAGATGATCCACCCGATCACCATGACG 
s GTCATGGTGATCGGGGGCTGGATCTGGAGCATGTG 
I49W barttin mCFP 
as CACATGCTCCAGATCCAGCCCCCGATCACCATGAC 
s GTCATGGTGATCGGGGGCATCTGGTGGAGCATGTGCCAGTGCTAC 
I50W barttin mCFP 
as GTAGCACTGGCACATGCTCCACCAGATGCCCCCGATCACCATGAC 
s GGGGCATCATCTGGTGGATGTGCCAGTGCTAC 
S52W barttin mCFP 
as GTAGCACTGGCACATCCACCAGATGATGCCCC 
s CATCATCTGGAGCTGGTGCCAGTGCTACC 
M53W barttin mCFP 
as GGTAGCACTGGCACCAGCTCCAGATGATG 
s CATCTGGAGCATGTGGCAGTGCTACCCCAAG 
C54W barttin mCFP 
as CTTGGGGTAGCACTGCCACATGCTCCAGATG 
s CATCTGGAGCATGTGCTGGTGCTACCCCAAGATC 
Q55W barttin mCFP 
as GATCTTGGGGTAGCACCAGCACATGCTCCAGATG 
 
PCR reactions were performed as recommended by manufacturer of the kit (Stratagene, 
Quikchange©PCR Kit) and indicated in Tab.3+4. 
Tab.5 List of primers designed for Quikchange® (Stratagene) site directed mutagenesis 
In the left column, the introduced substitution is noted followed by the sense (s) and the antisense primer sequence(as). Both are given 
in 5´-3´-orientation. The template BSND gene is harbored in the pcDNA3.1(+) vector. The triplett coding for the amino acids that is 
substituted to tryptophan is marked in bold letters TGG. 
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2.2.2.1.2 65B79BDpnI digestion 
 
After the Quikchange® PCR (step 2.2.2.1.1), the sample is incubated for 20 min at 37 °C with 
DpnI, a restriction enzyme which cuts only methylated DNA. This is only the case for the in 
bacteria generated template vector, but not the PCR product. This step is needed to avoid 
transformation of unchanged vectors.  
Before transformation, the cleared PCR product was checked for size in agarose gel 
electrophoresis. After transformation, the PCR product is sequenced, subcloned and again 
sequenced. 
 
 
2.2.2.1.3 66B80BAgarose gel electrophoresis 
 
2 % (w/v) agarose (Invitrogen) is dissolved in 1x TAE buffer (400 mM TRIS, 200 mM acetic 
acid, 10 mM EDTA)  with 0.005 % (v/v) ethidiumbromide or 0.01 % (v/v) SYBR®safe at 60 
°C and poured into the gel chamber. Both intercalating agents can be visualized with UV-light 
in a Gel-Doc. DNA ladder mix was loaded as size marker. The gels were run for one hour at 
20 V. 
 
 
2.2.2.1.4 67B81BDNA purification – gel extraction 
 
Plasmids or PCR fragments are extracted of agarose gels with Quiagen® Gel Extraction Kit 
following manufacturers’ instruction. After gel extraction and before transformation, the 
concentration of the vector-DNA is measured photometrically.  
 
 
2.2.2.1.5 68B82BCompetent cells 
 
E.coli cells (DH5-α) are made competent chemically according to Sambrook and Russell 
(2006). 100 ml antibiotic-free LB-Medium was incubated with cells until the optical density 
reached values of OD600 ≈ 0.5 – 0.6. After centrifugation (10 min, 3000 g, 4°C), the cells are 
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resuspended in 60 ml TFB I buffer and incubated on ice for 20-90 min. A second 
centrifugation step (10 min, 3000 g, 4°C) is followed by resuspension of the cells in 8 ml 
TBF II buffer. Aliquots of 200 µl are taken and frozen in nitrogen. Tab.6 shows the 
ingredients of the two used buffers. 
 
 
 
 
 
 
 
 
2.2.2.1.6 69B83BGrowth of transformed bacteria in LB-medium/ on LB-Agar plates 
 
Transformed bacteria are plated on LB-agar plates. After 14 hours of incubation at 37 °C, 
colonies are picked and further incubated in LB medium before plasmid recovery. LB-
medium contains Bacto-yeast extract (5 g/L), NaCl (10g/L) and Bacto-tryptone (10 g/L). The 
medium is autoclaved at 121 °C for 20 min.  
For LB-Agar plates, Bacto-Agar is added to the LB-medium to a final concentration of 20 
g/L. After sterilization in an autoclave and cooling down to approximately 60 °C, the LB-agar 
can be inoculated with ampicillin (100 µg/ml) and poured into dishes. 
 
 
2.2.2.1.7 70B84BTransformation 
 
For transformation, 40 µl of competent DH5-α cell suspension were mixed with 4-10 ng of 
DNA of step 2.2.2.1.4, and kept for 20 min at 42 °C. After 2 min on ice, 300 µl SOC-medium 
was added, follow by a 45 min incubation period at 37 °C while shaking.  
SOC-medium contains  
- 2 %  bacto-tryptone 
- 0.5 % bacto-yeast extract 
- 10  mM NaCl 
- 2.5  mM KCl 
 
Composition TBF I buffer TBF II buffer 
RbCl 100 mM 10 mM 
MnCl2 x 2 H20 50 mM --- 
CH3CO2K 30 mM --- 
CaCl2 x 2 H2O 10 mM 75 mM 
Glycerin (99.9 %) 15 % (v/v) 15 % (v/v) 
MOPS --- 10 mM 
pH 5.8 8.0 
Tab.6 Composition of buffers 
Two bufferes are needed for chemical 
generation of competent DH5-α cells. 
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After sterilization, MgCl2 and glucose are added to a final concentration of 20 mM. pH is set 
to 7.0. SOC-medium contains no antibiotics. 
 
After incubation, the cells are spun down (1 min, 800 x g). 260 µl of medium are discarded 
leaving 40 µl medium in the eppendorf tube. The cells are resuspended before plating on LB-
agar. The presence of ampicillin in the LB-agar and the ampicillin resistance gene on the 
vector allows selection of transformed cells. Plates are incubated at 37 °C for 16-20 hours. 
Colonies are picked and incubated in 5 or 200 ml LB-medium in presence of ampicillin for 
Mini or Maxi preparation. Amplified vectors are isolated with Quiagen Kits for plasmid 
recovery. 
  
 
2.2.2.1.8 71B85BVector recovery 
 
For vector recovery, Quiagen® Kits are used. Depending on the culture volume, Mini 
Preparation Kit or HiSpeed Plasmid Maxi Kits are used following manufacturers instruction. 
The concentrations of the purified vectors are either measured with the Nanodrop photometer 
or calculated densitometrically.  
 
2.2.2.1.9 72B86BGlycerol stock  
 
For long time storage, an aliquot of every transformed bacterial culture is taken. Therefore, 
equal volumes of cultured LB medium and 50 % glycerol are mixed and frozen in liquid 
nitrogen before storage at -80 °C. Depending on the volume of culture medium 100 µl or 
500 µl of inoculated LB medium are taken.  
 
2.2.2.1.10 73B87BControl restriction 
 
After vector recovery, size and quality is checked by cutting 1.5 µg of the vector with 
restriction enzymes. Ideally, a restriction site is introduced or deleted by PCR. This alteration 
results in different band patterns after enzymatic restriction and agarose gel electrophoresis 
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compared to template vector. However, this was the exception within the here performed 
Quikchange© PCRs. Only vectors of correct size and restriction pattern were sequenced. 
 
 
2.2.2.1.11 74B88BSequencing 
 
Sequencing PCRs are performed by GATC (Lindau/Düsseldorf). 
 
 
2.2.2.1.12 75B89BSubcloning 
 
Sequenced fragments of vector are subcloned. This means that the DNA of the mini or maxi 
preparation (2.2.2.1.8) is restricted within the sequence provided of GATC and cloned into the 
template vector. By doing so, replication errors are minimized.  
DNA restriction was always performed with two single cutting enzymes (most often AgeI and 
NheI). Sticky end restriction allows control of orientation of the insert. Restriction results in 
two fragments – one sequenced fragment which bears the mutation, and the rest of this 
amplified vector lacking this fragment. Same restriction is performed with the template vector 
that was already sequenced entirely. Before ligation of template vector and mutated DNA, the 
fragments are separated by agarose electrophoresis. DNA-gel extraction and ligation are 
described in following. 
 
2.2.2.1.13 76B90BLigation 
 
T4 DNA ligase (Fermentas) is used to ligate DNA fragments according to manufacturers’ 
instruction. In molar ratio, three DNA fragments of the insert are mixed with one fragment of 
template vector, ATP containing buffer and T4 DNA ligase and incubated for 20 minutes at 
37 °C. Transformation and plasmid recovery completes the Quikchange© protocol. In this 
study, only sticky end ligation was performed.  
For the calculation of the mass of the insert, we used following equation for 3:1 
stoichiometry: 
     vectorinsertsizevectorminsertm  13     (eq.1) 
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Fig.7 Scheme of SOE-PCR 
For covalent linkage of barttin to V166E 
rClC-K1 on genetic level, two primers are 
needed. One primer binds to the template with 
its full length. Here, the forward primer bound 
to the vector upstream the gene encoding for 
barttin as a start for amplification. The second 
primer fulfills several tasks. For C-terminal 
elongation of barttin, the stop codon is mutated 
to tryptophan. Therefore a point mutation in the 
complementary part of the reverse primer is 
generated. This primer additionally encodes a 
peptide linker carrying a restriction site for the 
subcloning into the host vector. Frame shift 
must not occur by the introduction of the linker. 
The second gene, here coding for (V166E) 
rClC-K1 must be within the same reading frame 
starting with ATG of the first protein. 
2.2.2.2 42B56BSide overlap extension PCR (SOE-PCR) 
 
SOE-PCR strategies are performed to fuse two proteins on DNA level.  Concatenated proteins 
should ensure a 1:1 stoichiometry. To guarantee an open reading frame coding for the fusion 
protein, the stop codon of the first protein needs to be mutated. Another important aspect is 
the finding of an appropriate linker sequence, coding for a peptide long enough to allow 
typical protein-protein interaction. This linker must not lead to a frame shift. Here, SOE-PCR 
was performed to link barttin to the N-terminus of ClC-K channels. 
SOE-PCR was also performed to generate chimeras. The B- and/or J-helices of ClC-K1 and 
ClC-2 were exchanged in order to validate the binding of barttin to these domains. Therefore, 
the linker sequence of the SOE-PCR is the sequence of the corresponding helix. 
 
 
2.2.2.2.1 77B91BCovalent link of barttin to rClC-K1 and V166E rClC-K1 
 
Barttin was covalently linked to the N-terminus of rClC-K1, respective V166E rClC-K1 with 
a PCR strategy depicted in Fig.7. 
As templates, pcDNA3.1 (+) barttin and pSVL (V166E) rClC-K1 IRES CD8 were used for 
SOE-PCR. The sequence of barttin was modified in two aspects. The stop codon was mutated 
from TGA to TGG resulting in non-stop barttin. Additionally, the sequence was C-terminally 
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elongated with the desired linker sequence. Both tasks were managed by the antisense primer.  
A restriction site (NotI) was introduced in the linker sequence for further cloning into the host 
vector.  
In Tab.7, the primers are listed. The mutated stop codon and the linker sequence are marked 
in bold letters. 
 
 
The SOE-PCR product of extended barttin was restricted with NotI for 30 min at 37 °C. 
Agarose gel electrophoresis yielded in purified DNA fragment, which was ligated into 
linearised pSVL vector (pSVL rClC-K1 IRES CD8, resp. pSVL rClC-K1 V166E IRES CD8).  
Transformation, colony picking, plasmid recovery and sequencing were performed as 
described. 
 
 
 
2.2.2.2.2 78B92BN-terminal link of the concatamers with mYFP (Quikchange) 
 
For easier detection, the built concatamers were N-terminally labeled with mYFP with 
Quikchange® strategy. The stop codon of the mYFP coding gene was mutated to TGG and at 
the N-terminus of the concatamer coding gene, an additional AgeI-restriction site was 
introduced by a point mutation. Cloning in into pSVL concatamers barttin-(V166E) rClC-K1 
IRES CD8 resulted in N-terminally mYFP-labeled concatamer mYFP-barttin-(V166E) rClC-
K1. The primers used for this PCR reaction are given in Tab.8. 
 
fw primer mYFP stopp mutation s 5´-CGAGCTGTACAAGTTTAAAGCGGCCGCTC-3´ 
rev primer mYFP stopp mutation as 5´-GAGCGGCCGCTTTAAACTTGTACAGCTCG-3´ 
   
fw primer concatamer N-terminus AgeI introduction s 5´-CTGCTCTAAACCGGTTCGATCCCTCGAG-3´ 
rev primer concatamer N-terminus AgeI introduction as 5´-CTCGAGGGATCGAACCGGTTTAGAGCAG-3´ 
 
 
 
 
fw within pcDNA3.1(+) s 5´-GCAGAGCTCTCTGGCT-3´ 
rev barttin nonstop and linker sequence with restriction 
site as 
5´-TGCAGCGGCCGCTCCACTCCATCTAGACGG 
AGCACAAACATCCCAGCCTTGGGTGTCAG-3´ 
Tab.8 Primers used for tagging YFP to concatamers 
Two PCR reactions were performed. In a first PCR step reaction, the stopp codon of mYFP is mutated to enable N-terminal labeling of the 
concatamers with mYFP in one open reading frame. For cloning in the mutated reporter gene, an additional restriction site within the 
vector coding for the concatamer is needed and introduced by indicated primers. 
Tab.7 Primers used for concatenation of barttin and (V166E) rClC-K1 
Mutated stopp codon and new linker sequence is marked with bold italic letters 
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Fig.8 Scheme of PCR reaction needed for helix substitution between rClC-K1 and ClC-2 
Bars (grey: ClC-K1, white: ClC-2) represent the genes with the sequences of a helix indicated in black. Five PCRs (PCR 1-
5) are needed together with six primers (a-f). PCR 1 amplifies the helix to be substituted (black bar) without any other parts 
of the donor gene (grey bar). PCR 2+3 amplify helix-corresponding upstream (PCR 2) and downstream (PCR 3) regions of 
the future host gene (white bar). PCR 2 and 3 are performed with overlapping primers, whereas the overlap is 
complementary to the helix to be introduced (PCR 1 product). Two PCR products serve as termplate in further PCRs. PCR 4 
combines PCR products 1 and 2 by a PCR with primers c and b.  In PCR 5, this upstream prolonged helix (PCR 4 product) 
is further combined with PCR 3 product by a PCR with primers c and f. PCR product 5 can now be cloned in the template 
host gene vector, here ClC-2, with appropriate restriction enzymes. 
2.2.2.2.3 79B93BGeneration of ClC-2 and V166E rClC-K1 chimera (SOE-PCR) 
 
Chimaeric channels are built for validation of barttin binding to the B- and/or J-helix. 
Substitutions of B- and J-helix of ClC-2 with the ones of ClC-K are expected to be a good 
tool to determine binding of barttin. For helix substitution, following three-step SOE-PCR 
strategy was used and sketched in fig.8. The three small boxes mark the initial PCRs (PCR1, 
PCR2 and PCR3 in Fig.8) and the grey box illustrates the second step in which two PCR 
products are combined (PCR4). Terminally, the product of PCR3 is added to the already 
combined DNA fragment (big black box, PCR5).  
There here used variation of the general PCR protocol that was run is listed in Tab.9. 
In one of the initial PCRs (PCR1), a helix sequence of the donor gene (black intermission in 
grey bar) is amplified with appropriate primers a+b, shown in Tab.10. In the two other initial 
PCRs, the future host gene (white bar) is amplified upstream (PCR 2, primer c+d) and 
downstream of the helix (PCR 3, primer e+f) that is to be substituted with extended primers. 
These three PCR products are combined stepwise in two further PCR reactions.  
In PCR4 (grey box), the PCR products 1 and 2 are mixed with primers c and b. The product of 
PCR4 is linked to the PCR3 product with primers c and f and boxed as PCR5. 
This PCR product was cloned in the host gene vector with appropriate restriction enzymes 
and ligation methods. The PCR products all were purified and checked for size in agarose 
gels.  
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PCR-Program: 
PCR-Step Temperatur (°C) Duration (sec) 
1 initial denaturation 94 120 
2 denaturation 94 10 
3 annealing 52 70 
4 elongation 72 330 
5 denaturation 94 15 
6 annealing 52 30 
7 elongation 72 330 
8 terminal elongation 72 420 
9 end/storage 4 infinite 
 
a Helix B ClC-K1 s GACTGGCACTTCCTGGTGGC 
b Helix B ClC-K1 as CCGGTATAGCCATTTGTGTGCTC 
c Helix B downstream ClC-K1 in ClC-2 s CACAAATGGCTATACCGGGGCTTGAACACCAGCATCTTG 
d Helix B downstream ClC-K1 in ClC-2 as  GCCAGCATCTCTGTGTTCCG 
e Helix B upstream ClC-K1 in ClC-2 s GAGCAAAGACCCCAACGAGAAG 
f Helix B upstream ClC-K1 in ClC-2 as CCACCAGGAAGTGCCAGTCTTCACCAACCCTGGATACTAGGAAC 
  
a Helix J ClC-K1 s GACCTGCCTGAAATCTTCTTCTTTG 
b Helix J ClC-K1 as CAACAGTCTGGAGGTGTACCGATTG 
c Helix J downstream ClC-K1 in ClC-2 s GTACACCTCCAGACTGTTGATGAGGAAACGCCTGCTCTTC 
d Helix J downstream ClC-K1 in ClC-2 as CAGGCACAATCCGGTAGGTG 
e Helix J upstream ClC-K1 in ClC-2 s CATTGGGCTGACCTGCGC 
f Helix J upstream ClC-K1 in ClC-2 as GAAGATTTCAGGCAGGTCAAAGGGGAAGTCGAGCCGG 
  
a Helix B ClC-2 s GATTGGATCTTCCTGGTCCTG 
b Helix B ClC-2 as CCGGGACATCCACTGCTGAG 
c Helix B downstream ClC-2 in ClC-K1 s CAGCAGTGGATGTCCCGGGAGGTTGGGGACGGCCAC 
d Helix B downstream ClC-2 in ClC-K1 as GTAGATGGAGGTGATGGTCTCCTG 
e Helix B upstream ClC-2 in ClC-K1 s GGTCCTGCTGGAGTTCGTGAC 
f Helix B upstream ClC-2 in ClC-K1 as CCAGGAAGATCCAATCCTCACCCACACGGAACAACC 
  
a Helix J ClC-2 s GACCTGCAGGAGCTGCCAG 
b Helix J ClC-2 as GAGGAAGCGATTGATGGTTTTC 
c Helix J downstream ClC-2 in ClC-K1 s CCATCAATCGCTTCCTCGCTACAAGCAAGCCGTCCTACG 
d Helix J downstream ClC-2 in ClC-K1 as GCCATCAGCACAGGCAGTGC 
e Helix J upstream ClC-2 in ClC-K1 s GCTTCTCGCAGAGCATCTCACC 
f Helix J upstream ClC-2 in ClC-K1 as GGCTGGCAGCTCCTGCAGGTCAAAGGGCACATCCACTCGG 
 
 
 
 
 
 
 
 
Tab.9 PCR program 
Initial denaturation was followed by 10 
cycles of 10 sec denaturation, 70 sec 
annealing and 5.5 min elongation (steps 
2-4). Additional 20 cycles of steps 5-7 
as indicated were performed for 
amplification. Terminal elongation and 
storage ended the PCR program.  
Tab.10 List of primers used for generation of chimeric channels 
B- and J-helices of ClC-K channels are supposed to bind barttin. These helices are exchanged by the corresponding domains of ClC-2 and 
vice versa. Here, four groups of primers are built each containing six primers (a-f). The first group is needed for building ClC-2 with 
B-helix of ClC-K. ClC-2 with the J-helix of ClC-K is generated with the second group of primers. The third and forth group facilitate the 
generation of chimeric channels with the backbone of ClC-K and the B-/J-helix of ClC-2.  All primers are given in 5´-3´ orientation and 
the SOE-sequences marked in bold italic letters.  
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2.2.3 19B33BCell culture 
 
2.2.3.1 43B57BCell lines 
 
Due to different tasks, several cell types are used. The here used cell lines are described in 
following passages. 
 
 
2.2.3.1.1 80B94BMDCKII for confocal microscopy and biotinylation assay 
 
This cell line is derived by S.H. Madin and N.B. Darby from the kidney tissue (distal tubule 
or collecting duct) of an adult female cocker spaniel in 1958. Main feature is their polarized 
epithelia. They shelter an extracellular matrix at the basal lamina for adhesion to adjacent 
tissues. This extracellular matrix makes these cells very hard or even unable to patch. This 
cell line is commonly used as a general model for epithelial cells, especially to investigate the 
sorting of proteins. (HAMAMATSU.COM) 
 
 
2.2.3.1.2 81B95BHEK293T for electrophysiology 
 
This cell line is derived from human embryonic kidney (HEK) cells from a healthy aborted 
fetus. It was cultured by Graham and van der Eb in the 1970s. F.Graham, inventor of the 
calcium-phosphat precipitation method for transfection, and co-workers (1977) succeeded in 
his 293rd experiment to transform HEK cells with sheared fragments of adenovirus 5 DNA 
(hence HEK293). Later on, simian virus 40 DNA was transformed. Theses cells constitutively 
express SV40 large T antigen for higher transfectability, but moreover this antigen can bind to 
promoter sequences for higher expression. 
Cells need nutrients to grow. MDCKII and HEK293T cells are cultured and transfected in 
DMEM (Dulbecco modified eagle medium) containing 10 % FBS, 200 µM L-Glutamine and 
in presence of penicillin (50 U/ml) and streptomycin (50 µg/ml).  
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2.2.3.1.3 82B96BFlp-in™ T-REx for stable cell lines 
 
This cell line is designed for rapid generation of stable cell lines that ensure stable expression 
of a certain protein. In a transcriptional active genomic locus, a recombinase site (Flp) allows 
targeted integration of a gene of interest. For integration, a designed Flp-In™ expression 
vector, here pcDNA™5/FRT/TO, is co-transfected with Flp recombinase vector, here pOG44. 
The FRT (flippase recognition target) coding vector is then inserted into the Flp site within 
the host cell genom. 
The basal medium consists of DMEM, 10 % FBS and L-glutamine. The expression of the 
inserted protein is under the control of a tetracycline promoter. Therefore, tetracycline-free 
FBS must be purchased. 0.1 % (v/v) zeocin and 0.15 % (v/v) blasticidin are recommended for 
cultivation of untransfected cells. The zeocin resistance gene lies within the Flp site and is 
interrupted upon gene insertion. Therefore, the medium for transfection contains only 
blasticidin. The vector encodes a hygromycin resistance gene. So, successful transfection can 
be checked by addition of 0.2 % (v/v) of hygromycin to the medium. Picking of single 
colonies and further passaging in selecting medium was performed several times (4-8 times) 
before the cells were frozen in liquid nitrogen for long time storage. 
 
 
2.2.3.2 44B58BSplitting 
 
Cells grown in 10 cm dishes are washed with PBS. 3 ml trypsin-EDTA (Gibco) is added until 
the cells detached. Harsh pipetting with a transfer pipette separates the cells. Air bubbles are 
avoided as good as possible. Addition of 7 ml medium inactivates the trypsin reaction, 
because of neutralization of the pH. The desired amounts of cells are transferred to a new 
dish, prefilled with 10 ml culture medium.  
 
2.2.3.3 45B59BTransfection 
 
DNA cannot pass the plasma membrane, because of size and charge. Here, two different 
protocols were performed to transfect cells with the desired DNA. Ca2PO3-precipitation is a 
cheap method used for the transfection of HEK293T and Flp-in™ T-Rex cells. MDCKII cells 
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cannot be transfected with this method. Therefore, transfection with Lipofectamin™2000 was 
performed. 
 
 
2.2.3.3.1 83B97BCa2PO3-precipitation 
 
The calcium phosphate precipitation method was first described by Graham and van der Eb 
(1973). DNA coprecipitates with calcium phosphate on a monolayer of cells which take up 
the DNA by an unsolved mechanism. The desired amount of plasmid DNA is diluted in 10 µl 
salmon sperm and 500 µl 100 mM CaCl2. This mix is added dropwise to 2x HEBS solution 
(274 mM NaCl, 40 mM Hepes, 12 mM dextrose, 10 mM KCl, 1.4 mM Na2HPO4) and mixed 
thoroughly. After 20-30 minutes at RT, the mix is added dropwise to 80 % confluent cells 
with 10 ml medium while shaking the 10 cm dish. 
 
2.2.3.3.2 84B98BLipofectamin ™ 2000 
 
MDCKII cells were transfected with Lipofectamin™ 2000 according to manufacturers’ 
instructions. 80 % confluency of cells was attained. The desired amount of DNA is diluted in 
OptiMEM. Lipofectamin™ is diluted in OptiMEM, too. After 5 minutes, the DNA-containing 
mix is added dropwise to the Lipofectamin-mix while mixing thoroughly after each drop. 
After 30-60 min incubation at RT, the mix is given to the cells in standard culture medium. 
For confocal microscopy, cells were grown in Ibidi 35µm high dishes. For biotinylation assay, 
10 cm dishes were used for culturing MDCKII cells. 
 
2.2.3.4 46B60BFreezing cells 
 
Cultured cells can be stored for long time at -80 °C. For that purpose, the cells are washed 
with PBS in a dish. Addition of 3 ml trypsin-EDTA detaches the cells. Trypsin is inactivated 
by addition of 7 ml medium. The cells are spun down (3 min, 1500 rpm, the supernatant is 
discarded) and resuspended in 3 ml MEM containing 20 % FBS.  Aliquots à 0.5 or 0.75 ml 
are taken and mixed with same volume of MEM containing 20 % FBS and 33 % (v/v) DMSO 
(di-methyl-sulf-oxid). In a Nunc-box, the cells are slowly cooled down to -80 °C. 
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2.2.3.5 47B61BThawing cells 
 
Frozen cells are thawed at room temperature. Washing of cells is recommended to get rid of 
dispensable DMSO. Therefore, cells are spun down (5 min, 800 rpm) and resuspended in 
standard culture medium for at least one time before transferring the cells into a culture dish.  
 
 
2.2.4 20B34BElectrophysiology 
 
We used standard whole cell patch clamp techniques as described by Sakmann and Neher in 
1984. Two electrodes as references record the potential between the interior and exterior of 
the cell. The quality of the Gigaseal was checked with a test pulse of 5 mV for 10 ms. Spikes 
at the beginning and end of the test pulse before and after opening of the cell were 
compensated by an analog procedure to minimize voltage errors due to capacitances of the 
pipette, respective cell. By application of voltages to the interior of the cell, the voltage 
dependence of over-expressed channels is displayed by the resulting current measured with a 
feedback amplifier. 
 
2.2.4.1 48B62BSetup 
 
All patch clamp recordings were digitized by Digidata 1440 and amplified by an Axopatch 
200B. We used the pClamp 8-10 software for recordings in combination with Excel and 
SigmaPlot for data analysis. A Leica inverted microscope was placed on a shock dampened 
table (TMC, Peabody, USA). The setup was protected against electrical radiation by a 
Faraday cage. A piezoelectric micromanipulator (SM-1, Luigs & Neumann, Ratingen) was 
used to move the pipette to the cell. 
 
 
2.2.4.2 49B63BPipettes and electrodes 
 
Pipettes were pulled from borosilicate glass capillaries (Harvard apparatus) with a 
micropipette puller (Sutter instruments). Heat polish of the pipettes with a microforge (MF-
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830, Narishige Japan) smoothed the edges. The opening tip of the pipettes had diameters of 
about 5 µm, resulting in resistances of 1-2.2 MΩ. For stationary noise analysis the pipettes 
were covered with dental wax (Moyco) to reduce their capacitance. Therefore the pipettes 
were pulled, polished, waxed and again polished.  
Silver wires were used as electrodes. These were chlorinated with hypochloric acid. 
 
2.2.4.3 50B64BPreparation of cells 
 
HEK293T and Flp-In T-Rex cells were used for whole cell patch clamp recordings. For 
transfection of HEK293T cells, the calcium phosphat precipitation protocol was chosen as 
described above. 2 µg pcDNA3.1 (-) YFP hClC-Ka, 2 µg pRcCMV YFP V166E rClC-K1 or 
4 µg of pcDNA3.1 (+) XX barttin mCFP (XX = WT or mutation, e.g. G10W) were 
transfected. 
When hClC-Ka was expressed, 12 hours after transfection the cells were splitted. After 
additional three hours, patch clamp recording started. When V166E rClC-K1 was expressed, 
splitting took place after 24 hours. 36h after transfection, patch clamp recordings started. 
Flp-In T-Rex cells were stable transfected as described (1.5.1.3) and splitted 12 hours before 
patch clamp recordings.  
The cells are washed three times with 5 ml bath solution before having 5 ml bath solution in a 
6 cm dish. 
 
2.2.4.4 51B65BSolutions 
 
Extracellular solution contained (in mM): NaCl (140), KCl (4), CaCl2 (2), MgCl2 (1), HEPES 
(5), pH 7.4; intracellular solution contained (in mM): NaCl (120), MgCl2 (2), EGTA (5), 
HEPES (10), pH 7.4. Chloride is the only anion present with almost symmetrical distribution. 
Nernst-equation results in a chloride reversal potential of -4.8 mV at room temperature 
(22°C). After splitting the cells in 6 cm dishes containing 3 ml medium and at least 3 hours 
incubation at 37 °C, the cells were washed 3x with 5 ml extracellular solution, before adding 
5 ml of the same solution for whole cell patch clamp recordings.  
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2.2.4.5 52B66BDetermination of relative open probabilities and times constants of 
activation 
 
In this study we investigated human and rodent ClC chloride channels. To determine the 
voltage dependencies of the channel, a voltage protocol is used. First, voltage steps between 
-155 and +125 mV were applied followed by a test pulse to -125 mV. For activation curves, 
the current amplitudes at the beginning of the tail pulse are plotted versus the applied voltage. 
Fitting this data with Boltzmann functions (eq.2) and normalizing the activation curves to the 
maximum of the fit results in relative open probabilities of the channels. 
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     (eq.2) 
 
In eq.2, V0.5 corresponds to the voltage of half-maximal activation. The current amplitude at 
certain voltages V can be estimated, as well as the minimal Imin and maximal Imax amplitude at 
very negative or positive potentials. The activation curves are now normalized to Imax to 
obtain relative open probabilities of the channel pchannel.  
 
As mentioned in the introduction, ClC channels are organized as dimers consisting of two 
protopores which are under the control of a fast protopore gate and a slow common gate. 
These gates are assumed to move independently and can be separated by a short interpulse of 
5 msec to +180 mV prior to the test pulse. The instantaneous test pulse current amplitude is 
then only dependent on the steady state slow gate open probability pslow gate that has been 
reached during the long prepulses of varying potentials. Same fitting procedure like before is 
used to obtain pslow gate. Then, the open probability of the fast gate pfast gate can be calculated by 
dividing the total channel open probability pchannel by its slow gate open probability pslow gate:  
 
slowgate
channel
fastgate p
pp        (eq.3) 
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For normalization, the calculated activation curve of the fast gate is fitted with Boltzmann 
functions analog to the fitting procedure mentioned above. For that purpose, Imax and Imin are 
substituted by pmax and pmin in eq.2. 
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Pchannel is now recalculated by multiplication of pfast gate and pslow gate. 
 
 
To determine the time course of activation τ, whole cell current recordings at +125 mV were 
fitted with a mono-exponential function:  
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       (eq.5) 
 
In this study, τ is the elapsed time until 63.2 % of ΔI is reached after a stimulus of a certain 
voltage. 
 
 
 
 
 
2.2.4.6 53B67BNoise analysis 
 
Here we performed stationary noise analysis of HEK293T cells coexpressing hClC-Ka 
together with barttin in order to receive single channel conductance, absolute open 
probabilities and the number of active channels in the plasma membrane. All recordings were 
filtered with a 10 kHz low pass Bessel filter. Noise analysis could be performed due to a 
dramatic increase in current variance upon hyperpolarization. This flickering is caused by 
statistical closure and reopening of some channels in the membrane. The highest variance can 
be observed, when the open probability of the channel is at 50 %. Then spontaneous opening 
and closing of the channel occurs with highest probability. 
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The macroscopic current (I) is the product of the number of channels (N), single channel 
amplitude (i) and the single channel open probability (po): 
 
opiNI         (eq.6) 
 
 
Current variance (σ2) is related to the single-channel properties as: 
 
N
IIi
2
2        (eq.7) 
 
It is assumed that the single channel conductance and the number of channels do not change 
during measurement. Background noise was subtracted. Plotting the variance, normalized by 
the product of the mean current (I) and the electrical driving force (V – Vr), versus the 
macroscopic conductance 
RVV
I
  leads to a linear regression of data point, whereas the slope 
is the negative reciprocal number of channels.  
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N
1  equals the slope, whereas 
RVV
i
 is the y-axis intercept of the linear regression 
corresponding to single channel conductance. The x-axis intercept is the maximum 
conductance of the whole cell. Normalization of conductance levels by maximum 
conductance and plotting versus applied voltage results in absolute open probabilities.  
 
 
 
 
 
 
 
-- Material and methods -- 
 - 37 - 
2.2.5 21B35BConfocal imaging 
 
Live cell confocal imaging was carried out with MDCK II cells on a Leica DM IRB inverted 
microscope with a TCS SP2 AOBS scan head. Subcellular distribution of barttin-mCFP was 
investigated using 405 nm excitation wavelength and fluorescence detection within the range 
of 450-500 nm. Excitation wavelength at 514 nm and fluorescence detection at 520-600 nm 
was used to study the distribution of YFP-ClC-Ka channels.  
MDCKII cells were transfected with the Lipofectamin™ protocol (see 2.2.3.3.2). 0.8 µg 
pcDNA3.1 (-) YFP-hClC-Ka and 1.2 µg pcDNA3.1 (+) XX barttin mCFP (XX = WT or 
mutation, e.g. I9W) were cotransfected in corresponding OptiMEM (2x100 µl) and 
Lipofectamin (4 µl) concentrations and 1 ml of culture medium in the Ibidi dishes. The 
culture medium was renewed after 20 hours. 48 hours after transfection, the imaging started. 
 
 
 
2.2.6 22B36BProtein biochemistry 
 
Barttin is the functional subunit of ClC-K channels. One of the tasks of barttin is to facilitate 
enhanced membrane insertion of the channel proteins. This can be quantified by biotinylation 
assay. Therefore, a ratio of surface membrane exposed and expressed protein is built to obtain 
the surface membrane fraction. 
 
Western blot analyses were performed as qualitative check of the biotinylation assay as well 
as check for the correct size of the built concatamers barttin/V166E rClC-K1. 
 
 
 
2.2.6.1 54B68B iotinylation assay 
 
Surface exposed proteins with extracellular primary amino-groups can be labeled with a 
modified biotin and purified via this label. Here, we want to quantify the amount of ClC-K 
channel protein or barttin that is brought to the membrane. The target proteins are labeled 
with fluorescence reporter genes. By comparing the fluorescence membrane fraction with the 
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fluorescence of the whole cell lysate, a relative surface membrane fraction is calculated. The 
fluorescence of the whole cell lysate corresponds to the relative expression level when 
normalized to the fluorescence of WT barttin or hClC-Ka in presence of WT barttin. 
In the following passages, the reaction steps are described in detail before Fig.10 gives an 
overview about the several steps of the protocol. 
2.2.6.1.1 85B99BLabeling with biotin 
 
MDCKII cells were transfected with 2 µg plasmids coding for barttin, respective barttin 
mutants together with 1 µg hClC-Ka coding plasmid (in 200 µl OptiMEM) using 
Lipofectamin™ (in another 200 µl OptiMEM) in 10 cm dishes in 6 ml transfection medium. 
12-18 hours after transfection, the medium was changed. 44 hours after transfection, EZ-
linked sulfo-NHS-SS-Biotin was dissolved in cold PBS to a concentration of 0.5 mg/ml. The 
cells were washed gently three times with PBS at RT (3 ml). PBS was removed by a vacuum 
pump. Preceding steps all were performed at 4 °C. Solutions should be cooled. Cells were 
incubated with 0.5 mg EZ-linked NHS-sulfo-SS-biotin for 30 min. Surface exposed primary 
amino groups, e.g. found in lysine or arginine, are bound by thioester-linked biotin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.9 Molecular structure of EZ-linked 
NHS-sulfo-SS-biotin 
Reactive centers are indicated. The left 
box is substituted by a primary amino 
group of a protein. After binding of the 
protein, biotin (right box) can bind to an 
avidin matrix for purification. The thiol-
bond is cleaved by DTT to elute the 
protein of the avidin matrix. 
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2.2.6.1.2 86B100BWhole cell lysate 
 
100 mM glycine/PBS is used for 3 washing steps. The last washing step was let stand for 20 
min. Free glycine quenches unbound biotin. After two additional washing steps with PBS, 
lysis was performed with 1 ml of modified RIPA buffer. The components of the here used 
RIPA and washing buffer are listed in Tab.11+12. 
 
RIPA buffer concentration 
HEPES 20 mM 
NaCl 100 mM 
EGTA 1 mM 
Na-orthovanadate 1 mM 
NaF 50 mM 
NP-40 alternate 1 % (v/v) 
Na-Deoxycholate 1 % (w/v) 
SDS (Sodium dodecyl 
sulphate) 0.1 % (v/v) 
Pi-mix complete 1 % (v/v) 
Benzonase 8 U/ml 
pH 7.4 
 
The lysate was cleared by a centrifugation step for 15 min at 4 °C with 13.000 g. Protein 
concentration was determined by BCA-Assay (Pierce) following manufacturers instruction. 
Comparable amounts of protein (≈ 50µg) were loaded onto SDS-PAGE gel for densitometric 
analysis of relative expression. WT barttin was present in all gels as reference. The 
fluorescence intensity of the bands corresponding to barttin, respective channel protein, was 
normalized to the one found in the presence of WT barttin to determine the relative expression 
level.  
 
 
2.2.6.1.3 87B101BSurface membrane fraction 
 
Surface membrane exposed proteins were labeled with enzyme linked biotin, as described 
above. Comparable amounts (around 1 mg per sample and experiment) of cleared lysates 
were incubated with High Capacity NeutrAvidin Resin™ (Thermo Scientific) that was 
equilibrated with RIPA-buffer. Biotin binds to the avidin-coated beads during a 2 hour 
incubation period at 4 °C while rotating. Proceeding, the beads were washed once with RIPA 
buffer and five times with washing buffer. The last washing step must not contain fluorescent 
protein. This was checked by SDS-PAGE (polyacrylamide gel electrophoresis) analysis. In 
Washing buffer concentration 
Triton X-100 0.1 % (v/v) 
NaCl 500 
EDTA 5 mM 
Tris 50 mM 
Pi-mix complete 1 % (v/v) 
pH 7.4 
Tab.11 Composition of lysis buffer (left) 
A modified RIPA-buffer was used for cell lysis. 
 Tab.12 Composition of the wash buffer (up) 
The detergent is change to exchange to micelles and 
their interior to purify resin bound proteins. 
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case of false positive fluorescence in gels of washing fractions, additional washing steps were 
performed. DTT containing Lämmli-buffer was used to cleave the disulfide bond within the 
spacer arm of SS-biotin, thereby eluting formerly surface exposed proteins of the matrix.  
SDS-PAGE gels and densitometric analysis quantifies the amount of surface exposed protein. 
The ratio of fluorescence of biotinylated protein and the fluorescence of protein in the cleared 
lysate marks the surface exposed fraction. The found ratio was normalized to the one found 
for WT barttin or hClC-Ka in presence of WT barttin. 
 
Fig. 10 Scheme of biotinylation assay procedure 
Cells are incubated with a modified biotin. The modification (Fig.9) allows labeling of primary amino groups exposed to the extracellular 
side of the cells. After washing and lysis of the cells, surface exposed proteins can be purified via the biotin-label along a NeutrAvidin 
Agarose resin. 
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2.2.6.2 55B69BSDS-PAGE gel 
 
12 % SDS-PAGE gels were poured for separation of proteins. In Tab.13, components of 
running and stacking gel are listed. Ammoniumpersulphate (APS) was freshly prepared in 
deionised water and crosslinks acrylamid monomers. N,N,N´-tetramethyl-ethylene diamin 
(TEMED) was purchased from Serva and is the catalysator of this crosslink reaction. 
 
 
SDS-PAGE gel 12 % running gel 4 % stacking gel 
H2O 1.65 (ml) 1.525 (ml) 
1.5 M Tris pH 8.8 1.25 (ml) --- 
1.5 M Tris pH 6.8 --- 0.625 (ml) 
Protogel 2 (ml) 0.325 (ml) 
10 % SDS 50 (µl) 25 (µl) 
10 % APS 50 (µl) 12.5 (µl) 
TEMED 5 (µl) 2.5 (µl) 
 
 
 
Samples were dissolved in 5 x Lämmli buffer (Tab.14). Dual Color marker (DC) was loaded 
for size estimation. Running buffer contained 25 mM Tris-Base, 192 mM glycine and 3.5 mM 
SDS. Gels were run at 90 V during stacking and 180 V for running gel. 
 
 
 
 
 
2.2.6.3 56B70BTyphoon laser scanning  
 
Fluorescent bands in SDS-PAGE gels were visualized with a fluorescence scanner (Typhoon, 
GE Healthcare). CFP was excited with coherent light of 457 nm, YFP was excited with 
488 nm. For emission detection, a 40 nm broad band pass filter was used with the center peak 
at 520 nm for both channels. 
For marker (Dual Color DC marker, BioRad) visualization, RFP was excited with 457 nm or 
633 nm. For emission detection, same filter as above or a red light corresponding 30 nm broad 
band pass filter was used with the center peak at 670 nm. 
 
Lämmli buffer concentration 
TrisHCl pH 6.8 250 mM 
SDS 10 % 
Glycerol 10 % 
DTT 100 mM 
Bromphenole blue 0.05 % 
Tab.14 Composition of running and stacking gel 
 
Tab.13Composition of the Lämmli buffer 
This buffer is needed to load the sample on the gel. 
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Fig. 11 Fluorescence scan of SDS-PAGE gel of 
MDCKII cells expressing YFP hClC-Ka (yellow) 
alone or with WT barttin mCFP (blue) 
hClC-Ka typically shows two bands without barttin. 
Barttin facilitates channels ER-exit by complex 
glycosylation. This additional mannose weighs on 
hClC-Ka resulting in a third band. DC size marker 
was loaded. 
2.2.6.4 57B71BSDS-PAGE gel analysis 
 
Fluorophore-tagged proteins allow quicker 
detection and more accurate densitometric 
analysis of SDS-PAGE gels than Western blot 
analysis. Therefore, mCFP (monomeric cyan 
fluorescent protein) was covalently linked to 
barttin and YFP (yellow fluorescent protein) to 
hClC-Ka. For almost all biochemical experiments, 
MDCKII cells were cotransfected as described. 
Loading of cleared lysate onto SDS-PAGE gels leads to a distinct band pattern, when scanned 
with a fluorescence laser scanner. An example is shown in Fig.11. Without barttin, a yellow 
double band of the channel can be detected at approximately 100 kDa. With barttin, a third 
smeary channel band appears at approximately 110 kDa, and the barttin band (colored in 
blue), of course. Janssen et al. showed in 2009 three channel bands are caused by different 
glycosylation states – unglycosylated, core glycosylated and complex glycosylated. The 
complex glycosylation of hClC-K channels only takes place in presence of barttin. By that, 
hClC-K can exit the ER and is further transported to the plasma membrane, together with 
barttin.  
To figure out the expression level and the surface membrane fraction of hClC-Ka and barttin, 
gels like the shown were run and densitometrically analyzed.  
Some gels were analysed with a different imaging device, the Fusion SL (Peqlab). This device 
uses diodes and no lasers for excitation. In contrast to the Typhoon, the Fusion device detects 
emitted light over the whole plate and not spotwise with confocal application. These two 
differences lead to lower fluorescence intensities and lower resolution. So, only one band 
corresponding to YFP hClC-Ka is detected Fig. 16 and 21. 
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2.2.6.5 58B72BDensitometric analysis 
 
Fluorescent band intensities were quantified using Image Quant TL software. Lanes were set 
manually and background subtraction was performed with the rolling ball algorithm. Bands 
with a minimum slope of 100 were detected and normalized to the band intensity of WT 
barttin or hClC-Ka coexpressed with barttin. 
To quantify the expression level of hClC-Ka, the intensity of the three bands were summed.  
For surface membrane fraction, the intensity of the fluorescent band of biotinylation protein is 
divided by the intensity of the fluorescent band of whole cell lysate (in case of hClC-Ka the 
sum of three bands was built).  
 
2.2.6.6 59B73BWestern blot 
 
General western blot protocol was used for transfer onto PVDF membranes (GE Healthcare). 
Protein transfer was performed at pH 9.9 for 1 h with 90 V at room temperature or for 16 
hours and 20 V at 4 °C. Blot membranes were blocked for at least 1 hour in TBS with 3 % 
BSA (bovine serum albumin). Before and after incubation with antibody-containing buffer, 
the membranes were washed twice with TBS/0.1 % Triton X-100 and once with TBS. Each 
washing step took 5 minutes while shaking. Incubation with primary or secondary antibody 
was performed for at least one hour at room temperature or overnight at 4 °C while shaking. 
 
2.2.6.6.1 88B102BQualitative control for surface membrane proteins 
 
The elution fraction of the biotinylation assay should not contain intracellular proteins as 
GAPDH (glycerin-aldehyde-3-phosphate-dehydrogenase) for instance. Therefore we 
performed western blots of gels loaded with this fraction. A primary antibody raised in mouse 
against human GAPDH (Santa Cruz, mouse anti-GAPDH, dilution 1:2500 in TBS with 1 % 
BSA) was used for detection. For visualization, a chemiluminescent procedure was used. A 
HRP- (horseradish-peroxidase) conjugated secondary antibody was used (HRP-anti-mouse, 
dilution 1:20000 in TBS with 3 % BSA) and detected with SuperSignal West Pico 
Chemiluminescent Substrate™ (Thermo Scientific). This substrate leads to enhanced 
chemiluminescence (ECL). 
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2.2.6.6.2 89B103BQualitative check for built concatamers 
 
As shown in the results, fluorophore labeled concatamers are no longer functional. Therefore 
we performed a western blot for detection of unlabeled concatamers. HEK293T cells 
expressing WT barttin and mutant barttin concatamers were lysed. The lysates were 
electrophoresed and western blotted. Two detection strategies were tried. First, a primary 
antibody that was raised in goat against human barttin (Santa Cruz, goat-anti-barttin, dilution 
1:2000 in TBS with 1 % BSA), and second, a primary antibody raised in rabbit against rat 
rClC-K1 were used. Detection with appropriate secondary antibodies (HRP-anti-goat, or 
HRP-anti-rabbit) and SuperSignal West Pico Chemiluminescent Substrate™ (Thermo 
Scientific) took place. 
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3 7BResults 
 
 
In this study, we examined sequence determinants at the functional modification of ClC-K 
chloride channels by barttin. For this purpose, we analyzed the effects of tryptophan-
substituted barttin on two ClC-K channel orthologs – the human hClC-Ka and the rodent 
rClC-K1 with the earlier mentioned gating glutamate introduced at amino acid position 166 
(V166E). We found residues to be crucial for the stability, trafficking or chaperone function 
of barttin, as well as residues that may play a major role in channel activation/gating 
regulation.   
 
 
3.1 4B18BhClC-Ka and the effects of barttin and mutant barttins  
 
3.1.1 23B37BhClC-Ka is activated by WT barttin – and only by four helix 1-
mutants  
 
HEK293T cells were co-transfected with plasmids encoding an N-terminally labeled fusion 
protein of hClC-Ka and YFP and a C-terminally labeled fusion protein of barttin and mCFP. 
Barttin was transfected with DNA amount 2-4 times larger than ClC-K encoding plasmids to 
ensure that all ClC-K proteins are complexed with barttin. Only cells with an obviously 
exceeding mCFP-fluorescence were selected for patch-clamp experiments to ensure a higher 
amount of barttin. 
 
Whole cell patch clamp measurements of HEK293T cells that express hClC-Ka channels in 
absence of barttin reveal currents that were indistinguishable from untransfected cells. Co-
expression of WT barttin induces hClC-Ka currents over the whole measured voltage range 
between -245 mV and +145 mV (Fig.12A). At very negative potentials the hClC-Ka/barttin 
current amplitudes decrease and current noise values increase (Fig.12A right panel). Fig.12B 
depicts an I-V-plot showing the voltage dependence of hClC-Ka currents in presence and 
absence of barttin. hClC-Ka/barttin currents display a hook-shaped I-V-dependence with a 
current maximum at around -150 mV.  
-- Results -- 
 - 46 - 
 
Fig.12C shows representative recordings of hClC-Ka channels for some exemplary barttin 
mutants. Some evoke larger currents, like F11W barttin and some evoke smaller currents, like 
M40W or I49W barttin. However, the voltage dependence of current amplitudes remained 
unchanged in any case. The reversal potential and the potential of maximum current at 
negative range were not shifted.  V13W, T23W, F24W, T36W and G41W barttin are 
examples for barttin mutations that failed to activate hClC-Ka. There are many possible 
reasons for these effects of tryptophan insertion on barttin function. Misfolded or degraded 
barttin proteins, or barttins that fail to bind to the ClC channel will lead to a loss of function. 
Mutants that impair subcellular trafficking or proper gating of hClC-Ka would evoke smaller 
or no currents. Lower expression of barttin could result in lower amplitudes.  
In Fig.12D hClC-Ka/barttin mean current amplitudes at a voltage of +105 mV are compared 
for the whole set of barttin mutants. Substitution of single amino acids by tryptophan in 
transmembrane helix 1 of barttin, TM1, impairs channel function for most residues. Only 
mutations at position I9, F11, L16 and L19 allow proper channel activation. hClC-Ka/barttin 
seems to be more resistant to tryptophan substitutions in helix 2 of barttin. 15 of 21 
tryptophan substitutions in the second transmembrane helix of barttin, TM2, do not impair 
activation of hClC-Ka. Four out of these mutantions evoke lower mean current amplitudes 
(F37W, M40W, G47W and Q55W barttin). In contrast to all other mutants marked with 
asterisks, the I-V-plots in presence of these four mutants show the characteristic hook-shaped 
Fig.12 (A) Representative recordings of HEK293T cells expressing hClC-Ka (left) or hClC-Ka with WT barttin (right) 
Voltage steps of 10 mV from -245mV to 145mV were applied with an in between holding potential of 0mV. (B) I-V-plot of hClC-Ka 
without and with WT barttin; reduction of amplitude is registered beyond -150mV with raising noise. (C) Representative recordings of 
hClC-Ka coexpressed with mutant barttins. F11W, M40W and I49W are examples for WT-like current traces, however with different 
amplitudes. V13W, T23W, F24W, T36W and G41W barttin are exemplary for mutations which inhibit currents of hClC-Ka. (D) 
Comparison of hClC-Ka amplitudes at 105mV. Only 4 of 18 barttins of helix 1 evoke hClC-Ka currents, as well as 15 of 21 barttins of 
helix 2 (highlighted with white bars). Black bars and bold letters represent residues which diminish the currents amplitude. 
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I-V-dependence. All mutants that significantly reduce mean current amplitudes are marked 
with bold letters in Fig.12D. Since lowering of the mean current amplitude can be due to 
multiple reasons, we examined single channel properties and trafficking of hClC-Ka co-
expressed with mutant barttin. 
 
 
3.1.2 24B38BFunctional barttin mutants leave single channel properties of 
hClC-Ka/barttin unaffected 
 
The amplitude of macroscopic hClC-Ka/barttin currents depends on the product of the single 
channel amplitude (i), the number of active channels in the plasma membrane (N) and the 
open probability of the channels (po) (see material & methods, eq.6). We used stationary noise 
analysis to investigate these channel properties. Plotting the macroscopic current variance, 
normalized by the product of the mean current amplitude I and the electrical driving force 
V-Vr (V = applied voltage, Vr = reversal potential), versus the macroscopic conductance 
I/(V-Vr) reveals the unitary channel conductance as y-axis-intercept. The number of active 
channels in the membrane can be obtained from the slope of the linear regression line of the 
same plot (material & methods, eq.7+8).  
 
Fig.13A shows representative noise analyses for hClC-Ka currents in presence of WT barttin 
or M40W barttin. The unitary channel conductance of about 20 pS is comparable for WT and 
mutant barttin, but the number of active channels and therefore the maximum conductance of 
the whole cell (x-axis intercept) is clearly reduced for M40W barttin. The quotient of the 
actual conductance at certain voltages by the maximum conductance gives the absolute open 
probability of the channel. Fig.13B illustrates the voltage dependence of absolute open 
probabilities indicating that there is no difference between M40W and WT barttin. M40W 
barttin was chosen as example for a barttin mutant that results in rather low hClC-Ka current 
amplitudes. However, even such a barttin mutant is able to transfer hClC-Ka channels into an 
open state with unaltered pore properties.  
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Fig.13 Stationary noise analysis of currents of HEK293T cells coexpressing hClC-Ka and barttin 
(A) Noise analysis of WT barttin and exemplary mutant M40W barttin reveals same unitary conductance (y-axis 
intercept). (B) Absolute maximal open probability of hClC-Ka coexpressed with WT barttin or exemplary barttin mutant 
M40W barttin. No changes in open probability are observed. (C) Bar charts sum noise analysis results of all scanned 
barttin mutants. No changes in unitary conductance or absolute maximal open probability could be examined. Due to 
very tiny currents, noise analysis was not performed for mutants marked with n.d. = not determinable. n≥4, all data + 
S.E.M. Students t-test was performed to test for significance. Bold letters highlight residues with still unknown reasons 
for low current amplitudes (Fig.12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Noise analyses were carried out for all mutants that activate hClC-Ka and results are 
summarized in Fig.13C. No difference in absolute maximal open probability at +5 mV or 
single channel conductance of hClC-Ka was detected in presence of WT barttin and any 
barttin mutant. We conclude that barttin mutants that activate hClC-Ka channels do not 
change the pore properties of the channel. 
Changes in current amplitudes therefore are caused by differences in the number of channels 
in the plasma membrane or by complete insufficiency of barttin to switch membrane inserted 
channels into an active state.  
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Fig.14 Fluorescent SDS-PAGE gel of whole 
cell lysate of MDCKII cells expressing 
hClC-Ka without or with barttin 
Without barttin (left lane) two prominent 
bands are visible corresponding to 
unglycosylated (+) and core glycosylated 
(++) channel protein. In the presence of 
barttin (hashtag #, right lane), hClC-Ka is 
complex glycosylated (+++).   
Fig.15 SDS-PAGE gel analysis; quantification of fluorescent band intensities of (A) barttin, normalized to WT barttin and (B) 
hClC-Ka, normalized to hClC-Ka in presence of WT barttin 
(A) Most barttin mutants do not express as well as WT barttin (asterisks), but low barttin expression does not correlate with low current 
amplitudes (black letters). Residues illuminated in light grey did not reduce mean current amplitude. For the others, the reason for low 
current amplitude needed to be found out. Reduced barttin expression often did not result in diminished mean current amplitude (e.g. 
I46W, I49W, I50W or S52W compared with Fig.12D). The minimal expression level for unaltered current amplitudes is below 16% 
(S52W) and above 1.6% (M40W). (B) Channel expression remains constant upon cotransfection with most barttins. Lower channel 
expression must not necessarily lead to a reduction in mean current amplitude (Y38W). Reduced barttin and reduced channel expression 
not necessarily lead to a decrease in current amplitude (G35W, A39W compared with Fig.12D). (Mann-Rank-Sum-Test was performed 
to check for significance * p<0.05; ** p<0.01; *** p<0.001). Data are mean + S.E. n ≥ 3. 
3.1.3 25B39BExpression level of mutant barttin and hClC-Ka 
 
Fig.14 shows a fluorescence scan of a representative SDS-
PAGE gel from lysed MDCK II cells that expressed YFP-
hClC-Ka in absence (left lane) or in presence (right lane) 
of WT barttin. Without barttin, two YFP bands can be 
seen between 75 and 100 kDa. In presence of WT barttin, 
a third YFP band appears at around 115-130 kDa. 
Barttin-mCFP migrates at around 60-65 kDa (#). The 
different molecular weights of hClC-Ka proteins are 
caused by different glycosylation states (Janssen et al. 
2009). The lightest band corresponds to unglycosylated 
channel (+) protein. During maturation the protein becomes core-glycosylated in the ER (++). 
Binding of additional oligosaccharides results in complex glycosylated channel proteins 
(+++), which may facilitate Golgi-exit and membrane trafficking. For the determination of 
relative expression levels, the fluorescence intensities of all YFP bands were summed and 
corrected for the protein concentration of the cleared cell lysates, as determined using a 
BCA-assay.  
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In Fig.15, expression levels were normalized to the expression of WT barttin in (A) and to the 
expression of hClC-Ka in presence of WT barttin in (B). In absence of WT barttin, the 
expression level of hClC-Ka increases by a factor 2. For determination of the expression level 
of hClC-Ka without barttin, no second plasmid was present. Cotransfection of additional 
plasmids influences the transcription of the first plasmid, as shown in Fig.16. Therefore, the 
relative expression level of hClC-Ka expressed without barttin is higher.  
Light grey letters and bars in A and B mark barttin mutations that did not lower the mean 
current amplitude. Black letters indicate mutations that lower the mean current amplitude for 
still unknown reason. 
 
 
The majority of barttin mutations affect the protein biosynthesis, because 29 out of 38 
investigated mutants displayed reduced expression levels. The hClC-Ka expression was 
slightly, but significantly reduced (asterisks) in presence of only 7 out of 38 barttin mutants. 
There is no clear correlation between both expression patterns. Low expressing barttin 
mutants like G35W or M40W do not evoke higher hClC-Ka expression, as might be expected 
if plasmids coding for these barttin mutants were not transcribed. As shown in Fig.16, the 
more barttin is expressed, the less channel protein is built. 
 
 
 
 
 
 
 
 
Fig.17 illustrates relative expression levels of barttin and current amplitudes of 
hClC-Ka/barttin channels in one plot. Dashed lines arbitrarily separate relative expression 
levels of barttin lower than 10 % and currents lower than 1 nA. 
  
 
Fig.16 Fluorescent SDS-PAGE gel to illustrate the lower 
expression level of hClC-Ka with raising concentration of 
co-transfected plasmids coding for barttin 
HEK293T cells were co-transfected with (upper row) 2 µg 
pcDNA3.1(-) YFP hClC-Ka and (lower row) various amounts 
of pcDNA3.1(+) barttin mCFP. 
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Expression levels of five mutant barttins are below 10 %. Of those, only M40W barttin 
activates hClC-Ka. Mutations F24W, M26W, G41W and V45W abolish hClC-K/barttin 
currents. A lot of barttin mutations reduce current amplitudes (bold letters in Fig.12D), even 
though expression levels are high and cells with excessive barttin expression were 
preferentially selected for electrophysiological recordings. These mutants include hClC-Ka 
activating F37W (n=6), G47W (n=12) and Q55W (n=8) (labeled in black in Fig.17) and many 
mutants that reveal current amplitudes below 1 nA (labeled in red).  
We conclude that significantly reduced current amplitudes in patch clamp recordings are in 
most cases not easily explained by reduced expression of barttin. Instead, one has to consider 
additional factors like impaired trafficking of barttin or channel protein to the plasma 
membrane, declined binding affinities between barttin and hClC-Ka or failures in activation 
of hClC-K channels. 
 
Fig.17 Plot of macroscopic hClC-Ka current amplitudes at 105 mV versus barttin expression levels 
A lower relative expression of barttin does not explain low currents or impaired activation of hClC-Ka. Dashed lines mark 10 % 
expression level and 1 nA current amplitude. Mutant barttins that show a significant reduction in mean current amplitude are marked in 
green, black and red. Green marked mutants are hardly expressed. Mutants marked in black activate hClC-Ka with unaltered pore 
properties, but these three mutants and M40W barttin reduce the mean current amplitude. Red marked barttin tryptophan mutants evoke 
low hClC-Ka current amplitudes although the rel. expression level is higher than 25 %. Even with lower expressing barttin mutants, 
regular current amplitudes could be recorded. Currents lower than 1 nA avoid noise analysis. 
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Fig.18 Excerpt of a fluorescence scan of SDS-PAGE gel of 
mutant barttins coexpressed with hClC-Ka 
Only barttin bands are shown. F24W and M26W barttin show 
altered refraction fronts. All other barttin mutations did not 
alter refraction front and could be detected at a same height as 
WT barttin or here shown exemplary mutants. 
3.1.4 26B40BF24W and M26W barttin are misfolded or degraded 
 
Fig.18 shows a CFP fluorescence scan of a representative SDS-PAGE gel with mCFP-barttin 
bands at 60-65 kDa. F24W and M26W barttin, however, migrate differently in the gel as 
compared to all other barttin mutants and WT 
barttin. Only F24W barttin and M26W barttin 
show a smaller band at around 55 kDa. 
Accordingly, these two barttin mutants are 
misfolded or degraded and the missing 
hClC-Ka channels activation is explained by 
improper barttin structure and function. 
 
 
3.1.5 27B41BSurface membrane insertion of ClC-K/barttin channels is impaired 
for some barttin mutants 
 
We next investigated surface 
membrane insertion of hClC-
Ka/barttin channels. MDCKII 
cells, coexpressing hClC-Ka and 
barttin, were incubated with 
modified biotin in the bath 
solution that labels primary amino 
groups of plasma membrane 
inserted proteins from the 
extracellular side. After lysis of 
the cells, labeled proteins were purified using a neutrAvidin matrix. SDS-PAGE gel analysis 
of the protein amount in whole cell lysates and of biotinylated proteins after purification 
(eluate) were used to quantify the plasma membrane inserted fractions of barttin and 
hClC-Ka. Representative fluorescence scans of SDS-PAGE gels are shown in Fig.19. The 
relative amount of complex glycosylated hClC-Ka proteins is obviously higher in the eluate 
than in the lysate.  
Fig.19 Fluorescence scan of SDS-PAGE gels of hClC-Ka coexpressed with 
mutant or WT barttin in MDCKII cells 
Cleared lysates (upper panel) and eluates (lower panel) are depicted for exemplary 
mutants (+++complex glycosylated band, ++core- and +unglycosylated bands). 
Only hClC-Ka bands are shown. 
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To quantify the plasma membrane inserted fraction of barttin and hClC-Ka, the fluorescence 
intensity of biotinylated protein (eluate) was divided by the fluorescence intensity of the 
cleared lysate. The results are depicted in Fig.20. Fractions were normalized to the values 
obtained from WT barttin (A) or hClC-Ka in presence of WT Barttin (B). Besides the two 
misfolded barttins (F24W and M26W, marked as grey bars), three mutant barttins, M40W, 
G41W and V45W, are hardly brought to the membrane (Fig.20A) and marked in green, 
analog to Fig.17. In presence of these mutants the surface membrane insertion of hClC-Ka 
channels was also significantly reduced. We conclude that impaired subcellular trafficking of 
M40W, G41W and V45W barttin is responsible for low hClC-Ka/barttin current amplitudes. 
There are more barttin mutants that impair trafficking of hClC-Ka, even though these barttins 
themselves insert adequately into the surface membrane. They are highlighted as red bars in 
Fig.20B. Four of them (I12W, G15W, A20W and G48W) have been previously shown to be 
sufficiently expressed, but were not able to produce hClC-Ka/barttin currents larger than 1 nA 
(compare Fig.17).  
Q55W and low expressing S52W barttin significantly decrease surface membrane insertion of 
hClC-Ka. These mutants, however, activate the channel protein, resulting in reduced current 
amplitudes for Q55W only. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.20 Quantification of surface membrane fraction of barttin (A) and hClC-Ka (B)  
For mutations marked with black letters in (A), low mean current amplitude has been recorded (compare with Fig.12D). 
Besides (F24W, M26W,) M40W, G41W and V45W, all barttin mutants are WT-like in their trafficking behavior. Despite 
regular barttin trafficking, I12W, G15W, A20W, G48W, S52W and Q55W barttin cannot bring as many channels to the plasma 
membrane as WT barttin. This explains the observed low mean current amplitude of hClC-Ka evoked by these mutant barttins. 
For mutations marked with black letters in (B), no explanation for low mean current amplitude was found. Mann-Rank-Sum 
test was performed to check for significance versus WT barttin or hClC-Ka in presence of barttin (* p<0.05; ** p<0.01; *** 
p<0.001). All data are mean ± S.E. n ≥ 3. 
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In summary, mutations M40W, G41W and V45W hinder trafficking of barttin and 
subsequently trafficking of the channel to the surface membrane. The mutations I12W, 
G15W, A20W, G48W, S52W and Q55W significantly interfere with the chaperone effect of 
barttin, which reduces the plasma membrane insertion of hClC-Ka channels. Lowered mean 
current amplitude of hClC-Ka evoked by Q55W barttin may be explained with fewer channels 
in the plasma membrane. S52W and Q55W barttin can activate hClC-Ka in contrast to I12W, 
G15W, A20W and G48W barttin. Therefore we assume only a partial loss of chaperone 
function.  
Several barttin mutations do not affect channel trafficking. The channel protein and its subunit 
are inserted into the plasma membrane, but hClC-Ka is not activated in presence of G10W, 
V13W, L14W, F17W, L18W, L21W, G22W, T23W, L25W, T36W, M44W or C54W barttin. 
The mean current amplitude is smaller than 1 nA and the I-V-plot does not show the 
characteristic hook-shaped I-V-dependence (compare with Fig.17). We assume effects of 
these barttin mutants on gating properties of hClC-Ka. The reasons for reduced current 
amplitudes remain unclear for F37W and G47W barttin. 
 
As shown before, the expression levels of barttin mutants differ (Fig.15) and the surface 
membrane fraction of hClC-Ka is expected to depend on the concentration of barttin. To 
estimate a relative amount of barttin that is needed to guarantee an excess by biotinylation 
assays, MDCKII cells were cotransfected with 2 µg of plasmids coding for hClC-Ka and 
varying amounts of plasmids coding for WT barttin. Fig.21A shows a representative 
fluorescent SDS-PAGE gel of the surface membrane fraction of hClC-Ka (upper row) and 
barttin (lower row) bands.  
Fig.21 A) Fluorescent SDS-PAGE gel of biotinylated, surface exposed proteins of MDCKII cells cotransfected with plasmids 
coding for WT barttin CFP (lower row) and YFP hClC-Ka (upper row) and (B) normalized surface membrane fraction of 
hClC-Ka in presence of different amounts of barttin 
The amounts of transfected plasmids are indicated. Analog to Fig.15, the amount of built channels decreases with raising barttin 
concentration.  B) The ratio of membrane fraction and total lysate fraction corresponds to the relative surface membrane fraction which 
were normalized to the value found with the highest barttin concentration. This ratio is the same for all observed barttin concentrations 
indicating that a relative barttin concentration of 12.5 % suffices to saturate all possible barttin binding sites in hClC-Ka when co-
expressing 2 µg of vectors expressing hClC-Ka and 4 µg of vectors expressing barttin. 
BA
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By normalizing the ratio of the band intensities of the whole cell lysates (Fig. 16) and the 
surface membrane fraction (Fig. 21A), it gets obvious that co-transfecting 0.5 µg (rel. cbarttin = 
0.125) or 4 µg barttin (rel. cbarttin = 1) coding plasmids together with 2 µg hClC-Ka coding 
plasmids results in comparable relative surface membrane fractions of the channel (Fig.21B). 
This indicates that barttin is present in excess even when the relative amount of barttin is 
reduced to around 12.5 %.  
Since chaperone function of barttin is certainly dependent on the availability of the accessory 
subunit, we correlated surface membrane insertion of hClC-Ka channels to the expression 
level of barttin mutants (Fig.22) to demonstrate whether the loss-of-chaperone function is 
caused by the mutation or if it is artificially caused by low expression. A vertical dashed line 
indicates the minimal relative expression level needed to guarantee an excess of barttin. 
Because of this excess above 12.5 % relative barttin expression, a regression line is missing. 
The correlation of surface membrane fraction and expression level allows evaluations of the 
chaperone effects of barttin mutants. The membrane insertion of hClC-Ka is unchanged even 
for low expressing barttin mutants like G35W barttin, or in contrast, S52W barttin, which is 
comparably low expressed, but fails to take as many channels to the membrane. The loss-of-
chaperone function of S52W barttin is not an effect of low expression, but caused by the 
mutation. 
 
Fig.22 Plot of surface membrane fraction of hClC-Ka versus the relative expression of barttin 
The values of Fig.20B were plotted versus the values of Fig.15A. White circle represent WT-like mutants, green circles mark low 
expressing or misfolded/degraded barttins. Red circles depict barttin mutants that evoke significant reduction in hClC-Ka surface 
membrane trafficking. A vertical dashed line marks the minimal relative barttin expression level and separates green marked mutants from 
the rest. A horizontal dashed line indicates a relative level of surface membrane inserted channel proteins in absence of barttin. 
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Fig.23 Confocal images of MDCKII cell expressing hClC-Ka without or with WT barttin 
Without barttin, most of expressed hClC-Ka (red) retains in intracellular compartments. Upon the presence 
of barttin (green), hClC-Ka is predominantly in the plasma membrane with its β-subunit. Scale bar = 10 µm 
3.1.6 28B42BInvestigation of subcellular barttin and hClC-Ka distribution by 
confocal imaging 
 
We next investigated subcellular distribution of barttin-mCFP and YFP-hClC-Ka channels 
using confocal microscopy. MDCKII cells were transfected with vectors encoding barttin-
mCFP and YFP-hClC-Ka and live cell imaging was performed 48 hours after transfection. 
hClC-Ka remains mostly in intracellular compartments, when barttin is absent. In presence of 
WT barttin both proteins, barttin and hClC-Ka, are co-localized in the plasma membrane 
(Fig.23). 
As expected from biotinylation experiments (Fig.20), some barttin mutants differ in their 
intracellular distribution, and co-localization with hClC-Ka is affected. When the chaperone 
function of barttin is impaired, larger amounts of channel protein are retained in intracellular 
compartments. 
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Fig.24 Confocal images of MDCKII cells expressing 
hClC-Ka with F24W or M26W barttin 
These two misfolded or degraded barttins cannot bring 
hClC-Ka to the plasma membrane. Scale bar = 10 µm 
Fig.25 Confocal images of MDCKII cells expressing M40W, G41W or V45W barttin (A) with or (B) without hClC-Ka 
Chaperone function of these three barttin (green) mutants seems to be impaired. Very low expression levels leave many 
questions. M40W barttin colocalize with hClC-Ka in the plasma membrane, while hClC-Ka (red) trafficking is impaired upon 
cotransfection with G41W and most severe with V45W barttin.  The trafficking of barttin itself is impaired for V45W barttin. 
Scale bar = 10 µm 
F24W and M26W barttin are misfolded or 
degraded, so no chaperone effect was observed, 
the channel was not complex glycosylated and 
here, confocal imaging showed that these two 
barttin proteins and hClC-Ka retain in intracellular 
compartments (Fig.24).  
 
 
 
M40W, G41W and V45W barttin are very low expressed and biotinylation experiments 
predict that these mutants are retained intracellularly together with coexpressed hClC-Ka. 
This is also confirmed by confocal imaging (Fig.25). 
 
Interruption of the chaperone function (Fig.25 upper lane) is obvious for G41W and V45W 
barttin and in full agreement with the results from biotinylation experiments. Membrane 
insertion of M40W barttin and coexpressed hClC-Ka is not as obviously impaired as expected 
from biotinylation experiments, explaining the relatively large current amplitudes with respect 
to a very low M40W barttin expression. 
Trafficking of M40W, G41W and V45W was also investigated in absence of hClC-Ka (Fig.25 
lower lane). Those confocal images show these barttins mainly in the cytoplasm. The 
trafficking of M40W barttin is distorted, but not entirely inhibited. In contrast, G41W barttin 
seems to be transported near, but not into the plasma membrane, whereas V45W barttin 
retains mainly in intracellular compartments. 
-- Results -- 
 - 58 - 
Fig.26 Confocal images of MDCKII cells expressing hClC-Ka (red) and barttin mutants (green) with impaired 
chaperone function 
The six depicted barttin mutants were shown to transport less channel protein to the membrane (Fig.20+22). Confocal 
images support these finding. However, S52W and Q55W barttin colocalize with the channel in the membrane which 
is expected, because only these two barttins can activate hClC-Ka with unaltered pore properties. Scale bar = 10 µm 
Regular barttin trafficking, but loss of its chaperone function was observed for six mutations. 
Confocal images (Fig.26) are not well-suited to discriminate between hClC-Ka channels that 
are located close to the membrane and those channels that interact with barttin and insert into 
the membrane. However, we found clear intracellular staining originating from YFP-hClC-Ka 
and clear membrane staining from barttin-mCFP for mutations G15W, A20W, and G48W. 
Images for I12W, S52W and Q55W barttin display some overlapping YFP and CFP 
fluorescence in the plasma membrane. Electrophysiological recordings irrevocably predict a 
colocalization of hClC-Ka and S52W or Q55W barttin in the membrane. Nevertheless, there 
might be a partial loss of chaperone function.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For many barttin mutants, expression level and surface membrane insertion are not altered. 
Some barttin mutants (I9W, F11W, L16W, L19W, G35W, Y38W, A39W, S42W, V43W, 
I46W, I49W, I50W and M53W, confocal images not shown) activate hClC-Ka like WT 
barttin. However, there are a number of mutations that prevent activation of hClC-Ka, even 
though the interaction between - and -subunits and channel insertion into the plasma 
membrane is not altered. Confocal images from hClC-Ka and these mutants (G10W, V13W, 
L14W, F17W, L18W, L21W, G22W, T23W, L25W, T36W, M44W or C54W) confirm the 
results of biotinylation experiments (Fig.20). Channel proteins and barttin are co-localized in 
the plasma membrane in Fig.27.  
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Fig.27 Confocal images of MDCKII cells expressing hClC-Ka (red) and barttin mutants (green) that cannot activate the 
channel 
All of the here shown images confirm results of biotinylation (see Fig.20+22). Barttin and inactive hClC-Ka are in the plasma 
membrane. Scale bar = 10 µm 
 
 
 
 
Fig.28 summarizes the results of tryptophan substitution in a topology model of barttin. White 
circles represent residues that result in fully functional barttin proteins after substitution to 
tryptophan. F24W and M26W barttin (dark grey circles) are misfolded or degraded and thus 
abolish hClC-Ka/barttin currents. Red circles mark mutants with an impaired chaperone 
function. S52W and Q55W are labeled in red and white for their ability to produce 
considerable current amplitudes through interaction with hClC-Ka, even though the 
interaction with the channel protein seems to be altered. Mutations that produce trafficking 
deficient barttins are displayed with green circles. Here again M40W is labeled green and 
white, since it allows some membrane insertion resulting in notable current amplitudes of 
hClC-Ka/barttin. The remaining residues that prevent hClC-Ka currents are labeled with 
yellow circles. Substitution of these residues by tryptophan is assumed to impair exclusively 
the gating of hClC-Ka. 
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Fig.28 Topology model of barttin and its functional determinants on hClC-Ka 
Two proposed transmembrane helices are illustrated by grey cylinders. Straight lines indicate the plasma membrane. 
N- and C-terminal of barttin are intracellular. By color coding residues, the effects on function are demonstrated. 
Residues marked in white can be substituted to tryptophan without any loss of function. F24 and M26 are needed for 
stability (dark grey). Residues 40, 41 and 45 are important for barttin trafficking (green). I12, G15, A20, G48, S52 and 
Q55 are needed for chaperone function (red). Residues marked in yellow avoid activation of hClC-Ka. 
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3.2 5B19BV166E rClC-K1 and the effects of barttin and barttin mutants 
 
3.2.1 29B43B arttin modifies gating of V166E rClC-K1  
 
rClC-K1 is the rodent ortholog of hClC-Ka. This channel is active even without barttin 
(Adachi et al. 1994, Kieferle et al. 1994, Uchida et al. 1996, Scholl et al. 2006). The mutation 
V166E introduces the so called ´gating glutamate´ that is lacking in ClC-K channels 
(Waldegger and Jentsch 2000). This mutation leads to prominent changes in gating behavior 
of the channel, especially in presence of barttin (Fischer et al. 2010). In whole cell patch 
clamp current recordings of HEK293T cells expressing V166E rClC-K1 without barttin, two 
gating processes can be seen (Fig.29 A). 
A fast gate opens at positive and closes at negative potentials. After a holding potential of 
0 mV, the fast gate closure at hyperpolarizing potentials is almost entirely masked by the slow 
gate that is closed at the holding potential. The slow gate opens at hyperpolarizing and closes 
at depolarizing potentials. To investigate gating properties of V166E rClC-K1, voltage steps 
between -155 and +125 mV were applied each followed by a test pulse to -125 mV. After a 
prepulse to -155 mV, voltage step to -125 mV illustrate both the fast and the slow gating 
process, since there is a fast activation followed by a slow deactivation (Fig.29A lower inset). 
Assuming that the two gates move independently, the two gating processes can be separated 
by introducing a short interpulse to +180 mV (5 msec) prior to the test pulse (upper inset 
Fig.29A). Such an interpulse opens the fast gate but leaves the slow gate nearly unaffected 
(Fischer et al. 2010). In this case, the instantaneous test pulse current amplitude is only 
dependent on the steady state slow gate open probability that has been reached during the long 
prepulses of varying potentials. Then, the open probability of the fast gate pfast gate can be 
calculated by dividing the total channel open probability pchannel by its slow gate open 
probability pslow gate (eq.3, material and methods). 
 
Fig.29C shows the activation curves of V166E rClC-K1 channels in absence of WT barttin 
depicting the described gating processes. Without barttin, V166E rClC-K1 activates 
bidirectionally. Boltzmann functions (eq.2 and 4) have been fit to the activation curves of the 
channel as well as to the slow and fast gate yielding values for V0.5, the voltage of half-
maximal activation, of -96.1 ± 3.4 mV for the entire channel, -105.5 ± 4.2 mV  for the slow 
gate and +67.7 ± 7.4 mV for the fast gate.  
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Fig.29 Whole cell patch clamp recordings of HEK293T cell expressing (A) V166E rCLC-K1 alone, or (B) together with WT 
barttin and corresponding activation curves (C+D) 
Without barttin, V166E rClC-K1 activates bidirectional with a fast opening at positive and a slow opening at negative potentials.  Both 
gating processes can be seen after a voltage jump from -155 mV to -125 mV (lower inset in A). The current amplitudes immediately after 
the voltage jump are plottet versus the voltage of the prepulse. Fitting procedure with Boltzmann functions leads to (C) relative open 
probabilities of the entire channel (p f+s). The relative open probability of the slow gate (p s) can be determined by the set of a short 
interpulse that entirely opens the fast gate (upper inset in A). The resulting current amplitude immediately after the voltage jump to -125 
mV is then only dependent on the prepulse initiated opening state of the slow gate. Plot of the current amplitude of the test pulse versus 
the voltage of the prepulse and normalization to the maximum of the Boltzmann fit results in p s. The relative open probability of the fast 
gate can be calculated by dividing p f+s by p s (see text and eq.3). Without barttin, the slow gate (grey circles) closes under depolarizing 
conditions. 
(B) Upon barttin binding, the channel mainly propagates a chloride inward current. Analog to A+C, voltage protocols (inset in B) and 
fitting procedures lead to (D) activation curves. The slow gate is set open over the whole measured voltage range. Barttin also shifts the 
activation curve of the fast gate to the left (light grey line in C and D).  
Data of activation curves are mean ± S.E.; n = 17 cells expressing channel only, n = 14 for cells coexpressing channel and WT barttin. 
 
 
WT barttin (Fig.29B+D) locks the slow gate to an open state (changes in relative open 
probability are less than 7 % over the measured voltage range) and changes the voltage 
dependence of fast gating. V166E rClC-K1/barttin is activated only monodirectionally with a 
V0.5 of +11.5 ± 1.1 mV, mainly depending on the fast gate activity. The changes in relative 
open probability of the slow gate are minimized with an unaltered V0.5 of -103.4 ± 7.4 mV. 
V0.5 of the fast gate activation dramatically shifts by about 60 mV to +7.4 ± 0.9 mV, a value 
that shows that the channel activity is mainly or only dependent on the fast gate activity.  
The fast gate activation is left-shifted and faster than without barttin. Current traces at +125 
mV can be fit with mono-exponential functions (eq.5) which results in values τ corresponding 
to the time course of activation. Without barttin we obtained a τ of 7.7 ± 1.5 ms which is 
shifted to +2.6 ± 0.2 ms in presence of barttin. 
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To sum up, WT barttin affects V166E rClC-K1 gating in several ways. The open probability 
of the slow gate is no longer voltage dependent and set to an open state. This and additional 
effects on fast gating were used as criteria to examine the interaction of V166E rClC-K1 with 
barttin mutants.  
 
 
3.2.2 30B44BMutant barttins interact with V166E rClC-K1 - and many alter the 
gating 
 
Fig. 30 and 31 show representative whole cell current recordings and activation curves of 
HEK293T cells co-expressing V166E rClC-K1 with barttin mutated within the first and 
second transmembrane helix, TM1 and TM2. Activation curves depict the voltage dependence 
of the channel (black circles) and the two gates (white triangles = fast gate, grey circles = 
slow gate). By color coding the letters, the here depicted current traces and activation curves 
measured with V166E rClC-K1 are compared with the results found for hClC-Ka (white = not 
affected, green = trafficking deficient barttin, red = partial loss of chaperone function, grey = 
degraded barttin, yellow = no activation of hClC-Ka). These two figures give a first overview 
of the effects of mutant barttins on the rodent channel homolog. Further analyses to quantify 
open probabilities, V0.5 and time constants of activation reveal deeper insights into functional 
determinants within the primary structure of barttin.  
 
Many mutations in TM1 of barttin lead to dysfunction of V166E rClC-K1/barttin channels. 
Since F24W and M26W barttin are degraded (Fig.18), V166E rClC-K1 currents and 
activation curves in presence of these mutants do not differ from measurements in absence of 
barttin.  
The rodent channel shows dramatically reduced current amplitudes in presence of I12W, 
G15W, F17W, L18W, A20W, L21W, G22W, T23W and L25W barttin. Since current 
amplitudes are smaller than in absence of barttin and time dependent gating is often 
diminished, there must be an interaction with inhibitory effect between these barttin mutants 
and the pore-forming subunit. Compared with the results found with hClC-Ka, chaperone-
function deficient barttin mutations I12W, G15W and A20W still allow interaction with 
V166E rClC-K1.  
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Fig.30 Representative whole cell current recordings of HEK293T cells coexpressing V166E rClC-K1 with barttins that were 
mutated within TM1 
Activation curves depict the voltage dependence of the channel modified by mentioned barttin, separated by gates. All hClC-Ka-activating 
barttin mutants (left in white) seem to regulate V166E rClC-K1 like WT barttin. In correspondence to the results with hClC-Ka, red boxes 
highlight residues with a reduction in chaperone function, grey boxes mark misfolded or degraded barttins whereas yellow marks illustrate 
gating deficient barttin mutants. All marked residues evoke altered regulation of V166E rClC-K1 as well. G10W, V13W and L14W 
barttin failed to open hClC-Ka, but the regulation of the rodent channel has tendencies to be like the regulation of WT barttin.  
-- Results -- 
 - 65 - 
  
 
 
Fig.31 Representative whole cell current recordings of HEK293T cells coexpressing V166E rClC-K1 with barttins that were 
mutated within TM2 
Activation curves depict the voltage dependence of the channel modified by mentioned barttin, separated by gates. Almost all hClC-Ka 
activating barttin mutants seem to regulate V166E rClC-K1 like WT barttin. Only A39W, M40W, G47W, I49W and Q55W barttin 
appear to evoke alternate gating of the rodent channel. None-hClC-Ka activating barttins (T36W, G41W, M44W, V45W, G48W and 
C54W barttin) also fail to regulate V166E rClC-K1 like WT barttin. The color code of the boxes is analog to Fig.30. 
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Voltage dependent gating over the entire measured voltage range can only be seen for seven 
barttin mutants (I9W, G10W, F11W, V13W, L14W, L16W and L19W barttin). Of those, 
I9W, F11W, L16W and L19W barttin also activate hClC-Ka. However, gating of V166E 
rClC-K1 seems to be altered with I9W barttin that provokes currents like G10W, V13W and 
L14W barttin. These barttins do not lock the slow gate to an open state over the measured 
voltage range and/or they exhibit altered fast gate regulation.  
 
Substitution of amino acids of TM2 left the function of barttin often unaltered. At first sight, 
barttin function is conserved for mutations G35W, F37W, Y38W, S42W, V43W, I46W, 
I50W, S52W and M53W. All barttins evoke currents with clear gating at negative and 
positive potentials. Upon coexpression with T36W, M40W, G41W, M44W, V45W and 
G48W barttin, time dependent current relaxations are similar to V166E rClC-K1 in absence of 
barttin. Of those mutants, only M40W barttin activates hClC-Ka.  A39W, G47W, I49W, 
C54W and Q55W barttin do not entirely open the slow gate, as seen by activation at negative 
potentials. Of those, only C54W barttin fails to activate hClC-Ka.  
 
3.2.3 31B45BHelix 1 is necessary for channel activation 
 
Fig.32 compares mean steady state current amplitudes at +125 mV and -155 mV. Such a plot 
illustrates that the channel without barttin (V166E) mainly conducts at negative potentials, 
and that WT barttin (WT) inverts the voltage dependence of gating. Additionally, this figure 
shows the dramatically reduced mean current amplitudes evoked by many mutations, 
especially within TM1. 
 
Fig.32 Comparison of steady state mean macroscopic current amplitudes at -155 mV and 125 mV of HEK293T cells 
coexpressing V166E rClC-K1 and barttin 
Variations in current amplitude are often observed, as indicated with asterisks (student´s t-test versus WT). At positive range, most 
often, a reduction in current amplitude is recorded. Especially mutations within helix 1 have dramatic effects on channel activation. 
At negative range, an increase in current amplitude corresponds to slow gate opening. By color-coding the letters (legend in box), 
the results of both channel orthologs can be compared. All data are mean ± s.e.; n ≥ 4 (* p<0.05, ** p<0.01, *** p<0.001). 
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Residues whose substitution to tryptophan lead to barttin degradation or gating (grey letters), 
trafficking (green) or chaperone function deficiency (red) for hClC-Ka (see box in Fig.32) all 
cause altered gating of V166E rClC-K1. Regarding the red labeled residues, there is no doubt 
about their interaction with V166E rClC-K1. The activation of the rodent channel homolog is 
hindered over nearly the entire measured voltage range coexpressed with I12W, G15W and 
A20W barttin. If these barttins did not interact with the channel, macroscopic currents like the 
ones seen in absence of barttin would be expected. G48W, S52W and Q55W barttin clearly 
bind to the channel, as shown by the stronger activation at positive than at negative potentials. 
The results for barttin mutants that failed to activate hClC-Ka (yellow letters) are divers, but 
all seem to interact with V166E rClC-K1, as shown by gating regulation (G10W, V13W, 
L14W, and C54W barttin) or low mean current amplitudes (F17W, L18W, A20W, L21W, 
G22W, T23W and L25W barttin). T36W and M44W barttin seem to interact, too, as they 
evoke strong activation of the channel at positive potentials. 
The absolute values of mean current amplitudes are not sufficient to describe the effect of 
tryptophan insertion on gating. For example, L19W barttin exhibits small current amplitudes, 
but modifies channel gating like WT barttin. In contrast, L14W barttin evoke large currents at 
positive potentials, but the slow gate is not set to an open state over the entire voltage range as 
seen at negative potentials. We therefore analyzed the regulation of gating in more detail. 
 
 
3.2.4 32B46BFunctional determinants important for slow gating of V166E 
rClC-K1 
 
The voltage dependence of relative slow gate open probabilities was fit with Boltzmann 
functions. From theses functions, the minimal and maximal relative open probabilities were 
obtained. We display the range of voltage dependent changes (Fig.33) by calculating the 
difference between the minimal and maximal open probabilities (Δpopen). For some mutants, 
the fitting procedure was not reliable (I12W, L21W, G22W, T23W). In this case we simply 
subtracted minimal and maximal values of open probabilities obtained in the voltage range 
between -155 mV and +125 mV. Blue and black colored bars represent barttin mutations that 
significantly differ in their slow gate activation of V166E rClC-K1 from WT barttin. When 
slow gate activation is additionally not distinguishable from V166E rClC-K1 in absence of 
barttin, bars are labeled in black. These mutants are either misfolded or degraded (F24W, 
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M26W) or lost the capability of slow gate regulation (T36W, G41W and M44W). It appears 
as if they can no longer bind to the channel or fail to regulate its gating. White bars represent 
mutations that similarly activate the slow gate as WT barttin. Letters of the residues have been 
color-coded to compare the results with the effects on hClC-Ka.  
 
 
 
The results for the two channels superimpose almost perfectly. hClC-Ka activating mutations 
behave like WT barttin on V166E rClC-K1 as well. Exceptions are I9W, A39W and G47W 
barttin that do not completely open the slow gate in V166E-rClC-K1, but activate hClC-Ka. 
Barttins that do not appropriately regulate hClC-Ka (marked in colored letters) also exhibit a 
deficient slow gate regulation in V166E rClC-K1.  
S52W barttin completely opens the slow gate of V166E rClC-K1, despite showing the biggest 
defect in chaperone function on hClC-Ka. All other chaperone function reducing mutations 
(red letters in Fig.33) modify slow gating of V166E rClC-K1, hence not like WT barttin. This 
indicates again that the interaction of these barttins with the α-subunit (rodent and human 
version) is not completely inhibited. 
 
The analysis of the changes of the relative slow gate open probability demonstrates that 
almost the entire first helix is needed for accurate slow gating, although the activation curves 
are often hard to evaluate. Only for three mutants the function could be conserved. In contrast 
to TM1, TM2 again is more resistant to mutations.  However, T36, G41 and M44 seem to be 
crucial for slow gating. Upon substitution to tryptophan, coexpression of one of these barttin 
mutants results in slow gate regulation of V166E rClC-K1 as if no barttin is present. 
 
 
Fig.33 Changes in relative open probabilities of the slow gate  
Mutants marked with black bars have no effect on the slow gate, while white marked residues behave like WT barttin. Blue marked 
residues show significant differences to V166E and WT (channel alone or in presence of WT barttin). Mutants marked with asterisks 
exhibit significant differences to values found in presence of WT barttin. All data are mean ± s.e.; n ≥ 4 (* p<0.05, ** p<0.01, *** 
p<0.001). Color-code of the letters compares the results with the results found with hClC-Ka.  
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3.2.5 33B47BMany mutant barttins lower minimal fast gate open probability 
 
We used the same fitting procedure to determine voltage-dependent changes in relative open 
probabilities of the fast gate (Δpopen). Results are shown as bar charts in Fig.34. Again, white 
bars represent substitutions which conserve the function of barttin and blue bars represent 
barttin mutations that lead to significant differences in fast gate regulation compared with WT 
barttin or barttinless channels while black bars indicate that no difference to fast gate 
regulation in absence of barttin is recorded. Many fast gate activation curves cannot be fit 
with Boltzmann functions (I12W, G15W, F17W, L18W, A20W, L21W, G22W, T23W and 
L25W), because of low current amplitudes and lack of gating. In these cases, the difference 
between minimal and maximal values obtained between -155 mV and +125 mV were 
calculated. All of these barttins evoke changes in relative fast gate open probability 
comparable to V166E rClC-K1 without barttin (black bars) or even below (grey bars, I12W 
and L21W barttin) values observed when no barttin is present.  
 
 
Compared with the mean current amplitudes and slow gate activation curves (Fig. 32 and 30), 
it gets obvious that all of these nine barttin mutants keep the fast gate in an almost closed state 
at negative potentials. Hardly any gating – activation or deactivation – is seen after a voltage 
step from 0 mV to -155 mV. But at this voltage the slow gate has its highest open probability, 
as shown in the activation curves in Fig.30+31. Only tiny instantaneous and steady state 
currents are observed. Upon depolarizing voltage steps to +125 mV, most often a fast 
activation is recorded. However, the slow gate open probability is even lower. So, the slow 
gate cannot be the reason for missing currents at negative potentials. We assume that the fast 
gate of V166E rClC-K1 is kept closed over almost the entire measured voltage range when 
Fig.34 Changes in relative open probabilities of the fast gate  
Mutants marked with black bars have no effect on the fast gate, while white marked residues behave like WT barttin. Blue marked 
residues raise the minimal fast gate open probability. Residues marked with grey bars hardly show any fast gating. Asterisks indicate 
significant differences to WT barttin. All data are mean ± s.e.; n ≥ 4 (* p<0.05, ** p<0.01, *** p<0.001). The color-code of the 
letters compares the results with those found with hClC-Ka.  
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one of the mentioned barttins is present. This group of fast gate closing mutants includes three 
barttin mutants that were reported to be chaperone-function deficient (I12W, G15W and 
A20W barttin). This discrepancy of results – missing interaction with hClC-Ka and 
interaction with V166E rClC-K1 - may be either explained by the fact that the human and the 
rodent channel are regulated in different ways or by the different expression systems. 
However, these results may be also explained by similarities. There is no entire loss-of-
chaperone function, but only a partial and the few channels that are in the plasma membrane 
are closed by these three chaperone-function deficient barttins. 
Coexpressing two of the three other chaperone-function deficient barttin mutants with V166E 
rClC-K1 also suggests the mentioned partial loss-of-chaperone function. Fast gating can be 
observed over the measured voltage range. Whereas S52W and Q55W barttin regulate the fast 
gate almost like WT barttin, G48W barttin has no influence on fast gating. Only for G48W 
barttin, the observed gating of V166E rClC-K1 can be explained with missing interaction. 
 
All barttin mutants that exhibit altered regulation of hClC-Ka do not regulate the fast gate of 
the rodent channel in WT barttin like fashion. But in contrast to slow gate regulation, more 
hClC-Ka activating mutants fail to regulate the fast gate of the rodent homolog in appropriate 
way (F11W, I46W, I50W, S52W and M53W barttin). As shown in the next two passages, 
there are more barttin mutants that slightly but significantly alter properties of only the fast 
gate. All of these barttins are subsequently summed in a table (Tab.16). 
 
In summary, TM1 is crucial for fast gating. Binding to the rodent channel is never inhibited 
by a substitution of a amino acid of TM1 to tryptophan. But regulation of fast gating is 
conserved only for two mutations (L16W and L19W). Upon coexpression with I9W, G10W, 
F11W, V13W and L14W barttin channel activation over the measured voltage range is 
observed, in contrast to the rest of TM1 tryptophan substitutions. Many substitutions to 
tryptophan within TM1 lead to a closure of the channel, probably because the fast gate 
remains closed over almost the entire measured voltage range. For substitutions within TM1, 
hClC-Ka activation could only be recorded with I9W, F11W, L16W and L19W barttin.  
Fewer mutations within TM2 than within TM1 hinder fast gate regulation. Eight mutations do 
not change fast gate regulation compared to WT barttin. For T36W, G41W, M44W and 
G48W barttin, the activation curves of the fast gate could be fit with Boltzmann functions, but 
the fast gate of V166E rClC-K1 is regulated as if no barttin is present. So, binding of these 
barttins to the rodent channel cannot be prompted with instance. Low expressing M40W and 
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Fig.35 Effect of barttin mutation on activation of the slow and the fast gate 
V0.5 of the slow gate is never shifted. Mutants marked with black bars have no effect on the fast gate, while white marked residues 
behave like WT barttin. Blue marked residues shift the fast gate in none WT barttin-like fashion. V0.5 could not be determined for 
mutations marked with n.d.. = not determinable. Asterisks indicate significant differences to WT barttin. All data are mean ± s.e.; n ≥ 
4 (* p<0.05, ** p<0.01, *** p<0.001). The color-code of the letters compares the results with those found with hClC-Ka. 
V45W barttin raise the changes in fast gate open probability compared to channels without 
barttin. Same holds true for I46W, G47W, I50W, S52W, M53W, C54W and Q55W barttin, 
but the macroscopic currents only show little, but significant changes, when compared to 
those in presence of WT barttin. Of these mentioned substitutions in TM2, T36W, G41W, 
M44W, V45W, G48W and C54W barttin fail to activate hClC-Ka. 
 
 
3.2.6 34B48BMany mutations of barttin vary the voltage dependence of the fast, 
but not of the slow gate of V166E rClC-K1 
 
WT barttin not only modifies the minimal and maximal open probabilities of V166E 
rClC-K1, but also shifts the activation curve of the fast gate. We fitted the fast and slow gate 
activation curves with Boltzmann functions (eq.2+4) and determined the voltage of half-
maximal activation V0.5. WT Barttin shifts the activation curve of the fast gate to a voltage 
close to the reversal potential (+67.7 ± 7.4 mV without and +7.4 ± 0.9 mV with barttin), while 
V0.5 of the slow gate remains unchanged (around -104 mV with and without barttin). Fig.35 
sums the effects of mutant barttins on V0.5 of the fast and slow gate in bar charts. The color 
code is identical to the previous figures. For nine mutants V0.5 of the fast gate could not be 
determined (n.d.). Low current amplitudes and lack of gating avoided fitting procedure. These 
mutants were shown to prevent fast deactivation at negative potentials. Some of them allow 
fast gate activation at very positive potentials. Within TM2 of barttin, T36 and the center of 
the helix, especially M44, seem to be essential for the voltage dependence of fast gating.  
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The mutant barttins earlier claimed to exhibit only small changes in relative open probabilities 
of the fast gate (I46W, I50W, S52W, M53W, C54W and Q55W barttin) do not show 
significant differences in respect to the shift of the activation curve. Therefore, the role of 
these residues in fast gate regulation is a minor one. Same could hold true for I9W, G10W, 
F11W and V13W barttin as well. V0.5 of the fast gate is shifted to a level obtained with WT 
barttin. But the earlier unsuspicious mutants S42W and I49W barttin, now exhibit a slight, but 
significant rightward-shift of V0.5. Of these twelve barttins mentioned above, only G10W, 
V13W and C54W barttin fail to activate hClC-Ka. All other none-activating barttin mutants 
do not regulate the fast gate of V166E rClC-K1 like WT barttin. The role of G47W barttin is 
not clear. This barttin exhibit altered slow and fast gating of V166E rClC-K1, but activates 
hClC-Ka. 
 
 
 
 
3.2.7 35B49BSummary: Topology models of the effects of substitution on V166E 
rClC-K1 and hClC-Ka 
 
In two topology models (Fig.36), the results of mutant barttins on hClC-Ka (A) and gating 
regulation of V166E rClC-K1 (B) are summarized. White circles represent barttin mutants 
that behave like WT barttin and black circles represent degraded or misfolded barttin mutants 
in both models. The model on the left hand side comprises effects on hClC-Ka. Red circles 
represent barttin mutants with deficits in chaperone-function and green circles indicate 
trafficking deficiency. Orange circles group barttins that fail to activate hClC-Ka for unknown 
reason. We presume impaired gating properties; however we cannot distinguish between 
effects on slow or fast gate regulation of hClC-Ka.  
In the model on the right hand side, displaying the effects on V166E rClC-K1, grey circles 
represent barttins that are non-functional. They do not show any effect on the channel. Dark 
blue circles represent residues that keep the fast gate almost closed over the entire voltage 
range and light blue circles indicate residues which evoke altered slow and fast gating. Yellow 
marked residues evoke marginal, but significant differences in fast gating, only. A39W barttin 
is the only mutant that solely alters slow gate regulation (red circle).  
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A      B 
 
Within TM1, two mutations left barttin function unaltered with hClC-Ka and V166E rClC-K1 
(L16W and L19W). Two barttins are degraded or misfolded (F24W and M26W).  The other 
barttin mutations within the first helix can be divided into two bigger groups. Mutants that 
activate V166E rClC-K1 (I9W, G10W, F11W, V13W and L14W; only I9W and F11W 
activate hClC-Ka) and mutants that keep the rodent and human channel closed over almost 
the entire voltage range (I12W, G15W, F17W, L18W, A20W, L21W, G22W, T23W and 
L25W).  
Helix two is more resistant to tryptophan substitution. Tryptophan replacing G35, F37, Y38 or 
V43 leaves the function of barttin on both types of ClC channel unchanged. A39W barttin 
only fails to lock the slow gate of V166E rClC-K1 into an open state, whereas the fast gate is 
regulated in WT barttin like fashion. It insignificantly decreases the current amplitude of 
hClC-Ka, presumably caused by reduced expression. Gating of hClC-Ka seems to be 
unaffected.  
All results of co-expressed ClC-K1/barttin mutation T36W and M44W are comparable to 
those when no barttin is present. Residues marked in blue (M40W, G41W, V45W, G47W, 
G48W, C54W and Q55W) alter slow and fast gating, but at different degrees. While the 
macroscopic currents of G47W, C54W and Q55W barttin coexpressed with V166E rClC-K1 
look similar to WT barttin, macroscopic currents evoked by M40W, G41W, V45W and 
G48W barttin hardly show differences to the ones in absence of barttin.  
Fig.36 Topology models of barttin and the effects of substituted residues on the hClC-Ka (left) or V166E rClC-K1 (right) 
Different effects caused by the substitution of an amino acid within the two transmembrane helices to tryptophan were observed. 
Color-coding the residues illustrate these effects as indicated. 
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The group labeled in light blue is quite inhomogeneous. Both gates of the channel are 
modified by the marked barttins, but the degree of functionality differs a lot, as shown in 
Tab.15.  
 
 
Significant changes to the results found for WT barttin are highlighted in grey. While for 
example G10W, V13W or Q55W barttin almost appear to act as WT barttin, other barttins in 
this group appear to have lost almost the entire functionality, like for example, M40W, G41W 
or G48W barttin. Fast gate regulation evoked by I9W barttin is comparable to the ones 
observed with G10W or V13W barttin. But I9W barttin even has a lower impact on the slow 
gate than the two other mentioned barttins. However, I9W barttin activates hClC-Ka. 
Compared with the results for hClC-Ka activation, it cannot be stated whether the slow or the 
fast gate regulation is essential for the activation of the human channel homolog.  
 
This becomes even more obvious when comparing these results with those barttins that 
change the regulation of only one gate (Tab.16). The slow gate regulation of A39W barttin is 
hindered and comparable to the one of I9W barttin. Both barttins activate hClC-Ka in contrast 
to G10W, V13W or L14W barttin that have stronger effect on the slow gate. So, proper fast 
gate and aggravated slow gate regulation is no hindrance for hClC-Ka activation. 
 
 
 
 Δ popen slow gate (%) Δ popen fast gate (%) V0.5 fast gate (mV) τ fast gate (ms) 
V166E rClC-K1 84.7 46.0 67.7 7.7 
WT barttin 6.9  81.5 7.4 2.4 
I9W barttin 31.7 61.4 10.7 3.7 
G10W barttin 16.3 60.0 10.6 5.3 
V13W barttin 19.1 66.6 1.7 4.1 
L14W barttin 21.3 58.1 36.1 4.8 
M40W barttin 45.1 57.8 21.1 3.3 
G41W barttin 89.1 49.3 34.0 8.2 
V45W barttin 38.8 60.6 19.0 2.8 
G47W barttin 29.9 69.9 20.3 4.5 
G48W barttin 52.7 48.1 39.5 6.6 
C54W barttin 21.9 72.2 10.2 3.9 
Q55W barttin 14.7 71.8 8.5 5.3 
Tab.15 Comparison of WT barttin and barttin mutants that alter slow and fast gate regulation 
Changes in relative open probabilities of the fast and slow gate are shown together with V0.5 of the fast gate the time constant of fast 
gate activation at +125 mV. Barttins written in italic letters cannot activate hClC-Ka while the others can. I9W barttin has a lower 
impact on slow gating than G10W, V13W or L14W barttin while fast gate regulation of I9W and the non-hClC-Ka-activating barttin 
mutants are comparable. Different regulation of hClC-Ka and V166E rClC-K1 is likely to be caused by different structure of the 
channel proteins at opposing positions. Same could hold true for G47W barttin as well. 
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S42W, I46W, I49W, I50W, S52W and M53W change only fast gate properties of V166E 
rClC-K1. For four of them (I46W, I49W, I50W, S52W), the expression is reduced. As shown 
in Tab. 16, the changes compared to the values found for WT barttin are very small. Thus, it 
is not surprising that these six mutants regulate hClC-Ka channels like WT barttin.  
 
These tables show that the deviations especially in appropriate fast gating are moderate for 
some mutations. Neglecting the minor changes of yellow labeled residues in Fig. 36B, the two 
topology models would superimpose almost perfectly. Exceptions are I9W, A39W and G47W 
barttin that activate hClC-Ka, but exhibit altered gating of V166E rClC-K1. 
 
  
 Δ popen slow gate (%) Δ popen fast gate (%) V0.5 fast gate (mV) τ fast gate (ms) 
V166E rClC-K1 84.7 46.0 67.7 7.7 
WT barttin 6.9  81.5 7.4 2.4 
F11W barttin 15.0 68.7 7.1 2.9 
S42W barttin 5.9 80.5 15.0 3.2 
I46W barttin 11.8 75.5 7.3 2.3 
I49W barttin 11.7 76.1 18.7 3.2 
I50W barttin 9.9 69.8 5.6 6.4 
S52W barttin 14.9 67.2 14.0 4.2 
M53W barttin 13.5 72.2 7.0 4.5 
A39W barttin 26.1 72.2 15.4 2.6 
Tab.16 Comparison of WT barttin and barttin mutants that alter regulation of only one gate 
Changes in relative open probabilities of the fast and slow gate are shown together with V0.5 of the fast gate the time constant of 
activation at +125 mV. Significant deviations to the values found with WT barttin are marked in grey. All of the here shown barttins 
activate hClC-Ka. A39W is the only mutation that solely changes slow gate regulation. The macroscopic currents of V166E rClC-K1 in 
presence of the other denoted barttins appear like the ones recorded in presence of WT barttin. However, fast gate properties are 
changed. Comparison of the values for Δ popen fast gate and V0.5 fast gate measured for A39W barttin with the other barttins in this table 
emphasize the mild effect on gating regulation.  
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4 8BDiscussion 
4.1 6B20BEffects of point mutations 
 
In this study we investigated the interaction of ClC-K channels with their accessory subunit 
barttin that effects channel trafficking and gating. Using a systematic tryptophan scanning 
mutagenesis, we analyzed the impact of every single amino acid of the first and second 
transmembrane helix of barttin (TM1 and TM2) on channel function. By this methodology we 
presumed to find a small number of amino acids in the barttin protein that represent essential 
sites for binding to the alpha subunits of the channel protein. However, an unexpected large 
number of point mutations altered the function of barttin, as shown in Fig. 36. We found 
couple of amino acids to be crucial for the stability, trafficking or chaperone function of 
barttin, as well as several residues that may play a major role in channel activation/gating 
regulation. While almost the entire TM1 mainly contributes to fast gate regulation, several 
amino acids of TM2 are needed for slow gating.  
 
Two residues at the extracellular ending of TM1 are crucial for the stability or structure of the 
protein. Upon substitutions F24W and M26W, barttin cannot be detected as full length 
protein. Degradation of all built proteins is demonstrated (Fig.18). As expected, coexpression 
of one of these barttins with hClC-Ka or V166E rClC-K1 did not modify channel properties. 
 
Whole cell current recordings of V166E rClC-K1 and hClC-Ka in presence of T36W or 
M44W barttin lead to macroscopic currents similar to those in absence of barttin. Binding 
between barttin and the channel subunit seems to be impaired at first glance. However, 
confocal images and moreover biotinylation assay impressively assure the interaction with 
hClC-Ka. These two residues then must be crucial for gating/activation of ClC-Ka. 
Co-expressed with V166E rClC-K1, there is no electrophysiological result that allows a 
statement on interaction. All evaluations of the macroscopic currents are similar to those 
when no barttin is present. However, gating and not interaction with V166E rClC-K1 and 
hClC-Ka seems to be hindered upon substitution of T36 or M44 to tryptophan. It is likely that 
these barttins loosely bind to both channel orthologs, but gating regulation is interfered. 
Confocal imaging and biotinylation assays of hClC-Ka co-expressed with these barttin allow 
clearer statements on the interaction. Preliminary data concerning the interaction with V166E 
rClC-K1 is shown in Fig.48 as supplemental data. The interaction is assumed according to 
-- Discussion -- 
 - 77 - 
confocal images. The chaperone function of barttin on V166E rClC-K1 seems to be conserved 
despite point mutations T36W or M44W within the structure of barttin. This indicates the 
necessity of these residues for channel gating. 
 
M40W, G41W and V45W barttin are poorly expressed and travel hardly to the plasma 
membrane (Fig. 22). Co-expressed with hClC-Ka, interaction of M40W barttin is 
demonstrated by channel activation (Fig.12 and 13). Co-expressed with V166E rClC-K1, 
patch clamp recordings show that all three barttins do interact with the channel and modify 
gating. It remains unclear whether the results found for G41W barttin are caused by the 
mutation or by the low expression of this barttin. For M40W and V45W barttin, it was shown 
that selected cells for patch clamp recordings had barttin in excess at the plasma membrane. 
With these barttins, the time constant of channel activation at +125 mV is the same as for WT 
barttin (Fig.41, supplemental data). Therefore, the observed changes in gating modification 
are caused by the mutation of barttin and are not artificial due to low expression and/or 
trafficking distortion.  
 
I12W, G15W, A20W, G48W, S52W and Q55W barttin evoked a significant reduction of 
channel protein in the plasma membrane, although trafficking of barttin itself is intact and 
barttin is expressed in such high levels that guarantee an excess of the subunit (Fig.20 and 
22). Therefore, they are good candidates to form the binding interface between barttin and 
hClC-Ka. However, interaction is not completely inhibited upon substitution of one amino 
acid to tryptophan. When compared to G35W barttin that is rather low expressed, but favors 
hClC-Ka trafficking (rel. insertion level of 80%, Fig.22), the S52W mutation clearly hinders 
the chaperone function of barttin. Nevertheless, patch clamp recordings and confocal images 
prove the interaction of S52W barttin and ClC-Ka channels in the plasma membrane. 
Compromising, a partial loss-of-function is assumed for S52W, but as consequence as well 
for I12W, G15W, A20W, G48W and Q55W barttin. These barttins all bring a comparable or 
even bigger fraction of hClC-Ka protein into the plasma membrane compared to S52W 
barttin. Therefore we assume interaction of all of these barttins with hClC-Ka, while only 
S52W and Q55W barttin can open the human channel. For some unknown reason, the 
trafficking of ClC-Ka is impaired when co-expressed with one of these six barttins. Probably, 
the binding affinity is reduced upon substitution of one of those residues. While these barttins 
traffic more or less regularly to the plasma membrane, the amount of channels in the 
cytoplasm is higher. But still, a couple of barttin bound channels are inserted into the plasma 
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membrane. These results fit to already published data. Riazuddin et al. (2009) showed that a 
point mutation I12T barttin allows activation of hClC-Ka/Kb, but trafficking is impaired. 
Substitution of I12 to bulky tryptophan instead of threonine may not only impair chaperone 
function, but also channel activation. Same may hold true for the other small amino acids 
G15, A20 and G48. As part of the binding interface, these residues are supposed to face 
towards the channel protein. Upon substitution to tryptophan, binding is aggravated, but not 
inhibited. However, a fine mechanism for channel activation is heavily disordered. 
It needs to be mentioned that in contrast to the patch clamp recordings, the experiments for 
surface membrane trafficking were performed with MDCKII cells which may have different 
regulation patterns.  
If trafficking and gating of the rodent channel homolog is regulated in similar ways like the 
human channel, patch clamp recordings with V166E rClC-K1 additionally contradict missing 
interaction. I12W, G15W and A20W barttin avoid channel activation over almost the entire 
measured voltage range. If they could not bind to V166E rClC-K1, macroscopic currents 
similar to those when no barttin is present are expected. However, each of these three 
mutations closes the channel.  
The three other chaperone-function deficient barttins also interact with the rodent channel 
homolog. For S52W and Q55W barttin, V0.5 of the fast gate and, in case of S52W barttin, as 
well Δ popen of the slow gate (Tab.15 and 16) is similar to the regulation of WT barttin. This 
only can be when barttin is in excess, and macroscopic currents are not a mixture of currents 
of barttin bound and unbound channels. For G48W barttin, the excessive binding of barttin to 
the channel protein in the plasma membrane cannot be assumed, although this barttin is 
sufficiently expressed and inserted into the surface membrane. But still, gating of the channel 
is influenced by G48W barttin, assuring that these two proteins bind to each other. 
The mutation G48W, as well as the other five mentioned mutations, obviously decreases the 
binding affinity to at least hClC-Ka. The changes in gating of V166E rClC-K1 may be again 
explained by a circumstance that several residues are needed for gating regulation. Binding 
still can occur, because probably several amino acids participate in binding to the channel, but 
proper gating of the channel needs the correct interplay of these residues. One single point 
mutation within TM1 or TM2 is not enough to prevent binding, but to impair gating.  
Concluding for these six barttin residues, we assume them to be part of the binding interface 
and they also participate in gating regulation. I12W, G15W and A20W barttin keep both 
channels closed, while S52W and Q55W barttin almost behave like WT barttin. The role of 
G48 on gating remains unsolved.  
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Many mutated barttins are still fully functional in regards of chaperone function, but fail to 
activate hClC-Ka. These residues are marked in orange in fig.36A. Most of them reside in 
TM1 and only a few in TM2. Due to different effects on V166E rClC-K1, these residues are 
divided into different groups - mutants that show no effect on V166E rClC-K1 (Fig. 36B, 
grey), mutants that close hClC-Ka and the fast gate of the rodent channel (dark blue), mutants 
with altered fast OR slow gating (yellow or red) and mutants with altered fast AND slow 
gating (light blue). The light blue group is the least homogeneous group. Some residues 
exhibit different function on hClC-Ka and V166E rClC-K1. These differences are probably 
due to different structures of the two orthologs, or, as shown in a recent study, 
post-translational modification of barttin plays a major role in hClC-Ka activation and V166E 
rClC-K1 gating regulation.  
Palmitoylation of barttin was shown to be important for channel regulation, especially for 
hClC-Ka activation (Steinke et al., unpublished data). C54 and C56 are the only cysteines that 
are palmitoylated within the primary structure of barttin. A double mutant C54S/C56S fails to 
activate hClC-Ka. Reduction in palmitoylation level is observed for the single mutants and is 
correlated with lower current amplitudes of hClC-Ka. The palmitoylation of barttin at C54 
and C56 is also reduced when G47 is substituted to arginine (Steinke et al., unpublished data). 
This dependence might contribute to the disease-causing effect of G47R barttin that reduces 
hClC-Ka/Kb currents (Janssen et al. 2009). It is possible that barttin with G47 substituted to 
tryptophan (G47W) is not properly palmitoylated as well. Current traces and open 
probabilities of V166E rClC-K1 coexpressed with G47R and G47W barttin appear similar 
and hClC-Ka is activated, but lower mean current amplitudes are evoked because of fewer 
active channels. C54W barttin abolishes hClC-Ka activation and this mutation does not fully 
open the slow gate of V166E rClC-K1 at positive potentials. This is likely to be caused by a 
reduction in palmitoylation level. Since acylation of tryptophan is impossible, only one 
palmitoylation site remains. In this study, bulky tryptophan at position 54 may hinder 
palmitoylation of C56, too.  
So far, barttin palmitoylation has not been explored when Q55, the residue in between the two 
palmitoylation sites, was mutated. When Q55 is substituted by bulky tryptophan, it is possible 
that palmitoylation of C54 and/or C56 is impaired, because recognition of the substrate by 
palmitate transferases might be hindered.  
G47W, C54W and Q55W most probable impair palmitoylation of barttin which is needed 
for hClC-Ka-activation and proper V166E rClC-K1 gating modulations thus explaining lower 
current amplitudes of hClC-Ka and altered gating of V166E rClC-K1. 
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Upon co-expression of F17W, L18W, L21W, G22W, T23W or L25W barttin with 
hClC-Ka, no channel activation could be recorded. These mutants are different from other 
mutations that fail to activate hClC-Ka, since the current amplitude remains small not only 
with the human, but also with the rodent channel homolog. Complexes are not retained in 
intracellular compartments as shown by biotinylation assays and confocal images. We assume 
a reduced open probability of human and rodent channel homolog when co-expressed with 
one of these barttin mutants.  
Despite the small current amplitudes, activation curves with V166E rClC-K1 could be 
determined providing unshifted slow gate activation curves. V0.5 of the fast gate could not be 
determined. Activation could only be seen at very positive potentials, indicating a rightward-
shift of the fast gate activation curve. The slow gate is not kept open over the measured 
voltage range. The fact that at negative potentials hardly any activation of the channel is 
recorded, although the activation curves indicate an opened slow gate, leads to the assumption 
that the fast gate open probability is low and voltage independent at negative potentials. An 
explanation might be a rightwardly shifted activation curve or a dramatically reduced absolute 
open probability. Noise measurements or single channel recordings would reveal deeper 
insights in the absolute open probabilities as well as the asymmetric use of anions could 
reveal additional information, too. 
I12W, G15W and A20W barttin exert similar effects on gating as the above described. 
Although they were already shown to be important for channel binding and trafficking, they 
play a role in gating regulation, too. If binding of these three barttins to V166E rClC-K1could 
not occur, currents similar to barttin-less channels are expected. 
If the closure of the fast gate was additionally mediated via parts of TM2, analog results 
would have been observed upon substitution of a residue of TM2 to tryptophan. This is not 
the case. Due to the similar effects on gating regulation, we assume direct binding of amino 
acids I12, G15, F17, L18, A20, L21, G22, T23 and L25 of TM1 to ClC-K which is crucial for 
the voltage dependence of the fast gate.  
 
In Fig. 36B, several residues marked in light blue alter fast and slow gate properties. These 
results are also listed in Tab. 15. The changes in function observed for G47W, C54W and 
Q55W barttin were already discussed as palmitoylation level dependent. M40W and V45W 
barttin were already discussed to be necessary mainly for slow gating. G41W barttin was 
shown to be low expressed and G48W barttin was shown to exhibit a partial loss-of-
chaperone function. Both mutations, G41W and G48W, could result in barttin-less channels in 
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the membrane and macroscopic currents that are a mixture of currents of barttin bound and 
unbound channels. 
Only four barttins remain unexplained in this group of light blue labeled barttins. Due to 
careful selection of patch clamped cells, a mixture of currents is not very likely for I9W, 
G10W, V13W and L14W barttin. More convincing, V0.5 of the fast gate activation of V166E 
rClC-K1 (Fig.35) contradicts a mixture of currents for three of these barttins. Besides, the 
expression level of all four is high enough to guarantee an excess of barttin (see. Fig.15 and 
21) and biotinylation assay reveals appropriate membrane insertion of these barttins and 
hClC-Ka (Fig.20). We therefore conclude that I9, G10, V13 but as well M40 and V45 exert 
an effect on gating. While the fast gate properties are almost similar to those observed in 
presence of WT barttin, the slow gate is not kept open at positive potentials. L14W barttin 
cause effects on gating of V166E rClC-K1 that could be the bridge to the effects observed for 
the mutants marked in dark blue as shown by the rightward-shift in fast gate activation 
(Fig.35). By listing these mutant barttins from the one that shows the biggest loss-of-function 
on slow gate regulation to the one which appears to reach almost the entire functionality of 
WT barttin (compare with Tab. 15), it gets obvious that the human and the rodent channel 
must be gated in different ways. In a row starting with M40W – V45W – I9W – L14W – 
V13W – G10W barttin, the latter three (and V45W) barttin do not activate hClC-Ka, although 
they nearly work like WT barttin on V166E rClC-K1. Different structures of the channels and 
therefore other regulatory mechanisms may be an explanation. But the different results found 
for hClC-Ka and V166E rClC-K1 can also be explained otherwise as described in following.  
Different post-translational modification may play a major role for the mentioned mutations 
within TM1. As shown in the work of Janssen et al. (2009), the disease-causing mutations 
R8L and G10S barttin evoke current traces and activation curves with V166E rClC-K1 similar 
to G47W/R or other palmitoylation aggravating barttin mutants (C54S or C56S, Steinke et al., 
unpublished data). And these macroscopic currents are similar to those measured with I9W, 
G10W, V13W and L14W barttin (Fig.30, Tab.15). However, Steinke et al. (unpublished data) 
found out that at least G10S is properly palmitoylated. Therefore, we assume this 
modification to take place for G10W barttin as well.  
If changes in gating are not caused by a reduction in palmitoylation level, the changes in 
gating behavior may be due to endogenous processes of the expression system. Co-expressed 
in Xenopus oocytes, mean current amplitudes of hClC-Kb in presence of G10S barttin are 
comparable to the ones evoked by WT barttin (Estévez et al. 2001), in contrast to the found 
results with the expression in human cell lines (Janssen et al. 2009). This discrepancy between 
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HEK293T cells and oocytes indicates that this residue G10 is somehow implicated in another 
mechanism crucial for channel regulation which may also play a role for the differences 
between the regulation of hClC-Ka and V166E rClC-K1. One may speculate that in only one 
of the two expression systems, a binding to another component or a protein modification is 
mediated via G10 and/or neighboring residues occurs. This indicates that G10 is facing away 
from the channel protein and contradicts a direct effect of G10 on gating. As mentioned 
before, binding probably occurs via amino acids I12 and G15, amongst others. In contrast to 
G10W, V13W and L14W barttin, I9W barttin still allows hClC-Ka activation because with 
this mutation, bulky tryptophan is too far away to sterically impair proper binding of I12 and 
G15.  
No matter if there is an additional binding partner or not, we conclude that the N-terminal 
region of TM1 is needed for the human channel activation. Binding is never inhibited upon 
mutations I9W, G10W, V13W or L14W barttin, but I9W barttin shows the biggest deficits in 
V166E rClC-K1 regulation although hClC-Ka is activated. We assume different regulation 
due to different structure or modification of the channels.   
Every third amino acid of an α-helix is supposed to face to the same side. Helix-helix 
interaction therefore may take place via every third amino acid of a helix. But here, almost 
every residue in TM1 seems to be essential for channel regulation. This implies that TM1 may 
have several docking stations within the ClC-K channel protein. 
 
F11W, S42W, I46W, I49W, I50W, S52W and M53W barttin are labeled in yellow in 
Fig.36B. These mutations evoke altered fast gating of V166E rClC-K1. Differences to WT 
and WT-like barttin mutations (L16W, L19W, G35W, F37W, Y38W and V43W) in concerns 
of V166E rClC-K1 regulation were only found for fast gate modulation. F11W, I46W, I50W, 
S52W and M53W barttin show significant changes in fast gate open probability, but changes 
still are bigger than 67 % (for WT barttin Δ popen   81%). Regarding the time constants of fast 
gate activation at hyperpolarization (Fig.41, supplemental data), only I50W, S52W and 
M53W slow down the gating kinetics. S42W and I49W barttin only shift V0.5 of the fast gate 
to more positive potentials compared to WT barttin. This shift in V0.5 is of significant 
difference, but not bigger than the one observed for other mutant barttins like L16W or 
A39W.  
All of those barttins activate hClC-Ka, indicating that these mutations do not influence the 
pore of the human channel ortholog. The rodent channel, however, needs the intracellular 
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orientated half of TM2 and F11 for fast gate regulation, but because of the small changes, the 
role of these residues for gating is a minor. 
 
A39W barttin is the only mutant that changes solely the regulation of the slow gate of the 
rodent channel (Fig.32+33 compared with Fig.34+35). The fast gate of V166E rClC-K1 is 
regulated in WT barttin fashion and hClC-Ka is activated. We therefore assume that proper 
slow gate activation is not the determining step in hClC-Ka activation. In addition to the 
results found for mutants that only alter the fast gate regulation, we can postulate that whether 
a inappropriate fast or slow gate regulation leads to impaired hClC-Ka activation, but the 
coordinated interplay of fast and slow gate is needed.  
A39W, M40W and V45W barttin change mainly the slow gate regulation of V166E rClC-K1. 
This and the previous passage clarified the need of TM2 for fast and slow gating of V166E 
rClC-K1, but the effect on fast gating remains rather small. 
 
 
4.2 7B21BHypothesis of binding 
 
As mentioned in the introduction, the N-terminus, the transmembrane core and a short stretch 
after the transmembrane helices (I72X barttin, Janssen et al. 2009) of barttin is expected to 
regulate gating. Substitution of an amino acid of the transmembrane core to tryptophan often 
leads to altered gating. Tajima et al. (2007) showed that barttin binds to the B- and the 
J-helices of rClC-K2. These aspects and following thoughts lead to a hypothesis how barttin 
may bind to ClC-K channels. 
 
The so-called gating glutamate is commonly accepted as the fast gate. In the crystal structure 
of EcClC (Fig.37), the B-helix of the channel is in close relationship of the gating glutamate 
E148. This residue is located at the beginning of the F-helix (Dutzler et al. 2003). A point 
mutation K231R ClC-1, corresponding to R147 in EcClC, leads to altered slow and fast 
gating (Fahlke et al. 1997, Gramkow et al., unpublished data). In ClC-5, corresponding 
residue (K210) is necessary for the selectivity of the pore (De Stefano et al. 2011). A recent 
study (Gradogna and Pusch 2013) has shown this residue in ClC-K channel (K165) to be 
sensitive to the extracellular pH.  
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In EcClC structure, the side chain of R147 is facing towards the B-helical residues D54 
(1.8 Å) and V57 (4.2 Å). The B-helix is a proposed barttin binding site (Tajima et al. 2007). 
F53 (3.4 Å) and again V57 (4.4 Å) may coordinate L139, a residue in the loop between the E- 
and the F-helix. Another B-helical residue is likely to influence the positioning of the F-helix. 
The distance V46 to I158 is only 3.6 Å.  
 
The B-helical residue D54 was shown to be essential for gating of ClC channels. In ClC-1, 
mutation of this residue to glycine (D136G) results in profound changes in the voltage 
dependence of gating (Fahlke et al. 1995). ClC-1 chloride channels usually show fast and 
slow gating as well. At hyperpolarizing potentials WT channels deactivate, but D136G 
hClC-1 activates without exhibition of fast gating processes. This underlines the importance 
of this aspartate residue for fast gate regulation. However, substitution of aspartate by 
asparagine (D54N) in EcClC does not affect transport function (Accardi et al. 2005). 
 
 
It was shown that many residues of TM1 of barttin keep the fast gate almost closed upon 
substitution to tryptophan. These results suggest that TM1 of barttin binds to the B-helix of 
the channel for fast gate regulation, because this domain is in close proximity to the proposed 
Fig.37 Pore-coordinating amino acids in EcClC and their proximity to the B-helix 
The outer (E148 via R147) chloride binding site is in close proximity to the B-helix that is assumed to bind barttin. Regulation of the 
selectivity filter via V46, F53, D54 and/or V57 is expected.  
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fast gate. Exchange of the B-helix probably introduces an additional fast gate (Fig.46, 
supplemental data), however the effect of barttin on the chimera ClC-2 with the B-Helix of 
ClC-K1 (Fig.47, supplemental data) could not be characterized in detail yet, and hence the 
here proposed regulation of fast gating by barttin. 
 
In following passage, a binding mechanism is proposed. TM1 of barttin is rich in leucines (I9, 
I12, L14, L16, L18, L19, L21 and L25). They could act as a leucine zipper. These residues are 
likely to form hydrophobic bonds with a partner protein (Kobe and Deisenhofer 1995A+B, 
Bornberg-Bauer et al. 1998), in this case ClC-K chloride channels. If overlapping heptad 
repeats of leucines or isoleucines are needed to form a leucine zipper, they are given as 
indicated in small letters in Tab.17 (9-16, 12-19, 14-21 and 18-25). Methionines, valines or 
phenylalanine may participate in such a binding domain as well (Gurezka and Langosch 
2001), thus enlarging this motif (11-18, 17-24, 19-26). The primary structure of TM1 of 
barttin is given in capital letters. Turquoise marks illustrate the high amount of unpolar amino 
acids. Besides one threonine and three small glycines, TM1 of barttin consists only of unpolar 
amino acids.  
 
 
IGFIVLGLFLLALGTFLM 
g.bc.e.gabc.e..abc 
 
 
 
Upon mutation of one of those residues of a possible leucine zipper, binding of barttin to the 
channel can still occur because many residues participate in binding, but the regulation of 
gating probably prerequisites exact interplay of many of these residues. Adaption of barttin to 
the channel protein seems to be very complex. 
 
On behalf of the α-subunit and within one of the proposed barttin binding sites (Tajima et al. 
2007), a leucine zipper may be indentified, as well, which is a prerequisite for dimerization of 
two helical structures. In Tab.18, this leucine zipper is indicated in small letters beyond the 
alignment of the B-helices of EcClC, ClC-Ka and ClC-K1. Different primary structure of the 
aligned B-helices of ClC-Ka and ClC-K1 are marked in grey and the proposed regulatory 
amino acids are marked in black. Outward facing residues within the structure of EcClC are 
marked in yellow. Beneath this alignment of the B-helix, barttin is aligned manually in 
regards of several aspects.  
Tab.17 TM1 of barttin and its unpolar residues 
Besides four amino acids, TM1 mainly consists of unpolar residues (turquoise 
marks). Amino acids of a possible leucine zipper (LZ) are indicated in small 
letters.  Overlapping heptad repeats of leucines, valins, isoleucines or 
phenylalanines are proposed to contribute to the formation of a LZ. 
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B-Helix 
      intracellular         extracellular 
 
Ec ClC (35) ILFMAAVVGTLVGLAAVAFDKGVAWLQNQRM 
 
ClC-Ka (49) DWYFLMTLGVLMALVSYAMNFAIGCVVRAHQ 
ClC-K1 (49) DWHFLVALGVLMALISYAMNFAIGRVVRAHK 
       gab.d.fga.cd...a.c.e..ab 
              ↕  ↕↕   ↕ ↕ ↕  ↕↕ 
  Barttin (9)           IGFIVLGLFLLALGTFLM 
              g.bcde.gabc.e..abc 
                     
 
 
 
 
 
The extracellular loop behind TM1 of barttin starts after M26. Regarding the crystal structure 
and the sequence of EcClC, the first extracellular amino acids after the B-helix may be the 
polar sequence NQR. TM1 of barttin and the B-helix of ClC-K channels are assumed to be 
oriented in parallel fashion because almost all point mutations evoke tremendous, but 
comparable effects on gating of ClC-K1/Ka. Therefore it is likely that the extracellular exit 
sites of the two binding partners reside, too. An additional assumption leads to the annealing 
of barttin to the B-helix in Tab. 18.  
Different regulation and missing activation of hClC-Ka co-expressed with G10W, V13W or 
L14W barttin is probably a result of deviating sequences of ClC-K channels and these three 
residues could oppose the B-helix (ClC-K) at positions 59, 62 and 63. In ClC-Ka, valine V63 
could oppose V13 of barttins primary structure, while in ClC-K1 an isoleucine I63 may be 
coordinated. Substitution of V13 to tryptophan may cause different effects on the channel due 
to the different lengths of the side chains of V/I63. Substitutions G10W or L14 may sterically 
impair the binding of V13.  
 
 
 
Closing speculations about the role of TM2 of barttin follow in this passage. Within TM2, 
three residues (A39, M40 and V45) were found to be important especially for slow gating. 
This regulation may take place via the J-helix of the channel, the second potential barttin 
binding site (Tajima et al. 2007). 
Tab.18 Alignment of B-helices of EcClC, ClC-Ka and ClC-K1 and residues proposed to build a leucine zipper 
Yellow marked indicate outward facing residues within the structure of EcClC. Grey marked illustrate different residues within 
ClC-Ka and ClC-K1. Black marks correspond to residues that may participate in gating regulation. In analogy to Tab.17, residues 
that may contribute to barttin binding via a leucine zipper are indicated with small letters. TM1 of barttin is aligned to the leucine 
zipper of the channel with respect of more assumptions (see text) with possible binding partners marked with arrows. Turquoise 
marks illustrate unpolar residues. 
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Fig.38 Pore-coordinating amino acids in EcClC and their proximity to the J-helix as well as the R-helix 
The inner (Y445 via L444) and central (F357 via I356) chloride binding site is in close proximity to the J-helix that is assumed to bind 
barttin. Regulation of the selectivity filter via F269, N270 and/or V273 is expected.  
In EcClC, Jayaram et al. (2008) assume that two gates of the Cl--pathway lay within the pore 
(E148 = Gluex and Y445 = Tyrc together with S107 = Serc). Fast and slow gate were stated to 
be independent (Accardi and Pusch, 2000), so these two gates of the chloride pathway are 
probably not the fast and the slow gate, although it is commonly accepted that E148 is the fast 
gate (Fahlke et al. 1997, Dutzler et al. 2003, Zuñiga et al. 2004, de Santiago et al. 2005) and 
that the C-terminus of the channel which is next to the Tyrc-bearing R-helix moves during 
slow gating (Bykova et al. 2006). Tyrc is a pore coordinating residue that may contribute as 
well to fast protopore gating together with E148. Further down the R-helix, another residue, 
threonine T452, was reported to participate in gating regulation (Wang et al. 2010, Chen et al. 
2003, Accardi and Pusch 2003). If barttin binds to the J-helix, additional positioning of the 
R-helix may be facilitated, leading to positional effects on the C-terminus and slow gate 
regulation. This positioning may take place via Q277 and R451, a J- and a R-helical residue 
which are 3.4 Å apart (not shown in Fig.38). 
 
 
 
The J-helix is in close proximity to the R-helix and another pore-coordinating residue (F357). 
Two residues of the J-helix, F269 and N270, are in close proximity to I356, respective L444, 
direct neighbors of pore coordinating F357 or Y445 (Fig.38). A third J-helical residue, V273, 
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is 4.3 Å away from I356 and only 3.4 Å away from L444. The J-helix may also play a role for 
the coordination of the central chloride binding site.  
 
Higher homology of the J-helix and only A39W and M40W barttin within TM2 that evoke 
different regulation of the two channels indicate a binding of TM2 to the J-helix, but still, it is 
not solved if one or more barttins bind to the channel protein. So, the orientation of barttin and 
the J-helix remain unclear. 
T36, A39, M40, G41, M44, V45 and G48 barttin probably bind to both observed ClC-K 
channel, but lost their capability to regulate gating. Possible mechanisms necessary for 
regulation could be phosphorylation of T36 (PKC), alkylation of M40 and M44, or H-bonds 
via glycines (Dong et al. 2012) G41 and G48 fitting in helix interstices.  
 
 
J-helix          
         extracellular               intracellular 
 
Ec ClC   (253) WLYLILGIIFGIFGPIFNKWVLGMQDLLHR 
ClC-Ka   (283) FFFVALGGICGVLSCAYLFCQRTFLSFIKT 
ClC-K1   (283) FFFVALGFICGVLSCAYLFCQRTFLRFIKT 
  
 
 
It remains unclear how barttin binds to the channel, and because of the unsolved binding 
stoichiometry further hypothesis of binding become even more speculative than the here 
proposed regulatory mechanisms within the channel structure. If one barttin is enough, which 
is not very likely, and TM1 is oriented almost parallel to the B-helix of the channel, and if 
both proposed barttin binding sites, the B- and the J-helix, are indeed bound by barttin, then 
the extracellular loop of barttin need to span over the channel protein because of the 
antiparallel orientation of the B- and the J-helices. Then, TM2 would cross the J-helix. This 
intra-protopore binding is illustrated in Fig. 39 A. In Fig. 39 B, a possibility of inter-dimer 
binding would be that the channels form a cluster with barttin as the glue. To occupy all 
binding domains of ClC-K, an excess of barttin must be guaranteed to satisfy the binding sites 
at the edges of the cluster. This could be the reason for the loss-of-function of the concatamer 
barttin/V166E rClC-K1.  
No matter if there is a 1:1 or higher stoichiometry, additional domains of the channel protein 
are likely to be under the control of barttin. ClC-K channels are complex glycosylated mainly 
Tab.19 Alignment of J-helices of EcClC, ClC-Ka and ClC-K1  
Yellow marked residues in the primary structure of EcClC are facing away of the core of the protopore and are therefore good 
candidates for barttin binding. Black marked residues are in close proximity to pore coordinating residues (compare with Fig.38). Grey 
marks illustrate different amino acids in ClC-Ka and ClC-K1.  
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in presence of barttin. Glycosylation site is the loop between the helices L and M (Estévez and 
Jentsch 2002). 
Furthermore, the loop between the D- and the E-helix and a di-leucine motif within the CBS-2 
domain were reported for ClC-2 and ClC-3 to be important for membrane targeting, 
respective sorting of the channel (Zhao et al. 2007, Cornejo et al. 2009). Adaptor proteins are 
known to regulate membrane trafficking and sorting of ClC-1 and ClC-2 (Stauber et al. 2010, 
Peña-Münzenmayer et al. 2005) and interestingly for a family member of one of these adaptor 
proteins (AP-1), the binding via a leucine zipper was published (Erlanson et al. 1996, Chytil 
et al. 1998). For ClC-K channels, these motifs may only be accessible in presence of barttin, 
as the membrane trafficking of the channel is dependent on the presence of the β-subunit and 
the basolateral orientation of the channel is dependent on the C-terminal of barttin (Janssen et 
al. 2009). 
 
 
 
 
 
A B 
Fig.39 two hypothetical binding possibilities of barttin to ClC-K channels  
A) intraprotopore binding of barttin (front: dark green; back: light green) to the B- (blue) and J-helix (orange) of ClC-K with a 1:1 
stoichiometry. Within one protopore, the short N-terminus of barttin resides in the intracellular compartment, TM1 crosses the 
membrane along the B-helix and the extracellular loop spans over the channel protein where TM2 crosses the J-helix and leaves the C-
terminus in the intracellular compartment. 
B) Scheme of clustered ClC-K channels with barttin bound between two channels. Two triangles with the barttin binding sites marked 
in blue (B-helix) and orange (J-helix) form the channel dimer. The triangle is completed by a black line corresponding to the protopore 
interface. One barttin molecule (two circles represent TM1 and TM2) could bind between two protopores of different channels and 
occupy both binding domains of the channel. An excess of barttin is needed to occupy the binding site at the border of the cluster. 
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4.3 8B22BConclusions 
 
The major findings of the here performed tryptophan scan are outlined in a topology model of 
barttin (Fig.40).  Yellow circles highlight residues that cannot activate hClC-Ka and keep the 
fast gate of V166E rClC-K1 almost closed over the measured voltage range. Residues marked 
in grey lost their gating capability. Blue represents barttin mutations that evoked altered 
function on the rodent and human channel (half of the circle marked in blue shows hClC-Ka 
activation) which is most likely explained by different structure of the binding interface on 
behalf of the channel protein.  
In regards of a better overview, the two barttin residues necessary for structure are no longer 
highlighted in color in Fig.40. As described, the mutations F24W and M26W interfere the 
building or the maintenance of barttin. Only misfolded or degraded barttin could be detected 
in SDS-PAGE gels. 
 
 
 
T36W, G41W and M44W barttin co-expressed with V166E rClC-K1 evoke relative slow gate 
open probabilities similar to those when no barttin is present and G48W barttin has only a 
minor impact on slow gating (Fig. 33),  but all four mutations still allow binding of barttin to 
Fig.40 Topology model of barttin with color-coded effects of tryptophan substitution 
The two proposed transmembrane helices of barttin are shown in grey cylinders. Regulatory residues within the secondary structure are 
marked yellow, grey or blue. Residues marked in grey regulate gating as if no barttin is present although the channel is brought to the 
membrane. Yellow marks represent residues that keep hClC-Ka and the fast gate of V166E rClC-K1 almost closed. Blue marked residues 
show different regulation of hClC-Ka and V166E rClC-K1, probably due to different channel structure. Circles marked half with blue 
indicate residues that activate hClC-Ka. 
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V166E rClC-K1. However, barttin excess at the plasma membrane could not be shown for 
G41W and G48W barttin. It was shown that T36W and M44W barttin bind to hClC-Ka as 
well. These two mutations lead to a loss-of-gating capability of barttin on both channel 
orthologs.  
 
We found several functional determinants within barttins structure. Many residues of TM1 
(I12, G15, F17, L18, A20, L21, G22, T23, L25) are crucial mainly for fast gate opening of 
V166E rClC-K1 and hClC-Ka activation (4.4.3). The fast gate remains closed over almost the 
entire voltage range.  
 
For I9W, G10W, V13W, L14W, A39W and M40W barttin, different regulation mechanisms 
on hClC-Ka and V166E rClC-K1 are observed. I9W, A39W and M40W barttin can activate 
hClC-Ka, but gating of V166E rClC-K1 is dramatically altered. G10W, V13W and L14W 
barttin cannot activate hClC-Ka, although gating of V166E rClC-K1 is not that severely 
impaired. It could not be determined whether accurate slow or fast gating is the essential 
regulatory mechanism needed for hClC-Ka-activation. Moreover coordinated interplay of the 
fast and the slow gate is needed. The different regulation of these residues is probably caused 
by different binding interface on the behalf of the channel.  
 
 
 
4.4 9B23BOutlook 
 
In this study, the binding interface could not be determined with instance. It appears as if 
many residues within barttins structure are needed to bind to ClC-K channel protein. So, a 
single point mutation did not prevent binding. But several functional residues have been 
found. However, the binding of two of the here investigated barttin mutants to the human 
channel remains unclear. Pull-down assays, high-resolution clear native gel electrophoresis 
and/or crosslinking strategies should be performed to clarify and characterize the eventual 
binding of G41W and G48W barttin to hClC-Ka.  
The binding of two other barttins to V166E rClC-K1 remained unclear. Biotinylation assays 
with cells co-expressing T36W or M44W barttin with V166E rClC-K1 should be performed, 
although confocal images already suggest their interaction.  
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The proposed binding interface of leucine-zipper-dimerization needs to be proven. 
Thermodynamic mutant cycles of TM1 and the B-helix of ClC-K chloride channels may 
provide additional information about interacting residues. The substitution of an unpolar by a 
charged residue within the B-helix of the channel may lead to changes in gating behavior or 
barttin binding that may be rescued by analog substitution of barttin within TM1.  
To answer the question of stoichiometry, LUX-FRET or TIRF microscopy could be the 
solution. In addition, the already measured concatamer barttin/V166E rClC-K1 could be 
linked with consecutive barttins. By whole cell patch clamp recordings, it should become 
obvious if a third, fourth or second barttin has no additional effect on gating of V166E 
rClC-K1. 
The N-terminal link of YFP to the concatamer barttin/V166E rClC-K1 leads to loss-of-
function, indicating the need of the N-terminal of barttin for gating regulation. Mass 
spectroscopy may confirm speculations on the modification of barttin in this or other regions. 
Deletion of the N-terminal and/or mutation of single amino acids could lead to new ideas of 
how this short sequence may regulate gating. It also needs to be shown that the concatamers 
are built in full length, but all attempts to pull-down or to immuno-detect the concatamer after 
western blotting were performed without success, so far. 
Single channel recordings of the chimera should be done to clarify the effect of the helix 
substitution on gating. The binding of WT barttin to the chimera ClC-2/B-helix of ClC-K1 
needs to be proven and characterized biochemically, too. Deeper insights in the signal 
transduction of barttin binding are expected.  
Further regulatory effects of barttin may allow better understanding of how barttin binds to 
the channel. As mentioned, the loop between the D- and the E-helix of ClC-2 chloride 
channels is necessary for membrane recycling (Cornejo et al. 2009), and the basolateral 
orientation of ClC-2 is mediated by the C-terminal of the channel (Peña-Münzenmayer et al. 
2005). Both tasks, membrane insertion and sorting, are fulfilled by barttin. Regulatory effects 
of barttin on corresponding regions in ClC-K need to be investigated.  
Besides the chaperone function, the glycosylation of the channel protein is barttin dependent. 
The effect of this modification is unknown at present. The glycosylated amino acid (in the 
loop between helices L and M, Estévez and Jentsch, 2002) may be under the influence of and 
therefore in spatial orientation to barttin as well. Another amino acid in ClC-Ka that may be 
influenced by barttin is K527 (K519 in ClC-0), a residue reported to be essential for channel 
activation (Wang et al. 2010). 
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A far away aim of this study is the generation of therapeutics for bartter syndrome type IV 
patients or the generation of new diuretics. Therefore, the binding of barttin and its regulatory 
effects on ClC-K channels need to be understood first. To regulate other close relatives of 
ClC-K, like ClC-1 or ClC-2, with modified barttins would furthermore enable us to eventually 
cure myotonia congenita or epilepsy. 
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Fig.41 Time constants of activation at 125 mV of all scanned barttin mutants 
Mutants marked with black bars evoked time constants similar to barttin-less channels, while white marked residues accelerate the 
fast gate in WT barttin like manner. Blue marked residues evoke time constants of activation in between the ones found for V166E 
rClC-K1 bound to WT- or no barttin. 
 
6 10BSupplemental data 
 
6.1 10B24BTime course of activation - many mutations slow down the fast 
gate kinetic 
 
The kinetics of activation of the fast gate of V166E rClC-K1 is changed by barttin. At 
+125 mV, WT barttin accelerates the time constant τ of activation of the fast gate from 
+7.7 ± 1.5 mV up to +2.6 ± 0.2 ms. Values for τ are given in bar charts in Fig.41 for all 
measured barttin mutants. Blue bars illustrate barttin mutants that show significant differences 
to values with and without WT barttin. Black bars correspond to time constants similar to 
those measured when no barttin is present. White bars show no difference to values found in 
presence of WT barttin. Color-coding the letters helps for comparison with results obtained on 
hClC-Ka. 
 
 
Except two, all mutants marked as functional deficient on hClC-Ka change fast gate kinetics. 
Surprisingly, low expressing M40W and V45W barttin are still able to accelerate the fast gate 
activation to values found with WT barttin, although they were additionally reported as 
trafficking and chaperone-function deficient. If only a portion of channels are bound by 
barttin, this would result in a mixture of currents, and as a consequence, a time constant that is 
in between the values found in presence and absence of barttin. Thus it is clear that these two 
barttins are in excess to the channel protein and nearly all channels are bound by barttin. 
 
The mutants that keep the fast gate close at hyperpolarizing condition all display time 
constants at +125 mV similar to the one found when no barttin is present. Same holds true for 
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T36W, G41W, M44W and G48W barttin – barttin mutants that do not affect open probability 
of the fast gate – but as well for hClC-Ka-activating and fast gate modifying G47W, I50W, 
M53W and Q55W barttin. I9W, S52W and C54W barttin slow down the fast gate to τ values 
significant different to the ones observed in presence or absence of WT barttin. I50W, S52W 
and M53W barttin evoke only altered fast gating as shown already by the analysis of the 
changes in relative open probabilities. 
 
 
 
6.2 11B25BConcatenated barttin/V166E rClC-K1 suggests a stoichiometry 
of barttin:protopore higher than 1:1 
 
 
Three barttin mutants express badly and hardly travel to the membrane. Macroscopic currents 
recorded with V166E rClC-K1 co-expressed with these barttins appear to be a mixture of 
barttin bound and unbound channels. We constructed concatenated proteins with WT, M40W, 
G41W or V45W barttin and V166E rClC-K1 in order to guarantee a 1:1 stoichiometry 
between barttin and the single protopore. 
 
Barttin was covalently fused to the N-terminus of V166E rClC-K1. Fig.42 shows 
representative whole cell patch clamp recordings of WT barttin coexpressed with V166E 
rClC-K1 (A, n=13) compared to the concatamer WT barttin/V166E-rClC-K1 (B, n=12) and 
the concatamer WT barttin/V166E rClC-K1 coexpressed with WT barttin (C, n=6) as 
indicated by topology models. When the concatamer was additionally labeled with YFP (D, 
n=7) at the N-terminal of barttin, channel function was altered. The currents diverge 
drastically from cells expressing concatamers containing WT barttin without YFP-label or 
from cells co-expressing WT barttin together with V166E rClC-K1. Most probable, the 
N-terminal of barttin has regulatory function on V166E rClC-K1, but due to the big 
fluorescence protein at the short N-terminal, this regulation can no longer take place. Please 
note that for tryptophan scanning analysis the fluorophore was generally added to the long 
C-terminus of barttin that had been shown to leave all barttin functions unchanged (Scholl et 
al. 2006). 
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Figs.42 E-G show representative current recordings of concatamers with mutant barttin. 
Fusion of M40W (n=5) or G41W barttin (n=4), as well as V45W (n=8) barttin to V166E 
rClC-K1 leads to impaired barttin function. Further analysis of relative open probabilities, 
V0.5 and kinetics reveal better insights in the regulatory capacity of the concatenated barttins. 
 
 
 
 
 
 
 
 
 
 
Fig. 42 Representative whole cell current recordings of HEK293T cells expressing (A) WT barttin and V166E rClC-K1, or 
concatenated (B) WT barttin/V166E rClC-K1, (C) WT barttin/V166E rClC-K1 together with additional WT barttin, (D) YFP-
WT barttin/V166E rClC-K1, (E) M40W barttin/V166E rClC-K1, (F) G41W barttin/V166E rClC-K1 and 
(G) V45W barttin/V166E rClC-K1 
The current traces of A, B and C look similar. N-terminally YFP-labeled concatamers exhibit impaired function. The concatamers built 
with mutant barttins all seem to have lost the functionality of barttin on the channel. The currents appear like the ones when no barttin is 
present. Further evaluations will show different results. 
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In Fig.43, I-V-plots emphazise the observations of the macroscopic currents. Normalizing 
steady state current amplitudes at -155 mV and comparing the I-V-plots of cells co-expressing 
WT barttin and V166E rClC-K1, they superimpose with the I-V-plot of cells expressing 
concatamers built with WT barttin. Additional barttin has no further effect.  
 
 
A                                                                 B 
 
 
 
The normalized I-V-plots illustrate that concatamers with mutant barttins appear to act as if 
no barttin is present. However, unpaired students´ t-test versus results found for channels 
without barttin reveals small, but significant differences (Fig.43 B, blue bars) in current 
amplitudes at +125 mV for concatamers built with M40W, G41W and V45W barttin. This 
indicates an interaction of these concatenated barttins with the channel protein. 
 
 
 
To validate this interaction, we next investigated the slow gate regulation. Activation curves 
are given in Fig.44A. Like before (see 3.2.4), changes in relative open probabilities were 
calculated and shown in Fig. 44B. 
Fig.43 Normalized I-V-plots illustrate impaired function of concatamers with mutant barttin 
(A) All I-V-plots were normalized to -155 mV. Red triangles represent the data of co-expressed WT barttin and 
V166E rClC-K1. This data superimpose with the data found for WT barttin concatenated to V166E rClC-K1. Black 
circles depict the I-V correlation of V166E rClC-K1 expressed in HEK293T cells.The data of concatamers built with 
mutant barttins (M40W, G41W, V45W barttin) superimpose almost entirely. (B) Comparison of relative current 
amplitudes at +125 mV. Asterisks indicate significant differences to cells coexpressing WT barttin and V166E rClC-
K1. A second students´ t-test versus values found for cells expressing only the channel protein results in color codes of 
the bars. Blue bars correspond to constructs exhibiting significant differences to the channel with or without WT 
barttin. White bars correspond to values found for the channel in presence of WT barttin. The mutant concatamers 
show a significant increase in relative mean current amplitude, indicating a weak, but existing interaction of these 
barttins with the channel.  
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Again, two students´ t-test were performed; once against the values found for cells co-
expressing WT barttin and V166E rClC-K1 (indicated with asterisks) and once against values 
found for cells only expressing V166E rClC-K1 (grey bars = no difference, blue bars = 
different to V166E rClC-K1 with and without barttin, white bars = different to V166E rClC-
K1 in absence of barttin). WT barttin concatenated to V166E rClC-K1 does not entirely lock 
the slow gate in an open state (A, green squares compared to red triangles). The difference in 
changes of rel. popen are small, but significant (B). Additional WT barttin restores this 
insufficiency (yellow diamonds). This indicates a higher stoichiometry than 1:1. 
 
A             B 
 
 
 
 
 
 
 
Concatamers with mutant barttin fail to open the slow gate at positive potentials. When co-
expressing V166E rClC-K1 with M40W or V45W barttin, changes in slow gating were 
observed (see Fig.33). These results could not be confirmed by the concatamers. Changes in 
the open probability of the slow gate are not different from those measured when only the 
channel protein is present. However, the concatamer G41W barttin-V166E rClC-K1 increases 
the relative open probability of the slow gate at +125 mV. This elevation is of significant 
difference compared to channels without barttin again indicating the interaction of both 
binding partners. 
 
Fig.44 Comparison of the effects of mutant concatamers on the slow gate of V166E rClC-K1 
(A) Activation curves of the slow gate of concatamers and V166E rClC-K1 in presence (red triangles) or absence (black 
circles) of WT barttin. The concatamers built with WT barttin fails to lock the slow gate into an open state over the 
measured voltage range (green squares). Additional WT barttin (yellow diamonds) restores this dysfunction. Mutant 
concatamers (blue pyramids, purple hexagons and light blue circles) act as if no barttin is present. In analogy to the 
evaluations in chapter 3.2.4, the activation curves are fit with Boltzmann functions and in (B), changes in relative open 
probabilities of the slow gate are compared. Two students´ t-tests were performed. Asterisks indicate differences to 
values found for cells co-expressing WT barttin with V166E rClC-K1. Black bars show no difference to cells expressing 
the channel only. Blue bars represent constructs which have an effect on the channel, but this effect is not like the one of 
WT barttin. White bars represent full functional constructs. The concatamers built with WT barttin and G41W barttin 
have an impact on the slow gate which is not like WT barttin. 
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Fast gate activation curves were treated as before (see 3.2.5). Changes in fast gate open 
probabilities were calculated and given in Fig.45. Again, two students´ t-test were performed. 
Significant differences to cells co-expressing WT barttin and V166E rClC-K1 are marked 
with asterisks. Significant differences to the channel alone are illustrated by blue and white 
bars, as before. Grey bars illustrate no significant difference to the channel alone.  
 
 
 
 
Experiments with co-expressing cells revealed that M40W and V45W barttin increase the 
changes in relative fast gate open probability (compared with Fig.34). Regarding the 
concatenated proteins, this holds true only for V45W barttin-V166E rClC-K1. And only this 
concatamer shows the tendencies for fast gate acceleration observed upon co-expression 
experiments, although tau does not reach the value found for WT barttin, like in earlier results 
(Fig. 45 B compared with Fig. 41). Another aspect of the fast gate evaluation is that kinetics 
of the concatamer WT barttin-V166E rClC-K1 is comparable to the results of coexpressed 
V166E rClC-K1 and WT barttin, but concatenated WT barttin-V166E rClC-K1 with 
additional barttin evoked slower time constants. This is in harsh contrast to the formerly 
observed restoration of function by additional barttin (compare with Fig. 44). 
 
 
 
 
 
 
Fig.45 (A) Changes in relative open probability of 
the fast gate and (B) time constants of activation at 
+125 mV of concatamers in comparison to cell 
expressing the channel only or co-expressing WT 
barttin 
Concatenated WT barttin does not show any 
differences in fast gate regulation regarding relative 
open probability or kinetics, compared to cells co-
expressing V166E rClC-K1 and WT barttin. In 
contrast, the results of concatenated mutant barttins 
do not confirm earlier results. In concatenated 
constructs, only V45W barttin seems to interact with 
the channel. Additional barttin expressed with the 
concatamer built with WT barttin slows down the fast 
gate for unknown reasons. 
   A        B 
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The macroscopic currents of V166E rClC-K1 that was N-terminally labeled with WT barttin 
are quite similar to those of cells co-expressing the channel and its subunit. The shown 
representative recording of the concatamer WT barttin/V166E rClC-K1 depicts a slow 
deactivation of the channel at positive potentials. Evaluations of concatamers reveal that the 
slow gate is not regulated like in co-expression experiments. A 1:1 stoichiometry is probably 
not enough to facilitate all barttin functions. Hence, 5 of 12 cells did not show any difference 
to the co-expression experiments.  
In addition, the results of the concatamers built with mutant barttin indicate that one barttin is 
not enough to facilitate all tasks. The results observed upon co-expressing M40W, G41W or 
V45W barttin with V166E rClC-K1 could not be confirmed by the corresponding 
concatamers, indicating a higher stoichiometry. Nevertheless, binding of these barttins even 
within the concatenated structure is assumed. 
N-terminal labeling of the concatamer barttin-V166E rClC-K1 with YFP leads to a loss-of-
function. The slow gate is no longer set to an open state over the measured voltage range. 
Obviously, YFP fusion to the N-terminus of barttin impairs barttin function. Loss-of-function 
of the YFP labeled concatamers emphasizes the necessity of the N-terminus of barttin for 
gating regulation. 
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6.3 12B26BChimeric channels reveal the B-helix to be essential for fast 
gating 
 
ClC-2 is the closest relative of ClC-K channels within the ClC-family. We used this channel 
to examine the binding of barttin to the B- and J-helices of ClC-K channels. In Fig. 46, two 
whole cell current recordings are shown. In A, current traces of ClC-2 show biphasic 
activation at negative potentials corresponding to the fast and the slow gate activation. ClC-2 
is an inward rectifier. The fast and the slow gate of ClC-2 were already reported to open under 
hyperpolarizing conditions (Garcia-Olivares et al. 2008). In B, current traces of a chimeric 
channel are given. For this construct, we used the backbone of ClC-2 and substituted the 
B-helix by the B-helix of rClC-K1. This substitution seems to introduce an additional fast gate 
that activates at positive potentials. 
 
 
 
 
 
 
 
 
Fig.46 Representative whole cell current recordings of HEK293T cells expressing A) hClC-2 or B) hClC-2 with B-helix of rClC-
K1 
Standard voltage protocols were run with a holding potential of 0 mV. Application of a test pulse to -125 mV reveals the opening state of 
the channels fast and slow gate due to the prepulses. (A) ClC-2 shows biphasic behavior. Magnification of the test pulse currents show a 
fast deactivation followed by slow activation coming from positive potentials. The fast gate is opened at positive potentials, in contrast to 
(B). Substitution of the B-helix leads to an inversion of the fast gate that is now opened at very negative potentials. 
-- Supplemental -- 
 - 112 - 
This experiment was planned to prove the binding of barttin to the B-helix. Co-expression of 
barttin reduces the mean current amplitude (Fig.47A+B) although more channels are built in 
presence of barttin (Fig.47C) and trafficking of barttin and chimeric channel seems to be not 
altered as shown by confocal images (Fig.47B). There may be some changes in the gating 
behavior of the chimer when barttin is present, but low current amplitude and moreover the 
unknown gating events of the chimer avoid further analysis of the gating events.  
 
 
Further constructs were built and measured. Another helix of rClC-K2 is reported to bind 
barttin, but substitution of the J-helix avoids macroscopic currents of chimeric channel with 
the backbone of hClC-2 or rClC-K1. Same holds true for chimeric channels in which the B- 
and the J-helices were swapped. 
Fig.47 (A) Mean current amplitudes and (B) representative whole cell current recordings of HEK293T cell expressing chimeric 
ClC-2 in presence and absence of barttin are compared with the expression level (C) and subcellular distribution (confocal 
images in B) 
The B-helix of ClC-2 was replaced by the B-helix of rClC-K1, a proposed binding site of barttin. Barttin reduces the mean current 
amplitude of the chimeric ClC-2, despite higher expression of the chimer in presence of barttin and despite appropriate membrane 
insertion of the channel (green) and barttin (blue).   
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6.4 13B27BPoint mutations T36W or M44W do not impair binding of barttin 
to V166E rClC-K1 
 
Macroscopic currents HEK293T cells co-expressing V166E rClC-K1 together with T36W or 
M44W barttin are alike the ones as if no barttin is present. Further analyses are needed to 
clarify the question if these barttins cannot bind to the channel protein, or if the missing gating 
alterations are caused by the introduced tryptophan. Confocal microscopy gives first insights.  
 
 
 
 
 
 
 
As shown by Scholl et al. (2006), when expressed without barttin, rClC-K1 mainly retains in 
intracellular compartments. In presence of barttin, the channel is taken to the membrane 
analog to hClC-Ka. In Fig.48, the chaperone function of barttin seems to be conserved for 
T36W and M44W barttin. Both binding partners, barttin and V166E rClC-K1, are 
predominantly expressed in the plasma membrane which lead to the assumption that both 
barttin mutants still can bind to the channel protein and the changes in gating behavior are in 
deed caused by the introduced point mutation.  
Additional quantification of the membrane insertion of the channel protein by biotinylation 
assays should be performed to validate this assumption. 
 
 
 
 
 
 
 
Fig.48 Confocal images of MDCKII cell co-expressing V166E rClC-K1 YFP (red) together with WT, T36W or M44W 
barttin mCFP (green) 
Without barttin, the channel remains mainly in the intracellular (Janssen et al. 2006). In the presence of barttin, ClC-K channels 
are taken to the membrane. This chaperone function is conserved upon barttin mutations T36W and M44W. Like with WT 
barttin, T36W and M44W barttin facilitate enhance membrane trafficking of the channel protein. Scale bar = 10 µm. 
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